id	sid	tid	token	lemma	pos
aiua-10710	1	1	stesura	stesura	PROPN
aiua-10710	1	2	seveso	seveso	NOUN
aiua-10710	1	3	319archivio	319archivio	PROPN
aiua-10710	1	4	italiano	italiano	NOUN
aiua-10710	1	5	di	di	NOUN
aiua-10710	1	6	urologia	urologia	PROPN
aiua-10710	1	7	e	e	PROPN
aiua-10710	1	8	andrologia	andrologia	PROPN
aiua-10710	1	9	2022	2022	NUM
aiua-10710	1	10	;	;	PUNCT
aiua-10710	1	11	94	94	NUM
aiua-10710	1	12	,	,	PUNCT
aiua-10710	1	13	3	3	NUM
aiua-10710	1	14	original	original	ADJ
aiua-10710	1	15	paper	paper	NOUN
aiua-10710	1	16	no	no	DET
aiua-10710	1	17	conflict	conflict	NOUN
aiua-10710	1	18	of	of	ADP
aiua-10710	1	19	interest	interest	NOUN
aiua-10710	1	20	declared	declare	VERB
aiua-10710	1	21	.	.	PUNCT
aiua-10710	2	1	remains	remain	VERB
aiua-10710	2	2	unclear	unclear	ADJ
aiua-10710	2	3	.	.	PUNCT
aiua-10710	3	1	the	the	DET
aiua-10710	3	2	most	most	ADV
aiua-10710	3	3	recognized	recognize	VERB
aiua-10710	3	4	theory	theory	NOUN
aiua-10710	3	5	is	be	AUX
aiua-10710	3	6	abnormal	abnormal	ADJ
aiua-10710	3	7	wound	wound	NOUN
aiua-10710	3	8	healing	healing	NOUN
aiua-10710	3	9	and	and	CCONJ
aiua-10710	3	10	aberrant	aberrant	ADJ
aiua-10710	3	11	fibrosis	fibrosis	NOUN
aiua-10710	3	12	following	follow	VERB
aiua-10710	3	13	minor	minor	ADJ
aiua-10710	3	14	trauma	trauma	NOUN
aiua-10710	3	15	to	to	ADP
aiua-10710	3	16	the	the	DET
aiua-10710	3	17	erected	erected	ADJ
aiua-10710	3	18	penis	penis	NOUN
aiua-10710	3	19	(	(	PUNCT
aiua-10710	3	20	4	4	NUM
aiua-10710	3	21	)	)	PUNCT
aiua-10710	3	22	.	.	PUNCT
aiua-10710	4	1	the	the	DET
aiua-10710	4	2	association	association	NOUN
aiua-10710	4	3	between	between	ADP
aiua-10710	4	4	pd	pd	PROPN
aiua-10710	4	5	and	and	CCONJ
aiua-10710	4	6	dupuytren	dupuytren	PROPN
aiua-10710	4	7	contraction	contraction	PROPN
aiua-10710	4	8	is	be	AUX
aiua-10710	4	9	a	a	DET
aiua-10710	4	10	strong	strong	ADJ
aiua-10710	4	11	proponent	proponent	NOUN
aiua-10710	4	12	of	of	ADP
aiua-10710	4	13	the	the	DET
aiua-10710	4	14	fibrotic	fibrotic	ADJ
aiua-10710	4	15	disease	disease	NOUN
aiua-10710	4	16	theory	theory	NOUN
aiua-10710	4	17	(	(	PUNCT
aiua-10710	4	18	5	5	NUM
aiua-10710	4	19	)	)	PUNCT
aiua-10710	4	20	.	.	PUNCT
aiua-10710	5	1	although	although	SCONJ
aiua-10710	5	2	various	various	ADJ
aiua-10710	5	3	types	type	NOUN
aiua-10710	5	4	of	of	ADP
aiua-10710	5	5	drugs	drug	NOUN
aiua-10710	5	6	have	have	AUX
aiua-10710	5	7	been	be	AUX
aiua-10710	5	8	used	use	VERB
aiua-10710	5	9	to	to	ADP
aiua-10710	5	10	date	date	NOUN
aiua-10710	5	11	in	in	ADP
aiua-10710	5	12	the	the	DET
aiua-10710	5	13	acute	acute	ADJ
aiua-10710	5	14	phase	phase	NOUN
aiua-10710	5	15	of	of	ADP
aiua-10710	5	16	pd	pd	PROPN
aiua-10710	5	17	,	,	PUNCT
aiua-10710	5	18	there	there	PRON
aiua-10710	5	19	is	be	VERB
aiua-10710	5	20	currently	currently	ADV
aiua-10710	5	21	no	no	DET
aiua-10710	5	22	satisfactory	satisfactory	ADJ
aiua-10710	5	23	and	and	CCONJ
aiua-10710	5	24	approved	approve	VERB
aiua-10710	5	25	oral	oral	ADJ
aiua-10710	5	26	drug	drug	NOUN
aiua-10710	5	27	therapy	therapy	NOUN
aiua-10710	5	28	.	.	PUNCT
aiua-10710	6	1	several	several	ADJ
aiua-10710	6	2	experimental	experimental	ADJ
aiua-10710	6	3	models	model	NOUN
aiua-10710	6	4	in	in	ADP
aiua-10710	6	5	human	human	ADJ
aiua-10710	6	6	cell	cell	NOUN
aiua-10710	6	7	cultures	culture	NOUN
aiua-10710	6	8	and	and	CCONJ
aiua-10710	6	9	rat	rat	NOUN
aiua-10710	6	10	models	model	NOUN
aiua-10710	6	11	have	have	AUX
aiua-10710	6	12	provided	provide	VERB
aiua-10710	6	13	new	new	ADJ
aiua-10710	6	14	insights	insight	NOUN
aiua-10710	6	15	into	into	ADP
aiua-10710	6	16	the	the	DET
aiua-10710	6	17	pathophysiology	pathophysiology	NOUN
aiua-10710	6	18	leading	lead	VERB
aiua-10710	6	19	to	to	ADP
aiua-10710	6	20	the	the	DET
aiua-10710	6	21	investigation	investigation	NOUN
aiua-10710	6	22	of	of	ADP
aiua-10710	6	23	alternative	alternative	ADJ
aiua-10710	6	24	approaches	approach	NOUN
aiua-10710	6	25	,	,	PUNCT
aiua-10710	6	26	including	include	VERB
aiua-10710	6	27	the	the	DET
aiua-10710	6	28	phosphodiesterase	phosphodiesterase	NOUN
aiua-10710	6	29	type	type	NOUN
aiua-10710	6	30	5	5	NUM
aiua-10710	6	31	inhibitors	inhibitor	NOUN
aiua-10710	6	32	(	(	PUNCT
aiua-10710	6	33	pde5i	pde5i	PROPN
aiua-10710	6	34	)	)	PUNCT
aiua-10710	6	35	as	as	ADP
aiua-10710	6	36	an	an	DET
aiua-10710	6	37	anti	anti	ADJ
aiua-10710	6	38	-	-	ADJ
aiua-10710	6	39	fibrotic	fibrotic	ADJ
aiua-10710	6	40	modality	modality	NOUN
aiua-10710	6	41	(	(	PUNCT
aiua-10710	6	42	6	6	NUM
aiua-10710	6	43	-	-	SYM
aiua-10710	6	44	7	7	NUM
aiua-10710	6	45	)	)	PUNCT
aiua-10710	6	46	.	.	PUNCT
aiua-10710	7	1	pd	pd	PROPN
aiua-10710	7	2	is	be	AUX
aiua-10710	7	3	associated	associate	VERB
aiua-10710	7	4	with	with	ADP
aiua-10710	7	5	erectile	erectile	ADJ
aiua-10710	7	6	dysfunction	dysfunction	NOUN
aiua-10710	7	7	(	(	PUNCT
aiua-10710	7	8	ed	ed	NOUN
aiua-10710	7	9	)	)	PUNCT
aiua-10710	7	10	in	in	ADP
aiua-10710	7	11	a	a	DET
aiua-10710	7	12	percentage	percentage	NOUN
aiua-10710	7	13	of	of	ADP
aiua-10710	7	14	patients	patient	NOUN
aiua-10710	7	15	ranging	range	VERB
aiua-10710	7	16	from	from	ADP
aiua-10710	7	17	40	40	NUM
aiua-10710	7	18	%	%	NOUN
aiua-10710	7	19	up	up	ADP
aiua-10710	7	20	to	to	PART
aiua-10710	7	21	70	70	NUM
aiua-10710	7	22	%	%	NOUN
aiua-10710	7	23	(	(	PUNCT
aiua-10710	7	24	3	3	NUM
aiua-10710	7	25	,	,	PUNCT
aiua-10710	7	26	8)	8)	NUM
aiua-10710	7	27	.	.	PUNCT
aiua-10710	7	28	proven	prove	VERB
aiua-10710	7	29	anti	anti	ADJ
aiua-10710	7	30	-	-	ADJ
aiua-10710	7	31	fibrotic	fibrotic	ADJ
aiua-10710	7	32	effect	effect	NOUN
aiua-10710	7	33	of	of	ADP
aiua-10710	7	34	pde5i	pde5i	PROPN
aiua-10710	7	35	in	in	ADP
aiua-10710	7	36	the	the	DET
aiua-10710	7	37	experimental	experimental	ADJ
aiua-10710	7	38	studies	study	NOUN
aiua-10710	7	39	and	and	CCONJ
aiua-10710	7	40	high	high	ADJ
aiua-10710	7	41	coexistence	coexistence	NOUN
aiua-10710	7	42	rate	rate	NOUN
aiua-10710	7	43	of	of	ADP
aiua-10710	7	44	ed	ed	NOUN
aiua-10710	7	45	with	with	ADP
aiua-10710	7	46	pd	pd	PROPN
aiua-10710	7	47	patients	patient	NOUN
aiua-10710	7	48	suggests	suggest	VERB
aiua-10710	7	49	that	that	SCONJ
aiua-10710	7	50	pde5i	pde5i	PROPN
aiua-10710	7	51	may	may	AUX
aiua-10710	7	52	contribute	contribute	VERB
aiua-10710	7	53	to	to	ADP
aiua-10710	7	54	the	the	DET
aiua-10710	7	55	treatment	treatment	NOUN
aiua-10710	7	56	of	of	ADP
aiua-10710	7	57	pd	pd	PROPN
aiua-10710	7	58	.	.	PUNCT
aiua-10710	8	1	however	however	ADV
aiua-10710	8	2	,	,	PUNCT
aiua-10710	8	3	very	very	ADV
aiua-10710	8	4	limited	limited	ADJ
aiua-10710	8	5	clinical	clinical	ADJ
aiua-10710	8	6	studies	study	NOUN
aiua-10710	8	7	were	be	AUX
aiua-10710	8	8	reported	report	VERB
aiua-10710	8	9	about	about	ADP
aiua-10710	8	10	this	this	DET
aiua-10710	8	11	subject	subject	NOUN
aiua-10710	8	12	in	in	ADP
aiua-10710	8	13	the	the	DET
aiua-10710	8	14	literature	literature	NOUN
aiua-10710	8	15	.	.	PUNCT
aiua-10710	9	1	we	we	PRON
aiua-10710	9	2	investigated	investigate	VERB
aiua-10710	9	3	whether	whether	SCONJ
aiua-10710	9	4	the	the	DET
aiua-10710	9	5	addition	addition	NOUN
aiua-10710	9	6	of	of	ADP
aiua-10710	9	7	pde-5i	pde-5i	PROPN
aiua-10710	9	8	to	to	PART
aiua-10710	9	9	combination	combination	VERB
aiua-10710	9	10	therapy	therapy	NOUN
aiua-10710	9	11	with	with	ADP
aiua-10710	9	12	colchicine	colchicine	NOUN
aiua-10710	9	13	and	and	CCONJ
aiua-10710	9	14	pentoxifylline	pentoxifylline	PROPN
aiua-10710	9	15	(	(	PUNCT
aiua-10710	9	16	ptx	ptx	PROPN
aiua-10710	9	17	)	)	PUNCT
aiua-10710	9	18	has	have	VERB
aiua-10710	9	19	any	any	DET
aiua-10710	9	20	benefit	benefit	NOUN
aiua-10710	9	21	on	on	ADP
aiua-10710	9	22	pd	pd	ADJ
aiua-10710	9	23	-	-	PUNCT
aiua-10710	9	24	related	relate	VERB
aiua-10710	9	25	symptoms	symptom	NOUN
aiua-10710	9	26	in	in	ADP
aiua-10710	9	27	patients	patient	NOUN
aiua-10710	9	28	with	with	ADP
aiua-10710	9	29	the	the	DET
aiua-10710	9	30	acute	acute	ADJ
aiua-10710	9	31	phase	phase	NOUN
aiua-10710	9	32	of	of	ADP
aiua-10710	9	33	pd	pd	PROPN
aiua-10710	9	34	and	and	CCONJ
aiua-10710	9	35	ed	ed	NOUN
aiua-10710	9	36	.	.	PROPN
aiua-10710	9	37	material	material	NOUN
aiua-10710	9	38	and	and	CCONJ
aiua-10710	9	39	methods	method	NOUN
aiua-10710	9	40	:	:	PUNCT
aiua-10710	9	41	this	this	DET
aiua-10710	9	42	study	study	NOUN
aiua-10710	9	43	was	be	AUX
aiua-10710	9	44	conducted	conduct	VERB
aiua-10710	9	45	according	accord	VERB
aiua-10710	9	46	to	to	ADP
aiua-10710	9	47	the	the	DET
aiua-10710	9	48	ethical	ethical	ADJ
aiua-10710	9	49	standard	standard	NOUN
aiua-10710	9	50	laid	lay	VERB
aiua-10710	9	51	down	down	ADP
aiua-10710	9	52	by	by	ADP
aiua-10710	9	53	the	the	DET
aiua-10710	9	54	1964	1964	NUM
aiua-10710	9	55	declaration	declaration	NOUN
aiua-10710	9	56	of	of	ADP
aiua-10710	9	57	helsinki	helsinki	PROPN
aiua-10710	9	58	and	and	CCONJ
aiua-10710	9	59	its	its	PRON
aiua-10710	9	60	later	later	ADJ
aiua-10710	9	61	amendments	amendment	NOUN
aiua-10710	9	62	.	.	PUNCT
aiua-10710	10	1	medical	medical	ADJ
aiua-10710	10	2	and	and	CCONJ
aiua-10710	10	3	sexual	sexual	ADJ
aiua-10710	10	4	history	history	NOUN
aiua-10710	10	5	,	,	PUNCT
aiua-10710	10	6	physical	physical	ADJ
aiua-10710	10	7	examination	examination	NOUN
aiua-10710	10	8	,	,	PUNCT
aiua-10710	10	9	records	record	NOUN
aiua-10710	10	10	of	of	ADP
aiua-10710	10	11	penile	penile	ADJ
aiua-10710	10	12	color	color	NOUN
aiua-10710	10	13	doppler	doppler	NOUN
aiua-10710	10	14	ultrasonography	ultrasonography	NOUN
aiua-10710	10	15	were	be	AUX
aiua-10710	10	16	retrospectively	retrospectively	ADV
aiua-10710	10	17	evaluated	evaluate	VERB
aiua-10710	10	18	.	.	PUNCT
aiua-10710	11	1	patients	patient	NOUN
aiua-10710	11	2	with	with	ADP
aiua-10710	11	3	pd	pd	PROPN
aiua-10710	11	4	symptoms	symptom	NOUN
aiua-10710	11	5	for	for	ADP
aiua-10710	11	6	no	no	ADV
aiua-10710	11	7	longer	long	ADJ
aiua-10710	11	8	than	than	ADP
aiua-10710	11	9	12	12	NUM
aiua-10710	11	10	months	month	NOUN
aiua-10710	11	11	and	and	CCONJ
aiua-10710	11	12	accompanied	accompany	VERB
aiua-10710	11	13	by	by	ADP
aiua-10710	11	14	ed	ed	PROPN
aiua-10710	11	15	were	be	AUX
aiua-10710	11	16	included	include	VERB
aiua-10710	11	17	into	into	ADP
aiua-10710	11	18	the	the	DET
aiua-10710	11	19	study	study	NOUN
aiua-10710	11	20	.	.	PUNCT
aiua-10710	12	1	as	as	ADP
aiua-10710	12	2	per	per	ADP
aiua-10710	12	3	our	our	PRON
aiua-10710	12	4	protocol	protocol	NOUN
aiua-10710	12	5	,	,	PUNCT
aiua-10710	12	6	patients	patient	NOUN
aiua-10710	12	7	who	who	PRON
aiua-10710	12	8	were	be	AUX
aiua-10710	12	9	receiving	receive	VERB
aiua-10710	12	10	any	any	DET
aiua-10710	12	11	treatment	treatment	NOUN
aiua-10710	12	12	for	for	ADP
aiua-10710	12	13	pd	pd	NOUN
aiua-10710	12	14	or	or	CCONJ
aiua-10710	12	15	ed	ed	NOUN
aiua-10710	12	16	,	,	PUNCT
aiua-10710	12	17	as	as	ADV
aiua-10710	12	18	well	well	ADV
aiua-10710	12	19	as	as	ADP
aiua-10710	12	20	those	those	PRON
aiua-10710	12	21	with	with	ADP
aiua-10710	12	22	psychosomatic	psychosomatic	ADJ
aiua-10710	12	23	ed	ed	NOUN
aiua-10710	12	24	,	,	PUNCT
aiua-10710	12	25	hypertension	hypertension	NOUN
aiua-10710	12	26	,	,	PUNCT
aiua-10710	12	27	coronary	coronary	ADJ
aiua-10710	12	28	artery	artery	NOUN
aiua-10710	12	29	disease	disease	NOUN
aiua-10710	12	30	,	,	PUNCT
aiua-10710	12	31	diabetes	diabetes	NOUN
aiua-10710	12	32	mellitus	mellitus	NOUN
aiua-10710	12	33	,	,	PUNCT
aiua-10710	12	34	hormonal	hormonal	ADJ
aiua-10710	12	35	disorders	disorder	NOUN
aiua-10710	12	36	,	,	PUNCT
aiua-10710	12	37	receiving	receive	VERB
aiua-10710	12	38	longterm	longterm	ADJ
aiua-10710	12	39	medication	medication	NOUN
aiua-10710	12	40	for	for	ADP
aiua-10710	12	41	any	any	DET
aiua-10710	12	42	disease	disease	NOUN
aiua-10710	12	43	,	,	PUNCT
aiua-10710	12	44	alcoholism	alcoholism	NOUN
aiua-10710	12	45	or	or	CCONJ
aiua-10710	12	46	smoke	smoke	NOUN
aiua-10710	12	47	abuse	abuse	NOUN
aiua-10710	12	48	were	be	AUX
aiua-10710	12	49	excluded	exclude	VERB
aiua-10710	12	50	.	.	PUNCT
aiua-10710	13	1	to	to	PART
aiua-10710	13	2	rule	rule	VERB
aiua-10710	13	3	out	out	ADP
aiua-10710	13	4	organic	organic	ADJ
aiua-10710	13	5	sexual	sexual	ADJ
aiua-10710	13	6	dysfunctions	dysfunction	NOUN
aiua-10710	13	7	and	and	CCONJ
aiua-10710	13	8	other	other	ADJ
aiua-10710	13	9	underlying	underlying	ADJ
aiua-10710	13	10	diseases	disease	NOUN
aiua-10710	13	11	,	,	PUNCT
aiua-10710	13	12	serum	serum	NOUN
aiua-10710	13	13	fasting	fast	VERB
aiua-10710	13	14	blood	blood	NOUN
aiua-10710	13	15	glucose	glucose	NOUN
aiua-10710	13	16	level	level	NOUN
aiua-10710	13	17	,	,	PUNCT
aiua-10710	13	18	sex	sex	NOUN
aiua-10710	13	19	hormones	hormone	NOUN
aiua-10710	13	20	and	and	CCONJ
aiua-10710	13	21	prolactin	prolactin	NOUN
aiua-10710	13	22	levels	level	NOUN
aiua-10710	13	23	were	be	AUX
aiua-10710	13	24	also	also	ADV
aiua-10710	13	25	evaluated	evaluate	VERB
aiua-10710	13	26	.	.	PUNCT
aiua-10710	14	1	in	in	ADP
aiua-10710	14	2	this	this	DET
aiua-10710	14	3	retrospective	retrospective	ADJ
aiua-10710	14	4	and	and	CCONJ
aiua-10710	14	5	non	non	ADJ
aiua-10710	14	6	-	-	ADJ
aiua-10710	14	7	randomized	randomized	ADJ
aiua-10710	14	8	clinical	clinical	ADJ
aiua-10710	14	9	study	study	NOUN
aiua-10710	14	10	,	,	PUNCT
aiua-10710	14	11	6	6	NUM
aiua-10710	14	12	-	-	PUNCT
aiua-10710	14	13	year	year	NOUN
aiua-10710	14	14	medical	medical	ADJ
aiua-10710	14	15	records	record	NOUN
aiua-10710	14	16	of	of	ADP
aiua-10710	14	17	636	636	NUM
aiua-10710	14	18	patients	patient	NOUN
aiua-10710	14	19	who	who	PRON
aiua-10710	14	20	were	be	AUX
aiua-10710	14	21	treated	treat	VERB
aiua-10710	14	22	for	for	ADP
aiua-10710	14	23	the	the	DET
aiua-10710	14	24	acute	acute	ADJ
aiua-10710	14	25	phase	phase	NOUN
aiua-10710	14	26	of	of	ADP
aiua-10710	14	27	pd	pd	PROPN
aiua-10710	14	28	in	in	ADP
aiua-10710	14	29	our	our	PRON
aiua-10710	14	30	institute	institute	NOUN
aiua-10710	14	31	were	be	AUX
aiua-10710	14	32	revaluated	revaluate	VERB
aiua-10710	14	33	.	.	PUNCT
aiua-10710	15	1	the	the	DET
aiua-10710	15	2	review	review	NOUN
aiua-10710	15	3	also	also	ADV
aiua-10710	15	4	elucidated	elucidate	VERB
aiua-10710	15	5	that	that	SCONJ
aiua-10710	15	6	186	186	NUM
aiua-10710	15	7	of	of	ADP
aiua-10710	15	8	these	these	DET
aiua-10710	15	9	patients	patient	NOUN
aiua-10710	15	10	were	be	AUX
aiua-10710	15	11	included	include	VERB
aiua-10710	15	12	into	into	ADP
aiua-10710	15	13	the	the	DET
aiua-10710	15	14	study	study	NOUN
aiua-10710	15	15	.	.	PUNCT
aiua-10710	16	1	patients	patient	NOUN
aiua-10710	16	2	were	be	AUX
aiua-10710	16	3	divided	divide	VERB
aiua-10710	16	4	into	into	ADP
aiua-10710	16	5	two	two	NUM
aiua-10710	16	6	groups	group	NOUN
aiua-10710	16	7	as	as	ADP
aiua-10710	16	8	group	group	NOUN
aiua-10710	16	9	1	1	NUM
aiua-10710	16	10	,	,	PUNCT
aiua-10710	16	11	who	who	PRON
aiua-10710	16	12	received	receive	VERB
aiua-10710	16	13	ptx	ptx	NOUN
aiua-10710	16	14	(	(	PUNCT
aiua-10710	16	15	400	400	NUM
aiua-10710	16	16	mg	mg	NOUN
aiua-10710	16	17	,	,	PUNCT
aiua-10710	16	18	twice	twice	ADV
aiua-10710	16	19	daily)-colchicine	daily)-colchicine	PROPN
aiua-10710	16	20	(	(	PUNCT
aiua-10710	16	21	0.5	0.5	NUM
aiua-10710	16	22	mg	mg	PROPN
aiua-10710	16	23	,	,	PUNCT
aiua-10710	16	24	plus	plus	CCONJ
aiua-10710	16	25	oral	oral	ADJ
aiua-10710	16	26	daily	daily	ADJ
aiua-10710	16	27	50	50	NUM
aiua-10710	16	28	mg	mg	NOUN
aiua-10710	16	29	sildenafil	sildenafil	X
aiua-10710	16	30	(	(	PUNCT
aiua-10710	16	31	n=107	n=107	PROPN
aiua-10710	16	32	)	)	PUNCT
aiua-10710	16	33	and	and	CCONJ
aiua-10710	16	34	as	as	SCONJ
aiua-10710	16	35	group	group	NOUN
aiua-10710	16	36	2	2	NUM
aiua-10710	16	37	received	receive	VERB
aiua-10710	16	38	ptx	ptx	NOUN
aiua-10710	16	39	objectives	objective	NOUN
aiua-10710	16	40	:	:	PUNCT
aiua-10710	16	41	the	the	DET
aiua-10710	16	42	aim	aim	NOUN
aiua-10710	16	43	of	of	ADP
aiua-10710	16	44	this	this	DET
aiua-10710	16	45	study	study	NOUN
aiua-10710	16	46	was	be	AUX
aiua-10710	16	47	to	to	PART
aiua-10710	16	48	investigate	investigate	VERB
aiua-10710	16	49	the	the	DET
aiua-10710	16	50	impact	impact	NOUN
aiua-10710	16	51	of	of	ADP
aiua-10710	16	52	the	the	DET
aiua-10710	16	53	addition	addition	NOUN
aiua-10710	16	54	of	of	ADP
aiua-10710	16	55	50	50	NUM
aiua-10710	16	56	mg	mg	NOUN
aiua-10710	16	57	daily	daily	ADJ
aiua-10710	16	58	sildenafil	sildenafil	NOUN
aiua-10710	16	59	to	to	ADP
aiua-10710	16	60	pentoxifylline	pentoxifylline	PROPN
aiua-10710	16	61	-	-	PUNCT
aiua-10710	16	62	colchicine	colchicine	PROPN
aiua-10710	16	63	combination	combination	NOUN
aiua-10710	16	64	therapy	therapy	NOUN
aiua-10710	16	65	on	on	ADP
aiua-10710	16	66	the	the	DET
aiua-10710	16	67	peyronie	peyronie	NOUN
aiua-10710	16	68	's	's	PART
aiua-10710	16	69	plaque	plaque	NOUN
aiua-10710	16	70	features	feature	NOUN
aiua-10710	16	71	in	in	ADP
aiua-10710	16	72	patients	patient	NOUN
aiua-10710	16	73	with	with	ADP
aiua-10710	16	74	the	the	DET
aiua-10710	16	75	acute	acute	ADJ
aiua-10710	16	76	phase	phase	NOUN
aiua-10710	16	77	of	of	ADP
aiua-10710	16	78	peyronie	peyronie	NOUN
aiua-10710	16	79	's	's	PART
aiua-10710	16	80	disease	disease	NOUN
aiua-10710	16	81	(	(	PUNCT
aiua-10710	16	82	pd	pd	NOUN
aiua-10710	16	83	)	)	PUNCT
aiua-10710	16	84	.	.	PUNCT
aiua-10710	17	1	methods	method	NOUN
aiua-10710	17	2	:	:	PUNCT
aiua-10710	17	3	in	in	ADP
aiua-10710	17	4	this	this	DET
aiua-10710	17	5	retrospective	retrospective	ADJ
aiua-10710	17	6	and	and	CCONJ
aiua-10710	17	7	non	non	ADJ
aiua-10710	17	8	-	-	ADJ
aiua-10710	17	9	randomized	randomized	ADJ
aiua-10710	17	10	clinical	clinical	ADJ
aiua-10710	17	11	study	study	NOUN
aiua-10710	17	12	,	,	PUNCT
aiua-10710	17	13	patients	patient	NOUN
aiua-10710	17	14	were	be	AUX
aiua-10710	17	15	divided	divide	VERB
aiua-10710	17	16	into	into	ADP
aiua-10710	17	17	2	2	NUM
aiua-10710	17	18	groups	group	NOUN
aiua-10710	17	19	as	as	ADP
aiua-10710	17	20	group	group	NOUN
aiua-10710	17	21	1	1	NUM
aiua-10710	17	22	;	;	PUNCT
aiua-10710	17	23	(	(	PUNCT
aiua-10710	17	24	n	n	NOUN
aiua-10710	17	25	=	=	SYM
aiua-10710	17	26	107	107	NUM
aiua-10710	17	27	)	)	PUNCT
aiua-10710	17	28	who	who	PRON
aiua-10710	17	29	received	receive	VERB
aiua-10710	17	30	colchicine	colchicine	PROPN
aiua-10710	17	31	and	and	CCONJ
aiua-10710	17	32	pentoxyfillin	pentoxyfillin	PROPN
aiua-10710	17	33	plus	plus	CCONJ
aiua-10710	17	34	50	50	NUM
aiua-10710	17	35	mg	mg	NOUN
aiua-10710	17	36	daily	daily	ADJ
aiua-10710	17	37	oral	oral	ADJ
aiua-10710	17	38	sildenafil	sildenafil	NOUN
aiua-10710	17	39	,	,	PUNCT
aiua-10710	17	40	and	and	CCONJ
aiua-10710	17	41	as	as	ADP
aiua-10710	17	42	group	group	NOUN
aiua-10710	17	43	2	2	NUM
aiua-10710	17	44	;	;	PUNCT
aiua-10710	17	45	(	(	PUNCT
aiua-10710	17	46	n	n	NOUN
aiua-10710	17	47	=	=	SYM
aiua-10710	17	48	79	79	NUM
aiua-10710	17	49	)	)	PUNCT
aiua-10710	17	50	who	who	PRON
aiua-10710	17	51	received	receive	VERB
aiua-10710	17	52	only	only	ADV
aiua-10710	17	53	colchicine	colchicine	PROPN
aiua-10710	17	54	and	and	CCONJ
aiua-10710	17	55	pentoxyfillin	pentoxyfillin	PROPN
aiua-10710	17	56	.	.	PUNCT
aiua-10710	18	1	patients	patient	NOUN
aiua-10710	18	2	were	be	AUX
aiua-10710	18	3	compared	compare	VERB
aiua-10710	18	4	in	in	ADP
aiua-10710	18	5	terms	term	NOUN
aiua-10710	18	6	of	of	ADP
aiua-10710	18	7	degree	degree	NOUN
aiua-10710	18	8	of	of	ADP
aiua-10710	18	9	curvature	curvature	NOUN
aiua-10710	18	10	,	,	PUNCT
aiua-10710	18	11	pain	pain	NOUN
aiua-10710	18	12	in	in	ADP
aiua-10710	18	13	erection	erection	NOUN
aiua-10710	18	14	and	and	CCONJ
aiua-10710	18	15	erectile	erectile	NOUN
aiua-10710	18	16	function	function	NOUN
aiua-10710	18	17	at	at	ADP
aiua-10710	18	18	the	the	DET
aiua-10710	18	19	baseline	baseline	NOUN
aiua-10710	18	20	and	and	CCONJ
aiua-10710	18	21	at	at	ADP
aiua-10710	18	22	6	6	NUM
aiua-10710	18	23	-	-	PUNCT
aiua-10710	18	24	month	month	NOUN
aiua-10710	18	25	follow	follow	NOUN
aiua-10710	18	26	up	up	ADP
aiua-10710	18	27	.	.	PUNCT
aiua-10710	19	1	pain	pain	NOUN
aiua-10710	19	2	in	in	ADP
aiua-10710	19	3	erection	erection	NOUN
aiua-10710	19	4	and	and	CCONJ
aiua-10710	19	5	erectile	erectile	NOUN
aiua-10710	19	6	function	function	NOUN
aiua-10710	19	7	were	be	AUX
aiua-10710	19	8	evaluated	evaluate	VERB
aiua-10710	19	9	by	by	ADP
aiua-10710	19	10	visual	visual	ADJ
aiua-10710	19	11	analogue	analogue	NOUN
aiua-10710	19	12	scale	scale	NOUN
aiua-10710	19	13	(	(	PUNCT
aiua-10710	19	14	ef	ef	PROPN
aiua-10710	19	15	-	-	PROPN
aiua-10710	19	16	vas	vas	NOUN
aiua-10710	19	17	)	)	PUNCT
aiua-10710	19	18	,	,	PUNCT
aiua-10710	19	19	and	and	CCONJ
aiua-10710	19	20	the	the	DET
aiua-10710	19	21	shortened	shorten	VERB
aiua-10710	19	22	version	version	NOUN
aiua-10710	19	23	of	of	ADP
aiua-10710	19	24	the	the	DET
aiua-10710	19	25	international	international	ADJ
aiua-10710	19	26	index	index	NOUN
aiua-10710	19	27	of	of	ADP
aiua-10710	19	28	erectile	erectile	NOUN
aiua-10710	19	29	function	function	NOUN
aiua-10710	19	30	(	(	PUNCT
aiua-10710	19	31	iief-5	iief-5	NUM
aiua-10710	19	32	)	)	PUNCT
aiua-10710	19	33	.	.	PUNCT
aiua-10710	20	1	improvement	improvement	NOUN
aiua-10710	20	2	in	in	ADP
aiua-10710	20	3	the	the	DET
aiua-10710	20	4	degree	degree	NOUN
aiua-10710	20	5	of	of	ADP
aiua-10710	20	6	curvature	curvature	NOUN
aiua-10710	20	7	and	and	CCONJ
aiua-10710	20	8	change	change	NOUN
aiua-10710	20	9	in	in	ADP
aiua-10710	20	10	ef	ef	PROPN
aiua-10710	20	11	-	-	PUNCT
aiua-10710	20	12	vas	vas	NOUN
aiua-10710	20	13	scores	score	NOUN
aiua-10710	20	14	were	be	AUX
aiua-10710	20	15	primary	primary	ADJ
aiua-10710	20	16	endpoints	endpoint	NOUN
aiua-10710	20	17	of	of	ADP
aiua-10710	20	18	the	the	DET
aiua-10710	20	19	study	study	NOUN
aiua-10710	20	20	.	.	PUNCT
aiua-10710	21	1	change	change	NOUN
aiua-10710	21	2	in	in	ADP
aiua-10710	21	3	iief-5	iief-5	NUM
aiua-10710	21	4	score	score	NOUN
aiua-10710	21	5	was	be	AUX
aiua-10710	21	6	the	the	DET
aiua-10710	21	7	secondary	secondary	ADJ
aiua-10710	21	8	endpoint	endpoint	NOUN
aiua-10710	21	9	of	of	ADP
aiua-10710	21	10	the	the	DET
aiua-10710	21	11	study	study	NOUN
aiua-10710	21	12	.	.	PUNCT
aiua-10710	22	1	results	result	NOUN
aiua-10710	22	2	:	:	PUNCT
aiua-10710	22	3	the	the	DET
aiua-10710	22	4	two	two	NUM
aiua-10710	22	5	groups	group	NOUN
aiua-10710	22	6	were	be	AUX
aiua-10710	22	7	statistically	statistically	ADV
aiua-10710	22	8	similar	similar	ADJ
aiua-10710	22	9	in	in	ADP
aiua-10710	22	10	terms	term	NOUN
aiua-10710	22	11	of	of	ADP
aiua-10710	22	12	demographics	demographic	NOUN
aiua-10710	22	13	and	and	CCONJ
aiua-10710	22	14	baseline	baseline	NOUN
aiua-10710	22	15	features	feature	NOUN
aiua-10710	22	16	of	of	ADP
aiua-10710	22	17	pd	pd	PROPN
aiua-10710	22	18	.	.	PUNCT
aiua-10710	23	1	a	a	DET
aiua-10710	23	2	statistically	statistically	ADV
aiua-10710	23	3	significant	significant	ADJ
aiua-10710	23	4	reduction	reduction	NOUN
aiua-10710	23	5	in	in	ADP
aiua-10710	23	6	degree	degree	NOUN
aiua-10710	23	7	of	of	ADP
aiua-10710	23	8	curvature	curvature	NOUN
aiua-10710	23	9	and	and	CCONJ
aiua-10710	23	10	ef	ef	PROPN
aiua-10710	23	11	-	-	ADJ
aiua-10710	23	12	vas	vas	NOUN
aiua-10710	23	13	scores	score	NOUN
aiua-10710	23	14	was	be	AUX
aiua-10710	23	15	shown	show	VERB
aiua-10710	23	16	in	in	ADP
aiua-10710	23	17	group	group	NOUN
aiua-10710	23	18	1	1	NUM
aiua-10710	23	19	compared	compare	VERB
aiua-10710	23	20	to	to	ADP
aiua-10710	23	21	group	group	NOUN
aiua-10710	23	22	2.there	2.there	NUM
aiua-10710	23	23	was	be	AUX
aiua-10710	23	24	also	also	ADV
aiua-10710	23	25	a	a	DET
aiua-10710	23	26	significantly	significantly	ADV
aiua-10710	23	27	higher	high	ADJ
aiua-10710	23	28	iief-5	iief-5	NUM
aiua-10710	23	29	score	score	NOUN
aiua-10710	23	30	in	in	ADP
aiua-10710	23	31	group	group	NOUN
aiua-10710	23	32	1	1	NUM
aiua-10710	23	33	compared	compare	VERB
aiua-10710	23	34	to	to	ADP
aiua-10710	23	35	group	group	NOUN
aiua-10710	23	36	2	2	NUM
aiua-10710	23	37	.	.	PUNCT
aiua-10710	24	1	no	no	DET
aiua-10710	24	2	significant	significant	ADJ
aiua-10710	24	3	side	side	NOUN
aiua-10710	24	4	effects	effect	NOUN
aiua-10710	24	5	were	be	AUX
aiua-10710	24	6	detected	detect	VERB
aiua-10710	24	7	in	in	ADP
aiua-10710	24	8	both	both	DET
aiua-10710	24	9	groups	group	NOUN
aiua-10710	24	10	during	during	ADP
aiua-10710	24	11	treatment	treatment	NOUN
aiua-10710	24	12	period	period	NOUN
aiua-10710	24	13	.	.	PUNCT
aiua-10710	25	1	conclusions	conclusion	NOUN
aiua-10710	25	2	:	:	PUNCT
aiua-10710	25	3	adding	add	VERB
aiua-10710	25	4	sildenafil	sildenafil	NOUN
aiua-10710	25	5	to	to	ADP
aiua-10710	25	6	pentoxifylline	pentoxifylline	PROPN
aiua-10710	25	7	-	-	PUNCT
aiua-10710	25	8	colchicine	colchicine	PROPN
aiua-10710	25	9	combination	combination	NOUN
aiua-10710	25	10	treatment	treatment	NOUN
aiua-10710	25	11	seems	seem	VERB
aiua-10710	25	12	to	to	PART
aiua-10710	25	13	improve	improve	VERB
aiua-10710	25	14	pd	pd	NOUN
aiua-10710	25	15	related	relate	VERB
aiua-10710	25	16	symptoms	symptom	NOUN
aiua-10710	25	17	in	in	ADP
aiua-10710	25	18	the	the	DET
aiua-10710	25	19	acute	acute	ADJ
aiua-10710	25	20	phase	phase	NOUN
aiua-10710	25	21	pd	pd	PROPN
aiua-10710	25	22	.	.	PUNCT
aiua-10710	26	1	pde5i	pde5i	PROPN
aiua-10710	26	2	may	may	AUX
aiua-10710	26	3	contribute	contribute	VERB
aiua-10710	26	4	to	to	PART
aiua-10710	26	5	relieve	relieve	VERB
aiua-10710	26	6	the	the	DET
aiua-10710	26	7	peyronie	peyronie	NOUN
aiua-10710	26	8	's	's	PART
aiua-10710	26	9	symptoms	symptom	NOUN
aiua-10710	26	10	in	in	ADP
aiua-10710	26	11	ed	ed	PROPN
aiua-10710	26	12	patients	patient	NOUN
aiua-10710	26	13	through	through	ADP
aiua-10710	26	14	their	their	PRON
aiua-10710	26	15	antifibrotic	antifibrotic	ADJ
aiua-10710	26	16	effects	effect	NOUN
aiua-10710	26	17	.	.	PUNCT
aiua-10710	27	1	key	key	ADJ
aiua-10710	27	2	words	word	NOUN
aiua-10710	27	3	:	:	PUNCT
aiua-10710	27	4	peyronie	peyronie	NOUN
aiua-10710	27	5	;	;	PUNCT
aiua-10710	27	6	oral	oral	ADJ
aiua-10710	27	7	treatment	treatment	NOUN
aiua-10710	27	8	;	;	PUNCT
aiua-10710	27	9	fibrosis	fibrosis	NOUN
aiua-10710	27	10	;	;	PUNCT
aiua-10710	27	11	antifibrotic	antifibrotic	ADJ
aiua-10710	27	12	treatment	treatment	NOUN
aiua-10710	27	13	.	.	PUNCT
aiua-10710	27	14	submitted	submit	VERB
aiua-10710	27	15	29	29	NUM
aiua-10710	27	16	june	june	PROPN
aiua-10710	27	17	2022	2022	NUM
aiua-10710	27	18	;	;	PUNCT
aiua-10710	27	19	accepted	accept	VERB
aiua-10710	27	20	2	2	NUM
aiua-10710	27	21	july	july	PROPN
aiua-10710	27	22	2022	2022	NUM
aiua-10710	27	23	introduction	introduction	NOUN
aiua-10710	27	24	peyronie	peyronie	NOUN
aiua-10710	27	25	’s	’s	PART
aiua-10710	27	26	disease	disease	NOUN
aiua-10710	27	27	(	(	PUNCT
aiua-10710	27	28	pd	pd	NOUN
aiua-10710	27	29	)	)	PUNCT
aiua-10710	27	30	is	be	AUX
aiua-10710	27	31	a	a	DET
aiua-10710	27	32	fibrotic	fibrotic	ADJ
aiua-10710	27	33	disorder	disorder	NOUN
aiua-10710	27	34	of	of	ADP
aiua-10710	27	35	tunica	tunica	PROPN
aiua-10710	27	36	albuginea	albuginea	NOUN
aiua-10710	27	37	with	with	ADP
aiua-10710	27	38	the	the	DET
aiua-10710	27	39	formation	formation	NOUN
aiua-10710	27	40	of	of	ADP
aiua-10710	27	41	penile	penile	ADJ
aiua-10710	27	42	plaque	plaque	NOUN
aiua-10710	27	43	.	.	PUNCT
aiua-10710	28	1	pd	pd	PROPN
aiua-10710	28	2	is	be	AUX
aiua-10710	28	3	a	a	DET
aiua-10710	28	4	relatively	relatively	ADV
aiua-10710	28	5	common	common	ADJ
aiua-10710	28	6	disorder	disorder	NOUN
aiua-10710	28	7	,	,	PUNCT
aiua-10710	28	8	with	with	ADP
aiua-10710	28	9	an	an	DET
aiua-10710	28	10	estimated	estimate	VERB
aiua-10710	28	11	prevalence	prevalence	NOUN
aiua-10710	28	12	of	of	ADP
aiua-10710	28	13	1.5	1.5	NUM
aiua-10710	28	14	%	%	NOUN
aiua-10710	28	15	in	in	ADP
aiua-10710	28	16	men	man	NOUN
aiua-10710	28	17	between	between	ADP
aiua-10710	28	18	30	30	NUM
aiua-10710	28	19	and	and	CCONJ
aiua-10710	28	20	40	40	NUM
aiua-10710	28	21	years	year	NOUN
aiua-10710	28	22	old	old	ADJ
aiua-10710	28	23	and	and	CCONJ
aiua-10710	28	24	as	as	ADV
aiua-10710	28	25	high	high	ADJ
aiua-10710	28	26	as	as	ADP
aiua-10710	28	27	6.5	6.5	NUM
aiua-10710	28	28	%	%	NOUN
aiua-10710	28	29	in	in	ADP
aiua-10710	28	30	older	old	ADJ
aiua-10710	28	31	men	man	NOUN
aiua-10710	28	32	(	(	PUNCT
aiua-10710	28	33	1	1	NUM
aiua-10710	28	34	)	)	PUNCT
aiua-10710	28	35	.	.	PUNCT
aiua-10710	29	1	pd	pd	PROPN
aiua-10710	29	2	is	be	AUX
aiua-10710	29	3	characterized	characterize	VERB
aiua-10710	29	4	by	by	ADP
aiua-10710	29	5	progressive	progressive	ADJ
aiua-10710	29	6	deformity	deformity	NOUN
aiua-10710	29	7	and	and	CCONJ
aiua-10710	29	8	unstable	unstable	ADJ
aiua-10710	29	9	plaque	plaque	NOUN
aiua-10710	29	10	with	with	ADP
aiua-10710	29	11	painful	painful	ADJ
aiua-10710	29	12	erection	erection	NOUN
aiua-10710	29	13	in	in	ADP
aiua-10710	29	14	the	the	DET
aiua-10710	29	15	acute	acute	ADJ
aiua-10710	29	16	phase;stabilization	phase;stabilization	NOUN
aiua-10710	29	17	of	of	ADP
aiua-10710	29	18	the	the	DET
aiua-10710	29	19	penile	penile	ADJ
aiua-10710	29	20	plaque	plaque	NOUN
aiua-10710	29	21	and	and	CCONJ
aiua-10710	29	22	penile	penile	ADJ
aiua-10710	29	23	curvature	curvature	NOUN
aiua-10710	29	24	are	be	AUX
aiua-10710	29	25	the	the	DET
aiua-10710	29	26	major	major	ADJ
aiua-10710	29	27	findings	finding	NOUN
aiua-10710	29	28	of	of	ADP
aiua-10710	29	29	the	the	DET
aiua-10710	29	30	chronic	chronic	ADJ
aiua-10710	29	31	phase	phase	NOUN
aiua-10710	29	32	which	which	PRON
aiua-10710	29	33	may	may	AUX
aiua-10710	29	34	require	require	VERB
aiua-10710	29	35	at	at	ADV
aiua-10710	29	36	least	least	ADV
aiua-10710	29	37	6	6	NUM
aiua-10710	29	38	months	month	NOUN
aiua-10710	29	39	and	and	CCONJ
aiua-10710	29	40	up	up	ADP
aiua-10710	29	41	to	to	PART
aiua-10710	29	42	18	18	NUM
aiua-10710	29	43	months	month	NOUN
aiua-10710	29	44	(	(	PUNCT
aiua-10710	29	45	2	2	NUM
aiua-10710	29	46	-	-	SYM
aiua-10710	29	47	3	3	NUM
aiua-10710	29	48	)	)	PUNCT
aiua-10710	29	49	.	.	PUNCT
aiua-10710	30	1	the	the	DET
aiua-10710	30	2	exact	exact	ADJ
aiua-10710	30	3	etiology	etiology	NOUN
aiua-10710	30	4	of	of	ADP
aiua-10710	30	5	plaque	plaque	NOUN
aiua-10710	30	6	formation	formation	NOUN
aiua-10710	30	7	effects	effect	NOUN
aiua-10710	30	8	of	of	ADP
aiua-10710	30	9	long	long	ADJ
aiua-10710	30	10	term	term	NOUN
aiua-10710	30	11	sildenafil	sildenafil	NOUN
aiua-10710	30	12	on	on	ADP
aiua-10710	30	13	the	the	DET
aiua-10710	30	14	acute	acute	ADJ
aiua-10710	30	15	phase	phase	NOUN
aiua-10710	30	16	of	of	ADP
aiua-10710	30	17	peyronie	peyronie	NOUN
aiua-10710	30	18	’s	’s	PART
aiua-10710	30	19	disease	disease	NOUN
aiua-10710	30	20	in	in	ADP
aiua-10710	30	21	a	a	DET
aiua-10710	30	22	combination	combination	NOUN
aiua-10710	30	23	treatment	treatment	NOUN
aiua-10710	30	24	murat	murat	NOUN
aiua-10710	30	25	topcuoglu	topcuoglu	PROPN
aiua-10710	30	26	1	1	NUM
aiua-10710	30	27	,	,	PUNCT
aiua-10710	30	28	murat	murat	PROPN
aiua-10710	30	29	çakan	çakan	ADJ
aiua-10710	30	30	2	2	NUM
aiua-10710	30	31	1	1	NUM
aiua-10710	30	32	department	department	NOUN
aiua-10710	30	33	of	of	ADP
aiua-10710	30	34	urology	urology	NOUN
aiua-10710	30	35	,	,	PUNCT
aiua-10710	30	36	alaaddin	alaaddin	VERB
aiua-10710	30	37	keykubat	keykubat	PROPN
aiua-10710	30	38	university	university	NOUN
aiua-10710	30	39	alanya	alanya	NOUN
aiua-10710	30	40	training	training	NOUN
aiua-10710	30	41	and	and	CCONJ
aiua-10710	30	42	research	research	NOUN
aiua-10710	30	43	hospital	hospital	NOUN
aiua-10710	30	44	,	,	PUNCT
aiua-10710	30	45	antalya	antalya	PROPN
aiua-10710	30	46	,	,	PUNCT
aiua-10710	30	47	turkey	turkey	PROPN
aiua-10710	30	48	;	;	PUNCT
aiua-10710	30	49	2	2	NUM
aiua-10710	30	50	department	department	NOUN
aiua-10710	30	51	of	of	ADP
aiua-10710	30	52	urology	urology	NOUN
aiua-10710	30	53	,	,	PUNCT
aiua-10710	30	54	dışkapı	dışkapı	PROPN
aiua-10710	30	55	yıldırım	yıldırım	NOUN
aiua-10710	30	56	beyazıt	beyazıt	NOUN
aiua-10710	30	57	training	training	NOUN
aiua-10710	30	58	and	and	CCONJ
aiua-10710	30	59	research	research	NOUN
aiua-10710	30	60	hospital	hospital	NOUN
aiua-10710	30	61	,	,	PUNCT
aiua-10710	30	62	ankara	ankara	PROPN
aiua-10710	30	63	,	,	PUNCT
aiua-10710	30	64	turkey	turkey	PROPN
aiua-10710	30	65	.	.	PUNCT
aiua-10710	31	1	doi	doi	NOUN
aiua-10710	31	2	:	:	PUNCT
aiua-10710	31	3	10.4081	10.4081	NUM
aiua-10710	31	4	/	/	SYM
aiua-10710	31	5	aiua.2022.3.319	aiua.2022.3.319	NOUN
aiua-10710	31	6	summary	summary	NOUN
aiua-10710	31	7	archivio	archivio	NOUN
aiua-10710	31	8	italiano	italiano	X
aiua-10710	31	9	di	di	X
aiua-10710	31	10	urologia	urologia	PROPN
aiua-10710	31	11	e	e	PROPN
aiua-10710	31	12	andrologia	andrologia	PROPN
aiua-10710	31	13	2022	2022	NUM
aiua-10710	31	14	;	;	PUNCT
aiua-10710	31	15	94	94	NUM
aiua-10710	31	16	,	,	PUNCT
aiua-10710	31	17	3	3	NUM
aiua-10710	31	18	m.	m.	NOUN
aiua-10710	31	19	topcuoglu	topcuoglu	NOUN
aiua-10710	31	20	,	,	PUNCT
aiua-10710	31	21	m.	m.	NOUN
aiua-10710	31	22	çakan	çakan	PROPN
aiua-10710	31	23	320	320	NUM
aiua-10710	31	24	(	(	PUNCT
aiua-10710	31	25	400	400	NUM
aiua-10710	31	26	mg	mg	NOUN
aiua-10710	31	27	,	,	PUNCT
aiua-10710	31	28	twice	twice	ADV
aiua-10710	31	29	daily)-colchicine	daily)-colchicine	PROPN
aiua-10710	31	30	(	(	PUNCT
aiua-10710	31	31	0.5	0.5	NUM
aiua-10710	31	32	mg	mg	PROPN
aiua-10710	31	33	,	,	PUNCT
aiua-10710	31	34	twice	twice	ADV
aiua-10710	31	35	daily	daily	ADV
aiua-10710	31	36	)	)	PUNCT
aiua-10710	31	37	(	(	PUNCT
aiua-10710	31	38	n=79	n=79	PROPN
aiua-10710	31	39	)	)	PUNCT
aiua-10710	31	40	and	and	CCONJ
aiua-10710	31	41	who	who	PRON
aiua-10710	31	42	were	be	AUX
aiua-10710	31	43	reluctant	reluctant	ADJ
aiua-10710	31	44	to	to	PART
aiua-10710	31	45	use	use	VERB
aiua-10710	31	46	of	of	ADP
aiua-10710	31	47	sildenafil	sildenafil	NOUN
aiua-10710	31	48	or	or	CCONJ
aiua-10710	31	49	unable	unable	ADJ
aiua-10710	31	50	to	to	PART
aiua-10710	31	51	purchase	purchase	VERB
aiua-10710	31	52	sildenafil	sildenafil	NOUN
aiua-10710	31	53	due	due	ADP
aiua-10710	31	54	to	to	ADP
aiua-10710	31	55	financial	financial	ADJ
aiua-10710	31	56	reasons	reason	NOUN
aiua-10710	31	57	.	.	PUNCT
aiua-10710	32	1	patients	patient	NOUN
aiua-10710	32	2	with	with	ADP
aiua-10710	32	3	plaque	plaque	NOUN
aiua-10710	32	4	calcification	calcification	NOUN
aiua-10710	32	5	detected	detect	VERB
aiua-10710	32	6	on	on	ADP
aiua-10710	32	7	penile	penile	ADJ
aiua-10710	32	8	ultrasonography	ultrasonography	NOUN
aiua-10710	32	9	were	be	AUX
aiua-10710	32	10	also	also	ADV
aiua-10710	32	11	excluded	exclude	VERB
aiua-10710	32	12	from	from	ADP
aiua-10710	32	13	the	the	DET
aiua-10710	32	14	study	study	NOUN
aiua-10710	32	15	.	.	PUNCT
aiua-10710	33	1	plaque	plaque	NOUN
aiua-10710	33	2	calcification	calcification	NOUN
aiua-10710	33	3	has	have	AUX
aiua-10710	33	4	been	be	AUX
aiua-10710	33	5	identified	identify	VERB
aiua-10710	33	6	as	as	ADP
aiua-10710	33	7	a	a	DET
aiua-10710	33	8	sign	sign	NOUN
aiua-10710	33	9	of	of	ADP
aiua-10710	33	10	chronic	chronic	ADJ
aiua-10710	33	11	phase	phase	NOUN
aiua-10710	33	12	and	and	CCONJ
aiua-10710	33	13	potential	potential	ADJ
aiua-10710	33	14	poor	poor	ADJ
aiua-10710	33	15	predictor	predictor	NOUN
aiua-10710	33	16	of	of	ADP
aiua-10710	33	17	response	response	NOUN
aiua-10710	33	18	to	to	ADP
aiua-10710	33	19	treatment	treatment	NOUN
aiua-10710	33	20	(	(	PUNCT
aiua-10710	33	21	9	9	NUM
aiua-10710	33	22	)	)	PUNCT
aiua-10710	33	23	.	.	PUNCT
aiua-10710	34	1	disease	disease	NOUN
aiua-10710	34	2	duration	duration	NOUN
aiua-10710	34	3	,	,	PUNCT
aiua-10710	34	4	erectile	erectile	ADJ
aiua-10710	34	5	pain	pain	NOUN
aiua-10710	34	6	,	,	PUNCT
aiua-10710	34	7	erectile	erectile	NOUN
aiua-10710	34	8	function	function	NOUN
aiua-10710	34	9	,	,	PUNCT
aiua-10710	34	10	and	and	CCONJ
aiua-10710	34	11	penile	penile	NOUN
aiua-10710	34	12	curvature	curvature	NOUN
aiua-10710	34	13	were	be	AUX
aiua-10710	34	14	assessed	assess	VERB
aiua-10710	34	15	at	at	ADP
aiua-10710	34	16	the	the	DET
aiua-10710	34	17	baseline	baseline	NOUN
aiua-10710	34	18	assessment	assessment	NOUN
aiua-10710	34	19	.	.	PUNCT
aiua-10710	35	1	penile	penile	NOUN
aiua-10710	35	2	curvature	curvature	NOUN
aiua-10710	35	3	was	be	AUX
aiua-10710	35	4	measured	measure	VERB
aiua-10710	35	5	according	accord	VERB
aiua-10710	35	6	to	to	ADP
aiua-10710	35	7	the	the	DET
aiua-10710	35	8	kelami	kelami	NOUN
aiua-10710	35	9	’s	’s	PART
aiua-10710	35	10	criteria	criterion	NOUN
aiua-10710	35	11	with	with	ADP
aiua-10710	35	12	a	a	DET
aiua-10710	35	13	goniometer	goniometer	NOUN
aiua-10710	35	14	by	by	ADP
aiua-10710	35	15	the	the	DET
aiua-10710	35	16	same	same	ADJ
aiua-10710	35	17	operator	operator	NOUN
aiua-10710	35	18	following	follow	VERB
aiua-10710	35	19	artificial	artificial	ADJ
aiua-10710	35	20	erection	erection	NOUN
aiua-10710	35	21	stimulated	stimulate	VERB
aiua-10710	35	22	by	by	ADP
aiua-10710	35	23	intracavernosal	intracavernosal	ADJ
aiua-10710	35	24	vasoactive	vasoactive	ADJ
aiua-10710	35	25	agent	agent	NOUN
aiua-10710	35	26	.	.	PUNCT
aiua-10710	36	1	the	the	DET
aiua-10710	36	2	severity	severity	NOUN
aiua-10710	36	3	of	of	ADP
aiua-10710	36	4	erectile	erectile	ADJ
aiua-10710	36	5	pain	pain	NOUN
aiua-10710	36	6	was	be	AUX
aiua-10710	36	7	assessed	assess	VERB
aiua-10710	36	8	by	by	ADP
aiua-10710	36	9	erectile	erectile	NOUN
aiua-10710	36	10	function	function	NOUN
aiua-10710	36	11	visual	visual	ADJ
aiua-10710	36	12	analogue	analogue	NOUN
aiua-10710	36	13	scale	scale	NOUN
aiua-10710	36	14	(	(	PUNCT
aiua-10710	36	15	efvas	efvas	NOUN
aiua-10710	36	16	)	)	PUNCT
aiua-10710	36	17	score	score	NOUN
aiua-10710	36	18	on	on	ADP
aiua-10710	36	19	a	a	DET
aiua-10710	36	20	scale	scale	NOUN
aiua-10710	36	21	of	of	ADP
aiua-10710	36	22	0	0	NUM
aiua-10710	36	23	-	-	SYM
aiua-10710	36	24	10	10	NUM
aiua-10710	36	25	,	,	PUNCT
aiua-10710	36	26	with	with	ADP
aiua-10710	36	27	0	0	NUM
aiua-10710	36	28	being	be	AUX
aiua-10710	36	29	no	no	DET
aiua-10710	36	30	pain	pain	NOUN
aiua-10710	36	31	and	and	CCONJ
aiua-10710	36	32	10	10	NUM
aiua-10710	36	33	being	be	AUX
aiua-10710	36	34	severe	severe	ADJ
aiua-10710	36	35	pain	pain	NOUN
aiua-10710	36	36	.	.	PUNCT
aiua-10710	37	1	erectile	erectile	NOUN
aiua-10710	37	2	function	function	NOUN
aiua-10710	37	3	was	be	AUX
aiua-10710	37	4	evaluated	evaluate	VERB
aiua-10710	37	5	through	through	ADP
aiua-10710	37	6	the	the	DET
aiua-10710	37	7	shortened	shorten	VERB
aiua-10710	37	8	version	version	NOUN
aiua-10710	37	9	of	of	ADP
aiua-10710	37	10	the	the	DET
aiua-10710	37	11	international	international	ADJ
aiua-10710	37	12	index	index	NOUN
aiua-10710	37	13	of	of	ADP
aiua-10710	37	14	erectile	erectile	NOUN
aiua-10710	37	15	function	function	NOUN
aiua-10710	37	16	(	(	PUNCT
aiua-10710	37	17	iief-5	iief-5	ADV
aiua-10710	37	18	)	)	PUNCT
aiua-10710	37	19	questionnaire	questionnaire	NOUN
aiua-10710	37	20	.	.	PUNCT
aiua-10710	38	1	each	each	DET
aiua-10710	38	2	question	question	NOUN
aiua-10710	38	3	is	be	AUX
aiua-10710	38	4	scored	score	VERB
aiua-10710	38	5	on	on	ADP
aiua-10710	38	6	a	a	DET
aiua-10710	38	7	scale	scale	NOUN
aiua-10710	38	8	of	of	ADP
aiua-10710	38	9	1	1	NUM
aiua-10710	38	10	to	to	PART
aiua-10710	38	11	5	5	NUM
aiua-10710	38	12	and	and	CCONJ
aiua-10710	38	13	5	5	NUM
aiua-10710	38	14	is	be	AUX
aiua-10710	38	15	indicating	indicate	VERB
aiua-10710	38	16	best	good	ADJ
aiua-10710	38	17	function	function	NOUN
aiua-10710	38	18	.	.	PUNCT
aiua-10710	39	1	the	the	DET
aiua-10710	39	2	collected	collect	VERB
aiua-10710	39	3	database	database	NOUN
aiua-10710	39	4	of	of	ADP
aiua-10710	39	5	baseline	baseline	NOUN
aiua-10710	39	6	and	and	CCONJ
aiua-10710	39	7	outcomes	outcome	NOUN
aiua-10710	39	8	at	at	ADP
aiua-10710	39	9	sixth	sixth	ADJ
aiua-10710	39	10	month	month	NOUN
aiua-10710	39	11	of	of	ADP
aiua-10710	39	12	treatment	treatment	NOUN
aiua-10710	39	13	in	in	ADP
aiua-10710	39	14	both	both	DET
aiua-10710	39	15	groups	group	NOUN
aiua-10710	39	16	were	be	AUX
aiua-10710	39	17	compared	compare	VERB
aiua-10710	39	18	in	in	ADP
aiua-10710	39	19	terms	term	NOUN
aiua-10710	39	20	of	of	ADP
aiua-10710	39	21	penile	penile	ADJ
aiua-10710	39	22	curvature	curvature	NOUN
aiua-10710	39	23	,	,	PUNCT
aiua-10710	39	24	ef	ef	PROPN
aiua-10710	39	25	-	-	PROPN
aiua-10710	39	26	vas	vas	NOUN
aiua-10710	39	27	,	,	PUNCT
aiua-10710	39	28	and	and	CCONJ
aiua-10710	39	29	iief-5	iief-5	NUM
aiua-10710	39	30	scores	score	NOUN
aiua-10710	39	31	.	.	PUNCT
aiua-10710	40	1	the	the	DET
aiua-10710	40	2	primary	primary	ADJ
aiua-10710	40	3	endpoints	endpoint	NOUN
aiua-10710	40	4	of	of	ADP
aiua-10710	40	5	the	the	DET
aiua-10710	40	6	study	study	NOUN
aiua-10710	40	7	were	be	AUX
aiua-10710	40	8	the	the	DET
aiua-10710	40	9	improvement	improvement	NOUN
aiua-10710	40	10	in	in	ADP
aiua-10710	40	11	curvature	curvature	NOUN
aiua-10710	40	12	and	and	CCONJ
aiua-10710	40	13	change	change	NOUN
aiua-10710	40	14	in	in	ADP
aiua-10710	40	15	ef	ef	PROPN
aiua-10710	40	16	-	-	PUNCT
aiua-10710	40	17	vas	vas	NOUN
aiua-10710	40	18	scores	score	NOUN
aiua-10710	40	19	.	.	PUNCT
aiua-10710	41	1	change	change	NOUN
aiua-10710	41	2	in	in	ADP
aiua-10710	41	3	iief-5	iief-5	NUM
aiua-10710	41	4	score	score	NOUN
aiua-10710	41	5	was	be	AUX
aiua-10710	41	6	the	the	DET
aiua-10710	41	7	secondary	secondary	ADJ
aiua-10710	41	8	endpoint	endpoint	NOUN
aiua-10710	41	9	of	of	ADP
aiua-10710	41	10	the	the	DET
aiua-10710	41	11	study	study	NOUN
aiua-10710	41	12	.	.	PUNCT
aiua-10710	42	1	statistical	statistical	ADJ
aiua-10710	42	2	analysis	analysis	NOUN
aiua-10710	42	3	mean	mean	NOUN
aiua-10710	42	4	,	,	PUNCT
aiua-10710	42	5	standard	standard	ADJ
aiua-10710	42	6	deviation	deviation	NOUN
aiua-10710	42	7	,	,	PUNCT
aiua-10710	42	8	median	median	NOUN
aiua-10710	42	9	lowest	low	ADJ
aiua-10710	42	10	,	,	PUNCT
aiua-10710	42	11	median	median	ADJ
aiua-10710	42	12	highest	high	ADJ
aiua-10710	42	13	,	,	PUNCT
aiua-10710	42	14	frequency	frequency	NOUN
aiua-10710	42	15	and	and	CCONJ
aiua-10710	42	16	ratio	ratio	NOUN
aiua-10710	42	17	values	value	NOUN
aiua-10710	42	18	were	be	AUX
aiua-10710	42	19	used	use	VERB
aiua-10710	42	20	in	in	ADP
aiua-10710	42	21	descriptive	descriptive	ADJ
aiua-10710	42	22	statistics	statistic	NOUN
aiua-10710	42	23	of	of	ADP
aiua-10710	42	24	the	the	DET
aiua-10710	42	25	data	datum	NOUN
aiua-10710	42	26	.	.	PUNCT
aiua-10710	43	1	the	the	DET
aiua-10710	43	2	distribution	distribution	NOUN
aiua-10710	43	3	of	of	ADP
aiua-10710	43	4	the	the	DET
aiua-10710	43	5	variables	variable	NOUN
aiua-10710	43	6	was	be	AUX
aiua-10710	43	7	measured	measure	VERB
aiua-10710	43	8	with	with	ADP
aiua-10710	43	9	the	the	DET
aiua-10710	43	10	kolmogorov	kolmogorov	ADJ
aiua-10710	43	11	-	-	PUNCT
aiua-10710	43	12	smirnov	smirnov	ADJ
aiua-10710	43	13	test	test	NOUN
aiua-10710	43	14	.	.	PUNCT
aiua-10710	44	1	the	the	DET
aiua-10710	44	2	mannwhitney	mannwhitney	ADJ
aiua-10710	44	3	test	test	NOUN
aiua-10710	44	4	was	be	AUX
aiua-10710	44	5	used	use	VERB
aiua-10710	44	6	to	to	PART
aiua-10710	44	7	analyze	analyze	VERB
aiua-10710	44	8	quantitative	quantitative	ADJ
aiua-10710	44	9	independent	independent	ADJ
aiua-10710	44	10	data	datum	NOUN
aiua-10710	44	11	.	.	PUNCT
aiua-10710	45	1	chi	chi	ADJ
aiua-10710	45	2	-	-	PUNCT
aiua-10710	45	3	square	square	PROPN
aiua-10710	45	4	test	test	NOUN
aiua-10710	45	5	was	be	AUX
aiua-10710	45	6	used	use	VERB
aiua-10710	45	7	for	for	ADP
aiua-10710	45	8	the	the	DET
aiua-10710	45	9	analysis	analysis	NOUN
aiua-10710	45	10	of	of	ADP
aiua-10710	45	11	qualitative	qualitative	ADJ
aiua-10710	45	12	independent	independent	ADJ
aiua-10710	45	13	data	datum	NOUN
aiua-10710	45	14	and	and	CCONJ
aiua-10710	45	15	fisher	fisher	PROPN
aiua-10710	45	16	test	test	NOUN
aiua-10710	45	17	was	be	AUX
aiua-10710	45	18	used	use	VERB
aiua-10710	45	19	when	when	SCONJ
aiua-10710	45	20	the	the	DET
aiua-10710	45	21	chi	chi	ADJ
aiua-10710	45	22	-	-	PUNCT
aiua-10710	45	23	square	square	ADJ
aiua-10710	45	24	test	test	NOUN
aiua-10710	45	25	conditions	condition	NOUN
aiua-10710	45	26	were	be	AUX
aiua-10710	45	27	not	not	PART
aiua-10710	45	28	met	meet	VERB
aiua-10710	45	29	.	.	PUNCT
aiua-10710	46	1	spss	spss	PROPN
aiua-10710	46	2	22.0	22.0	NUM
aiua-10710	46	3	program	program	NOUN
aiua-10710	46	4	was	be	AUX
aiua-10710	46	5	used	use	VERB
aiua-10710	46	6	in	in	ADP
aiua-10710	46	7	the	the	DET
aiua-10710	46	8	analysis	analysis	NOUN
aiua-10710	46	9	.	.	PUNCT
aiua-10710	47	1	p	p	NOUN
aiua-10710	47	2	value	value	NOUN
aiua-10710	47	3	less	less	ADJ
aiua-10710	47	4	than	than	ADP
aiua-10710	47	5	0.05	0.05	NUM
aiua-10710	47	6	was	be	AUX
aiua-10710	47	7	considered	consider	VERB
aiua-10710	47	8	as	as	ADP
aiua-10710	47	9	statistically	statistically	ADV
aiua-10710	47	10	significant	significant	ADJ
aiua-10710	47	11	.	.	PUNCT
aiua-10710	48	1	results	result	VERB
aiua-10710	48	2	our	our	PRON
aiua-10710	48	3	retrospective	retrospective	ADJ
aiua-10710	48	4	review	review	NOUN
aiua-10710	48	5	revealed	reveal	VERB
aiua-10710	48	6	that	that	SCONJ
aiua-10710	48	7	636	636	NUM
aiua-10710	48	8	patients	patient	NOUN
aiua-10710	48	9	with	with	ADP
aiua-10710	48	10	acute	acute	ADJ
aiua-10710	48	11	phase	phase	NOUN
aiua-10710	48	12	of	of	ADP
aiua-10710	48	13	pd	pd	PROPN
aiua-10710	48	14	were	be	AUX
aiua-10710	48	15	treated	treat	VERB
aiua-10710	48	16	at	at	ADP
aiua-10710	48	17	our	our	PRON
aiua-10710	48	18	center	center	NOUN
aiua-10710	48	19	during	during	ADP
aiua-10710	48	20	the	the	DET
aiua-10710	48	21	study	study	NOUN
aiua-10710	48	22	period	period	NOUN
aiua-10710	48	23	.	.	PUNCT
aiua-10710	49	1	as	as	ADP
aiua-10710	49	2	per	per	ADP
aiua-10710	49	3	our	our	PRON
aiua-10710	49	4	protocol	protocol	NOUN
aiua-10710	49	5	,	,	PUNCT
aiua-10710	49	6	186	186	NUM
aiua-10710	49	7	of	of	ADP
aiua-10710	49	8	636	636	NUM
aiua-10710	49	9	patients	patient	NOUN
aiua-10710	49	10	were	be	AUX
aiua-10710	49	11	enrolled	enrol	VERB
aiua-10710	49	12	in	in	ADP
aiua-10710	49	13	our	our	PRON
aiua-10710	49	14	study	study	NOUN
aiua-10710	49	15	.	.	PUNCT
aiua-10710	50	1	the	the	DET
aiua-10710	50	2	baseline	baseline	PROPN
aiua-10710	50	3	characteristics	characteristic	NOUN
aiua-10710	50	4	of	of	ADP
aiua-10710	50	5	these	these	DET
aiua-10710	50	6	patients	patient	NOUN
aiua-10710	50	7	are	be	AUX
aiua-10710	50	8	displayed	display	VERB
aiua-10710	50	9	in	in	ADP
aiua-10710	50	10	table	table	NOUN
aiua-10710	50	11	1	1	NUM
aiua-10710	50	12	.	.	PUNCT
aiua-10710	51	1	mean	mean	PROPN
aiua-10710	51	2	age	age	NOUN
aiua-10710	51	3	was	be	AUX
aiua-10710	51	4	56.1±	56.1±	PROPN
aiua-10710	51	5	10.2	10.2	NUM
aiua-10710	51	6	in	in	ADP
aiua-10710	51	7	group	group	NOUN
aiua-10710	51	8	1	1	NUM
aiua-10710	51	9	and	and	CCONJ
aiua-10710	51	10	53.54	53.54	NUM
aiua-10710	51	11	±	±	NUM
aiua-10710	51	12	13.4	13.4	NUM
aiua-10710	51	13	in	in	ADP
aiua-10710	51	14	group	group	NOUN
aiua-10710	51	15	2	2	NUM
aiua-10710	51	16	.	.	PUNCT
aiua-10710	52	1	there	there	PRON
aiua-10710	52	2	was	be	VERB
aiua-10710	52	3	no	no	DET
aiua-10710	52	4	statistical	statistical	ADJ
aiua-10710	52	5	difference	difference	NOUN
aiua-10710	52	6	between	between	ADP
aiua-10710	52	7	the	the	DET
aiua-10710	52	8	groups	group	NOUN
aiua-10710	52	9	in	in	ADP
aiua-10710	52	10	terms	term	NOUN
aiua-10710	52	11	of	of	ADP
aiua-10710	52	12	demographics	demographic	NOUN
aiua-10710	52	13	and	and	CCONJ
aiua-10710	52	14	pd	pd	PROPN
aiua-10710	52	15	characteristics	characteristic	NOUN
aiua-10710	52	16	at	at	ADP
aiua-10710	52	17	the	the	DET
aiua-10710	52	18	baseline	baseline	ADJ
aiua-10710	52	19	period	period	NOUN
aiua-10710	52	20	.	.	PUNCT
aiua-10710	53	1	the	the	DET
aiua-10710	53	2	mean	mean	ADJ
aiua-10710	53	3	duration	duration	NOUN
aiua-10710	53	4	of	of	ADP
aiua-10710	53	5	pd	pd	PROPN
aiua-10710	53	6	symptoms	symptom	NOUN
aiua-10710	53	7	was	be	AUX
aiua-10710	53	8	9.2	9.2	NUM
aiua-10710	53	9	±	±	NUM
aiua-10710	53	10	2.1	2.1	NUM
aiua-10710	53	11	months	month	NOUN
aiua-10710	53	12	in	in	ADP
aiua-10710	53	13	group	group	NOUN
aiua-10710	53	14	1	1	NUM
aiua-10710	53	15	and	and	CCONJ
aiua-10710	53	16	8.9	8.9	NUM
aiua-10710	53	17	±	±	NUM
aiua-10710	53	18	2.0	2.0	NUM
aiua-10710	53	19	month	month	NOUN
aiua-10710	53	20	in	in	ADP
aiua-10710	53	21	group	group	NOUN
aiua-10710	53	22	2	2	NUM
aiua-10710	53	23	(	(	PUNCT
aiua-10710	53	24	no	no	DET
aiua-10710	53	25	statistically	statistically	ADV
aiua-10710	53	26	significant	significant	ADJ
aiua-10710	53	27	difference	difference	NOUN
aiua-10710	53	28	between	between	ADP
aiua-10710	53	29	the	the	DET
aiua-10710	53	30	groups	group	NOUN
aiua-10710	53	31	)	)	PUNCT
aiua-10710	53	32	.	.	PUNCT
aiua-10710	54	1	change	change	NOUN
aiua-10710	54	2	in	in	ADP
aiua-10710	54	3	mean	mean	ADJ
aiua-10710	54	4	degree	degree	NOUN
aiua-10710	54	5	of	of	ADP
aiua-10710	54	6	curvature	curvature	NOUN
aiua-10710	54	7	angle	angle	NOUN
aiua-10710	54	8	was	be	AUX
aiua-10710	54	9	11.02	11.02	NUM
aiua-10710	54	10	±	±	NUM
aiua-10710	54	11	2.3º	2.3º	NOUN
aiua-10710	54	12	and	and	CCONJ
aiua-10710	54	13	6.6	6.6	NUM
aiua-10710	54	14	±	±	NUM
aiua-10710	54	15	1.7º	1.7º	NUM
aiua-10710	54	16	group	group	NOUN
aiua-10710	54	17	1	1	NUM
aiua-10710	54	18	and	and	CCONJ
aiua-10710	54	19	group	group	NOUN
aiua-10710	54	20	2	2	NUM
aiua-10710	54	21	,	,	PUNCT
aiua-10710	54	22	respectively	respectively	ADV
aiua-10710	54	23	.	.	PUNCT
aiua-10710	55	1	although	although	SCONJ
aiua-10710	55	2	a	a	DET
aiua-10710	55	3	significant	significant	ADJ
aiua-10710	55	4	difference	difference	NOUN
aiua-10710	55	5	in	in	ADP
aiua-10710	55	6	mean	mean	NOUN
aiua-10710	55	7	degree	degree	NOUN
aiua-10710	55	8	of	of	ADP
aiua-10710	55	9	curvature	curvature	NOUN
aiua-10710	55	10	was	be	AUX
aiua-10710	55	11	shown	show	VERB
aiua-10710	55	12	in	in	ADP
aiua-10710	55	13	group	group	NOUN
aiua-10710	55	14	1	1	NUM
aiua-10710	55	15	at	at	ADP
aiua-10710	55	16	the	the	DET
aiua-10710	55	17	sixth	sixth	ADJ
aiua-10710	55	18	month	month	NOUN
aiua-10710	55	19	of	of	ADP
aiua-10710	55	20	the	the	DET
aiua-10710	55	21	treatment	treatment	NOUN
aiua-10710	55	22	compared	compare	VERB
aiua-10710	55	23	to	to	PART
aiua-10710	55	24	baseline	baseline	VERB
aiua-10710	55	25	,	,	PUNCT
aiua-10710	55	26	no	no	DET
aiua-10710	55	27	significant	significant	ADJ
aiua-10710	55	28	change	change	NOUN
aiua-10710	55	29	in	in	ADP
aiua-10710	55	30	mean	mean	ADJ
aiua-10710	55	31	degree	degree	NOUN
aiua-10710	55	32	of	of	ADP
aiua-10710	55	33	curvature	curvature	NOUN
aiua-10710	55	34	was	be	AUX
aiua-10710	55	35	revealed	reveal	VERB
aiua-10710	55	36	in	in	ADP
aiua-10710	55	37	group	group	NOUN
aiua-10710	55	38	2	2	NUM
aiua-10710	55	39	after	after	ADP
aiua-10710	55	40	the	the	DET
aiua-10710	55	41	treatment	treatment	NOUN
aiua-10710	55	42	period	period	NOUN
aiua-10710	55	43	.	.	PUNCT
aiua-10710	56	1	ef	ef	X
aiua-10710	56	2	-	-	PUNCT
aiua-10710	56	3	vas	vas	NOUN
aiua-10710	56	4	showed	show	VERB
aiua-10710	56	5	a	a	DET
aiua-10710	56	6	significant	significant	ADJ
aiua-10710	56	7	reduction	reduction	NOUN
aiua-10710	56	8	in	in	ADP
aiua-10710	56	9	both	both	DET
aiua-10710	56	10	groups	group	NOUN
aiua-10710	56	11	,	,	PUNCT
aiua-10710	56	12	with	with	ADP
aiua-10710	56	13	a	a	DET
aiua-10710	56	14	statistically	statistically	ADV
aiua-10710	56	15	higher	high	ADJ
aiua-10710	56	16	reduction	reduction	NOUN
aiua-10710	56	17	in	in	ADP
aiua-10710	56	18	group	group	NOUN
aiua-10710	56	19	1	1	NUM
aiua-10710	56	20	patients	patient	NOUN
aiua-10710	56	21	compared	compare	VERB
aiua-10710	56	22	to	to	ADP
aiua-10710	56	23	group	group	NOUN
aiua-10710	56	24	2	2	NUM
aiua-10710	56	25	patients	patient	NOUN
aiua-10710	56	26	(	(	PUNCT
aiua-10710	56	27	table	table	NOUN
aiua-10710	56	28	2	2	NUM
aiua-10710	56	29	)	)	PUNCT
aiua-10710	56	30	.	.	PUNCT
aiua-10710	57	1	at	at	ADP
aiua-10710	57	2	sixth	sixth	ADJ
aiua-10710	57	3	month	month	NOUN
aiua-10710	57	4	treatment	treatment	NOUN
aiua-10710	57	5	follow	follow	VERB
aiua-10710	57	6	up	up	ADP
aiua-10710	57	7	,	,	PUNCT
aiua-10710	57	8	68	68	NUM
aiua-10710	57	9	of	of	ADP
aiua-10710	57	10	107	107	NUM
aiua-10710	57	11	patients	patient	NOUN
aiua-10710	57	12	(	(	PUNCT
aiua-10710	57	13	64	64	NUM
aiua-10710	57	14	%	%	NOUN
aiua-10710	57	15	)	)	PUNCT
aiua-10710	57	16	in	in	ADP
aiua-10710	57	17	group	group	NOUN
aiua-10710	57	18	1	1	NUM
aiua-10710	57	19	stated	state	VERB
aiua-10710	57	20	completely	completely	ADV
aiua-10710	57	21	relief	relief	NOUN
aiua-10710	57	22	in	in	ADP
aiua-10710	57	23	pain	pain	NOUN
aiua-10710	57	24	during	during	ADP
aiua-10710	57	25	erection	erection	NOUN
aiua-10710	57	26	,	,	PUNCT
aiua-10710	57	27	while	while	SCONJ
aiua-10710	57	28	completely	completely	ADV
aiua-10710	57	29	relief	relief	NOUN
aiua-10710	57	30	in	in	ADP
aiua-10710	57	31	pain	pain	NOUN
aiua-10710	57	32	was	be	AUX
aiua-10710	57	33	described	describe	VERB
aiua-10710	57	34	by	by	ADP
aiua-10710	57	35	37	37	NUM
aiua-10710	57	36	of	of	ADP
aiua-10710	57	37	79	79	NUM
aiua-10710	57	38	patients	patient	NOUN
aiua-10710	57	39	(	(	PUNCT
aiua-10710	57	40	47	47	NUM
aiua-10710	57	41	%	%	NOUN
aiua-10710	57	42	)	)	PUNCT
aiua-10710	57	43	in	in	ADP
aiua-10710	57	44	group	group	NOUN
aiua-10710	57	45	2	2	NUM
aiua-10710	57	46	.	.	PUNCT
aiua-10710	58	1	mean	mean	PROPN
aiua-10710	58	2	iief-5	iief-5	NUM
aiua-10710	58	3	scores	score	NOUN
aiua-10710	58	4	increased	increase	VERB
aiua-10710	58	5	from	from	ADP
aiua-10710	58	6	12.78	12.78	NUM
aiua-10710	58	7	±	±	NUM
aiua-10710	58	8	6.46	6.46	NUM
aiua-10710	58	9	to	to	ADP
aiua-10710	58	10	17.89	17.89	NUM
aiua-10710	58	11	±	±	NUM
aiua-10710	58	12	82	82	NUM
aiua-10710	58	13	in	in	ADP
aiua-10710	58	14	group	group	NOUN
aiua-10710	58	15	1	1	NUM
aiua-10710	58	16	and	and	CCONJ
aiua-10710	58	17	from	from	ADP
aiua-10710	58	18	11.86	11.86	NUM
aiua-10710	58	19	±	±	NUM
aiua-10710	58	20	6.21	6.21	NUM
aiua-10710	58	21	to	to	ADP
aiua-10710	58	22	13.02	13.02	NUM
aiua-10710	58	23	±	±	NUM
aiua-10710	58	24	6.78	6.78	NUM
aiua-10710	58	25	in	in	ADP
aiua-10710	58	26	group	group	NOUN
aiua-10710	58	27	2	2	NUM
aiua-10710	58	28	at	at	ADP
aiua-10710	58	29	the	the	DET
aiua-10710	58	30	postoperative	postoperative	ADJ
aiua-10710	58	31	period	period	NOUN
aiua-10710	58	32	.	.	PUNCT
aiua-10710	59	1	compared	compare	VERB
aiua-10710	59	2	with	with	ADP
aiua-10710	59	3	the	the	DET
aiua-10710	59	4	baseline	baseline	NOUN
aiua-10710	59	5	values	value	NOUN
aiua-10710	59	6	,	,	PUNCT
aiua-10710	59	7	the	the	DET
aiua-10710	59	8	mean	mean	NOUN
aiua-10710	59	9	iief-5	iief-5	NUM
aiua-10710	59	10	scores	score	NOUN
aiua-10710	59	11	in	in	ADP
aiua-10710	59	12	group	group	NOUN
aiua-10710	59	13	1	1	NUM
aiua-10710	59	14	were	be	AUX
aiua-10710	59	15	significantly	significantly	ADV
aiua-10710	59	16	different	different	ADJ
aiua-10710	59	17	at	at	ADP
aiua-10710	59	18	sixth	sixth	ADJ
aiua-10710	59	19	month	month	NOUN
aiua-10710	59	20	treatment	treatment	NOUN
aiua-10710	59	21	follow	follow	VERB
aiua-10710	59	22	up	up	ADP
aiua-10710	59	23	,	,	PUNCT
aiua-10710	59	24	while	while	SCONJ
aiua-10710	59	25	no	no	DET
aiua-10710	59	26	significant	significant	ADJ
aiua-10710	59	27	changes	change	NOUN
aiua-10710	59	28	were	be	AUX
aiua-10710	59	29	found	find	VERB
aiua-10710	59	30	in	in	ADP
aiua-10710	59	31	group	group	NOUN
aiua-10710	59	32	2	2	NUM
aiua-10710	59	33	(	(	PUNCT
aiua-10710	59	34	table	table	NOUN
aiua-10710	59	35	2	2	NUM
aiua-10710	59	36	)	)	PUNCT
aiua-10710	59	37	.	.	PUNCT
aiua-10710	60	1	no	no	DET
aiua-10710	60	2	clinically	clinically	ADV
aiua-10710	60	3	significant	significant	ADJ
aiua-10710	60	4	side	side	NOUN
aiua-10710	60	5	effects	effect	NOUN
aiua-10710	60	6	were	be	AUX
aiua-10710	60	7	observed	observe	VERB
aiua-10710	60	8	in	in	ADP
aiua-10710	60	9	any	any	DET
aiua-10710	60	10	patients	patient	NOUN
aiua-10710	60	11	in	in	ADP
aiua-10710	60	12	both	both	DET
aiua-10710	60	13	groups	group	NOUN
aiua-10710	60	14	.	.	PUNCT
aiua-10710	61	1	discussion	discussion	NOUN
aiua-10710	61	2	our	our	PRON
aiua-10710	61	3	study	study	NOUN
aiua-10710	61	4	investigated	investigate	VERB
aiua-10710	61	5	the	the	DET
aiua-10710	61	6	addition	addition	NOUN
aiua-10710	61	7	of	of	ADP
aiua-10710	61	8	pde5i	pde5i	PROPN
aiua-10710	61	9	to	to	ADP
aiua-10710	61	10	conventional	conventional	ADJ
aiua-10710	61	11	combined	combine	VERB
aiua-10710	61	12	oral	oral	ADJ
aiua-10710	61	13	therapy	therapy	NOUN
aiua-10710	61	14	in	in	ADP
aiua-10710	61	15	acute	acute	NOUN
aiua-10710	61	16	-	-	PUNCT
aiua-10710	61	17	phase	phase	NOUN
aiua-10710	61	18	pd	pd	NOUN
aiua-10710	61	19	and	and	CCONJ
aiua-10710	61	20	found	find	VERB
aiua-10710	61	21	that	that	SCONJ
aiua-10710	61	22	adding	add	VERB
aiua-10710	61	23	a	a	DET
aiua-10710	61	24	pde5i	pde5i	PROPN
aiua-10710	61	25	to	to	ADP
aiua-10710	61	26	the	the	DET
aiua-10710	61	27	conventional	conventional	ADJ
aiua-10710	61	28	treatment	treatment	NOUN
aiua-10710	61	29	of	of	ADP
aiua-10710	61	30	pd	pd	PROPN
aiua-10710	61	31	patients	patient	NOUN
aiua-10710	61	32	may	may	AUX
aiua-10710	61	33	be	be	AUX
aiua-10710	61	34	worthwhile	worthwhile	ADJ
aiua-10710	61	35	,	,	PUNCT
aiua-10710	61	36	in	in	ADP
aiua-10710	61	37	the	the	DET
aiua-10710	61	38	improvement	improvement	NOUN
aiua-10710	61	39	of	of	ADP
aiua-10710	61	40	degree	degree	NOUN
aiua-10710	61	41	of	of	ADP
aiua-10710	61	42	curvature	curvature	NOUN
aiua-10710	61	43	and	and	CCONJ
aiua-10710	61	44	erectile	erectile	ADJ
aiua-10710	61	45	pain	pain	NOUN
aiua-10710	61	46	.	.	PUNCT
aiua-10710	62	1	the	the	DET
aiua-10710	62	2	acute	acute	ADJ
aiua-10710	62	3	phase	phase	NOUN
aiua-10710	62	4	is	be	AUX
aiua-10710	62	5	characterized	characterize	VERB
aiua-10710	62	6	by	by	ADP
aiua-10710	62	7	painful	painful	ADJ
aiua-10710	62	8	erections	erection	NOUN
aiua-10710	62	9	,	,	PUNCT
aiua-10710	62	10	soft	soft	ADJ
aiua-10710	62	11	plaques	plaque	NOUN
aiua-10710	62	12	,	,	PUNCT
aiua-10710	62	13	while	while	SCONJ
aiua-10710	62	14	the	the	DET
aiua-10710	62	15	chronic	chronic	ADJ
aiua-10710	62	16	phase	phase	NOUN
aiua-10710	62	17	is	be	AUX
aiua-10710	62	18	characterized	characterize	VERB
aiua-10710	62	19	by	by	ADP
aiua-10710	62	20	fibrotic	fibrotic	ADJ
aiua-10710	62	21	/	/	SYM
aiua-10710	62	22	calcified	calcified	ADJ
aiua-10710	62	23	plaque	plaque	NOUN
aiua-10710	62	24	and	and	CCONJ
aiua-10710	62	25	stable	stable	ADJ
aiua-10710	62	26	disease	disease	NOUN
aiua-10710	62	27	.	.	PUNCT
aiua-10710	63	1	although	although	SCONJ
aiua-10710	63	2	spontaneous	spontaneous	ADJ
aiua-10710	63	3	remission	remission	NOUN
aiua-10710	63	4	is	be	AUX
aiua-10710	63	5	reported	report	VERB
aiua-10710	63	6	in	in	ADP
aiua-10710	63	7	3	3	NUM
aiua-10710	63	8	-	-	SYM
aiua-10710	63	9	13	13	NUM
aiua-10710	63	10	%	%	NOUN
aiua-10710	63	11	of	of	ADP
aiua-10710	63	12	pd	pd	PROPN
aiua-10710	63	13	cases	case	NOUN
aiua-10710	63	14	,	,	PUNCT
aiua-10710	63	15	the	the	DET
aiua-10710	63	16	disease	disease	NOUN
aiua-10710	63	17	stabilizes	stabilize	VERB
aiua-10710	63	18	or	or	CCONJ
aiua-10710	63	19	worsens	worsen	VERB
aiua-10710	63	20	in	in	ADP
aiua-10710	63	21	majority	majority	NOUN
aiua-10710	63	22	of	of	ADP
aiua-10710	63	23	the	the	DET
aiua-10710	63	24	cases	case	NOUN
aiua-10710	63	25	(	(	PUNCT
aiua-10710	63	26	10	10	NUM
aiua-10710	63	27	)	)	PUNCT
aiua-10710	63	28	.	.	PUNCT
aiua-10710	64	1	to	to	ADP
aiua-10710	64	2	date	date	NOUN
aiua-10710	64	3	,	,	PUNCT
aiua-10710	64	4	various	various	ADJ
aiua-10710	64	5	oral	oral	ADJ
aiua-10710	64	6	medications	medication	NOUN
aiua-10710	64	7	have	have	AUX
aiua-10710	64	8	been	be	AUX
aiua-10710	64	9	used	use	VERB
aiua-10710	64	10	in	in	ADP
aiua-10710	64	11	the	the	DET
aiua-10710	64	12	acute	acute	ADJ
aiua-10710	64	13	phase	phase	NOUN
aiua-10710	64	14	,	,	PUNCT
aiua-10710	64	15	including	include	VERB
aiua-10710	64	16	potassium	potassium	NOUN
aiua-10710	64	17	aminobenzoate	aminobenzoate	NOUN
aiua-10710	64	18	,	,	PUNCT
aiua-10710	64	19	colchicine	colchicine	PROPN
aiua-10710	64	20	,	,	PUNCT
aiua-10710	64	21	ptx	ptx	NOUN
aiua-10710	64	22	,	,	PUNCT
aiua-10710	64	23	vitamin	vitamin	NOUN
aiua-10710	64	24	e	e	NOUN
aiua-10710	64	25	,	,	PUNCT
aiua-10710	64	26	tamoxifen	tamoxifen	NOUN
aiua-10710	64	27	,	,	PUNCT
aiua-10710	64	28	orgotein	orgotein	ADV
aiua-10710	64	29	,	,	PUNCT
aiua-10710	64	30	and	and	CCONJ
aiua-10710	64	31	carnitine	carnitine	ADJ
aiua-10710	64	32	acetyl	acetyl	NOUN
aiua-10710	64	33	ester	ester	NOUN
aiua-10710	64	34	table	table	NOUN
aiua-10710	64	35	1	1	NUM
aiua-10710	64	36	.	.	PUNCT
aiua-10710	65	1	mean	mean	VERB
aiua-10710	65	2	baseline	baseline	ADJ
aiua-10710	65	3	clinical	clinical	ADJ
aiua-10710	65	4	characteristics	characteristic	NOUN
aiua-10710	65	5	of	of	ADP
aiua-10710	65	6	the	the	DET
aiua-10710	65	7	patients	patient	NOUN
aiua-10710	65	8	.	.	PUNCT
aiua-10710	66	1	group	group	NOUN
aiua-10710	66	2	1	1	NUM
aiua-10710	66	3	(	(	PUNCT
aiua-10710	66	4	n	n	NOUN
aiua-10710	66	5	=	=	SYM
aiua-10710	66	6	107	107	NUM
aiua-10710	66	7	)	)	PUNCT
aiua-10710	66	8	group	group	NOUN
aiua-10710	66	9	2	2	NUM
aiua-10710	66	10	(	(	PUNCT
aiua-10710	66	11	n	n	NOUN
aiua-10710	66	12	=	=	SYM
aiua-10710	66	13	79	79	NUM
aiua-10710	66	14	)	)	PUNCT
aiua-10710	66	15	p	p	NOUN
aiua-10710	66	16	age	age	NOUN
aiua-10710	66	17	56.1	56.1	NUM
aiua-10710	66	18	±	±	NUM
aiua-10710	66	19	10.2	10.2	NUM
aiua-10710	66	20	53.54	53.54	NUM
aiua-10710	66	21	±	±	NUM
aiua-10710	66	22	13.4	13.4	NUM
aiua-10710	66	23	0.456	0.456	NUM
aiua-10710	66	24	duration	duration	NOUN
aiua-10710	66	25	of	of	ADP
aiua-10710	66	26	symptoms	symptom	NOUN
aiua-10710	66	27	(	(	PUNCT
aiua-10710	66	28	months	month	NOUN
aiua-10710	66	29	)	)	PUNCT
aiua-10710	66	30	9.2	9.2	NUM
aiua-10710	66	31	±	±	NUM
aiua-10710	66	32	2.1	2.1	NUM
aiua-10710	66	33	8.9	8.9	NUM
aiua-10710	66	34	±	±	NUM
aiua-10710	66	35	2.0	2.0	NUM
aiua-10710	66	36	0.836	0.836	NUM
aiua-10710	66	37	erectile	erectile	NOUN
aiua-10710	66	38	function	function	NOUN
aiua-10710	66	39	visual	visual	ADJ
aiua-10710	66	40	analog	analog	NOUN
aiua-10710	66	41	scale	scale	NOUN
aiua-10710	66	42	(	(	PUNCT
aiua-10710	66	43	ef	ef	NOUN
aiua-10710	66	44	-	-	PUNCT
aiua-10710	66	45	vas	vas	NOUN
aiua-10710	66	46	)	)	PUNCT
aiua-10710	66	47	score	score	VERB
aiua-10710	66	48	6.89	6.89	NUM
aiua-10710	66	49	±	±	NUM
aiua-10710	66	50	3.02	3.02	NUM
aiua-10710	66	51	6.14	6.14	NUM
aiua-10710	66	52	±	±	NUM
aiua-10710	66	53	2.78	2.78	NUM
aiua-10710	66	54	0.642	0.642	NUM
aiua-10710	66	55	degree	degree	NOUN
aiua-10710	66	56	of	of	ADP
aiua-10710	66	57	curvature	curvature	NOUN
aiua-10710	66	58	(	(	PUNCT
aiua-10710	66	59	º	º	NOUN
aiua-10710	66	60	)	)	PUNCT
aiua-10710	66	61	35.1	35.1	NUM
aiua-10710	66	62	±	±	NUM
aiua-10710	66	63	16.3	16.3	NUM
aiua-10710	66	64	36.6	36.6	NUM
aiua-10710	66	65	±	±	NUM
aiua-10710	66	66	17.8	17.8	NUM
aiua-10710	66	67	0.696	0.696	NUM
aiua-10710	66	68	iief-5	iief-5	NUM
aiua-10710	66	69	score	score	VERB
aiua-10710	66	70	13.78	13.78	NUM
aiua-10710	66	71	±	±	NUM
aiua-10710	66	72	6.46	6.46	NUM
aiua-10710	66	73	14.10	14.10	NUM
aiua-10710	66	74	±	±	NUM
aiua-10710	66	75	6.77	6.77	NUM
aiua-10710	66	76	0.976	0.976	NUM
aiua-10710	66	77	table	table	NOUN
aiua-10710	66	78	2	2	NUM
aiua-10710	66	79	.	.	PUNCT
aiua-10710	66	80	comparison	comparison	NOUN
aiua-10710	66	81	of	of	ADP
aiua-10710	66	82	the	the	DET
aiua-10710	66	83	groups	group	NOUN
aiua-10710	66	84	at	at	ADP
aiua-10710	66	85	pre	pre	ADJ
aiua-10710	66	86	-	-	NOUN
aiua-10710	66	87	treatment	treatment	NOUN
aiua-10710	66	88	and	and	CCONJ
aiua-10710	66	89	post	post	ADJ
aiua-10710	66	90	-	-	ADJ
aiua-10710	66	91	treatment	treatment	NOUN
aiua-10710	66	92	evaluation	evaluation	NOUN
aiua-10710	66	93	regarding	regard	VERB
aiua-10710	66	94	peyronie	peyronie	NOUN
aiua-10710	66	95	plaque	plaque	NOUN
aiua-10710	66	96	characteristics	characteristic	NOUN
aiua-10710	66	97	and	and	CCONJ
aiua-10710	66	98	iief-5	iief-5	NUM
aiua-10710	66	99	questionnaire	questionnaire	NOUN
aiua-10710	66	100	.	.	PUNCT
aiua-10710	67	1	group	group	NOUN
aiua-10710	67	2	1	1	NUM
aiua-10710	67	3	group	group	NOUN
aiua-10710	67	4	2	2	NUM
aiua-10710	67	5	post	post	ADJ
aiua-10710	67	6	-	-	ADJ
aiua-10710	67	7	treatment	treatment	ADJ
aiua-10710	67	8	comparison	comparison	NOUN
aiua-10710	67	9	(	(	PUNCT
aiua-10710	67	10	n	n	NOUN
aiua-10710	67	11	=	=	SYM
aiua-10710	67	12	107	107	NUM
aiua-10710	67	13	)	)	PUNCT
aiua-10710	67	14	(	(	PUNCT
aiua-10710	67	15	n	n	NOUN
aiua-10710	67	16	=	=	SYM
aiua-10710	67	17	79	79	NUM
aiua-10710	67	18	)	)	PUNCT
aiua-10710	67	19	between	between	ADP
aiua-10710	67	20	the	the	DET
aiua-10710	67	21	group	group	NOUN
aiua-10710	67	22	1	1	NUM
aiua-10710	67	23	and	and	CCONJ
aiua-10710	67	24	group	group	NOUN
aiua-10710	67	25	2	2	NUM
aiua-10710	67	26	pre	pre	ADJ
aiua-10710	67	27	-	-	ADJ
aiua-10710	67	28	treatment	treatment	ADJ
aiua-10710	67	29	post	post	ADJ
aiua-10710	67	30	-	-	NOUN
aiua-10710	67	31	treatment	treatment	NOUN
aiua-10710	67	32	p	p	NOUN
aiua-10710	67	33	pre	pre	ADJ
aiua-10710	67	34	-	-	ADJ
aiua-10710	67	35	treatment	treatment	ADJ
aiua-10710	67	36	post	post	NOUN
aiua-10710	67	37	-	-	NOUN
aiua-10710	67	38	treatment	treatment	ADJ
aiua-10710	67	39	p	p	NOUN
aiua-10710	67	40	p	p	NOUN
aiua-10710	67	41	degree	degree	NOUN
aiua-10710	67	42	of	of	ADP
aiua-10710	67	43	curvature	curvature	NOUN
aiua-10710	67	44	(	(	PUNCT
aiua-10710	67	45	º	º	NOUN
aiua-10710	67	46	)	)	PUNCT
aiua-10710	67	47	35.1	35.1	NUM
aiua-10710	67	48	±	±	NUM
aiua-10710	67	49	16.3	16.3	NUM
aiua-10710	67	50	24.08	24.08	NUM
aiua-10710	67	51	±	±	NUM
aiua-10710	67	52	11.2	11.2	NUM
aiua-10710	67	53	0.045	0.045	NUM
aiua-10710	67	54	36.6	36.6	NUM
aiua-10710	67	55	±	±	NUM
aiua-10710	67	56	17.8	17.8	NUM
aiua-10710	67	57	30.0	30.0	NUM
aiua-10710	67	58	±	±	NUM
aiua-10710	67	59	14.3	14.3	NUM
aiua-10710	67	60	0.067	0.067	NUM
aiua-10710	67	61	0.022	0.022	NUM
aiua-10710	67	62	erectile	erectile	NOUN
aiua-10710	67	63	function	function	NOUN
aiua-10710	67	64	visual	visual	ADJ
aiua-10710	67	65	analog	analog	NOUN
aiua-10710	67	66	scale	scale	NOUN
aiua-10710	67	67	(	(	PUNCT
aiua-10710	67	68	ef	ef	NOUN
aiua-10710	67	69	-	-	PUNCT
aiua-10710	67	70	vas	vas	NOUN
aiua-10710	67	71	)	)	PUNCT
aiua-10710	67	72	score	score	VERB
aiua-10710	67	73	6.89	6.89	NUM
aiua-10710	67	74	±	±	NUM
aiua-10710	67	75	3.02	3.02	NUM
aiua-10710	67	76	3.89	3.89	NUM
aiua-10710	67	77	±	±	NUM
aiua-10710	67	78	1.06	1.06	NUM
aiua-10710	67	79	0.024	0.024	NUM
aiua-10710	67	80	6.14	6.14	NUM
aiua-10710	67	81	±	±	NUM
aiua-10710	67	82	2.78	2.78	NUM
aiua-10710	67	83	4.7	4.7	NUM
aiua-10710	67	84	±	±	NUM
aiua-10710	67	85	1.78	1.78	NUM
aiua-10710	67	86	0.039	0.039	NUM
aiua-10710	67	87	0.038	0.038	NUM
aiua-10710	67	88	iief-5	iief-5	NUM
aiua-10710	67	89	score	score	VERB
aiua-10710	67	90	12.78	12.78	NUM
aiua-10710	67	91	±	±	NUM
aiua-10710	67	92	6.46	6.46	NUM
aiua-10710	67	93	17.89	17.89	NUM
aiua-10710	67	94	±	±	NUM
aiua-10710	67	95	82	82	NUM
aiua-10710	67	96	0.021	0.021	NUM
aiua-10710	67	97	11.86	11.86	NUM
aiua-10710	67	98	±	±	NUM
aiua-10710	67	99	6.34	6.34	NUM
aiua-10710	67	100	13.02	13.02	NUM
aiua-10710	67	101	±	±	NUM
aiua-10710	67	102	6.78	6.78	NUM
aiua-10710	67	103	0.123	0.123	NUM
aiua-10710	67	104	0.006	0.006	NUM
aiua-10710	67	105	321archivio	321archivio	PROPN
aiua-10710	67	106	italiano	italiano	NOUN
aiua-10710	67	107	di	di	NOUN
aiua-10710	67	108	urologia	urologia	PROPN
aiua-10710	67	109	e	e	PROPN
aiua-10710	67	110	andrologia	andrologia	PROPN
aiua-10710	67	111	2022	2022	NUM
aiua-10710	67	112	;	;	PUNCT
aiua-10710	67	113	94	94	NUM
aiua-10710	67	114	,	,	PUNCT
aiua-10710	67	115	3	3	NUM
aiua-10710	67	116	effects	effect	NOUN
aiua-10710	67	117	of	of	ADP
aiua-10710	67	118	sildenafil	sildenafil	NOUN
aiua-10710	67	119	on	on	ADP
aiua-10710	67	120	peyronie	peyronie	NOUN
aiua-10710	67	121	’s	’s	PART
aiua-10710	67	122	disease	disease	NOUN
aiua-10710	67	123	(	(	PUNCT
aiua-10710	67	124	11	11	NUM
aiua-10710	67	125	)	)	PUNCT
aiua-10710	67	126	.	.	PUNCT
aiua-10710	68	1	the	the	DET
aiua-10710	68	2	clinical	clinical	ADJ
aiua-10710	68	3	benefits	benefit	NOUN
aiua-10710	68	4	of	of	ADP
aiua-10710	68	5	oral	oral	ADJ
aiua-10710	68	6	agents	agent	NOUN
aiua-10710	68	7	such	such	ADJ
aiua-10710	68	8	as	as	ADP
aiua-10710	68	9	potassium	potassium	NOUN
aiua-10710	68	10	aminobenzoate	aminobenzoate	NOUN
aiua-10710	68	11	,	,	PUNCT
aiua-10710	68	12	ptx	ptx	NOUN
aiua-10710	68	13	,	,	PUNCT
aiua-10710	68	14	colchicine	colchicine	PROPN
aiua-10710	68	15	,	,	PUNCT
aiua-10710	68	16	and	and	CCONJ
aiua-10710	68	17	coenzyme	coenzyme	PROPN
aiua-10710	68	18	q10	q10	PROPN
aiua-10710	68	19	have	have	AUX
aiua-10710	68	20	been	be	AUX
aiua-10710	68	21	reported	report	VERB
aiua-10710	68	22	in	in	ADP
aiua-10710	68	23	different	different	ADJ
aiua-10710	68	24	studies	study	NOUN
aiua-10710	68	25	and	and	CCONJ
aiua-10710	68	26	are	be	AUX
aiua-10710	68	27	considered	consider	VERB
aiua-10710	68	28	as	as	ADP
aiua-10710	68	29	a	a	DET
aiua-10710	68	30	part	part	NOUN
aiua-10710	68	31	of	of	ADP
aiua-10710	68	32	single	single	ADJ
aiua-10710	68	33	or	or	CCONJ
aiua-10710	68	34	multimodal	multimodal	NOUN
aiua-10710	68	35	therapy	therapy	NOUN
aiua-10710	68	36	for	for	ADP
aiua-10710	68	37	clinical	clinical	ADJ
aiua-10710	68	38	use	use	NOUN
aiua-10710	68	39	,	,	PUNCT
aiua-10710	68	40	but	but	CCONJ
aiua-10710	68	41	no	no	DET
aiua-10710	68	42	single	single	ADJ
aiua-10710	68	43	oral	oral	ADJ
aiua-10710	68	44	pharmacotherapy	pharmacotherapy	NOUN
aiua-10710	68	45	has	have	AUX
aiua-10710	68	46	been	be	AUX
aiua-10710	68	47	approved	approve	VERB
aiua-10710	68	48	for	for	ADP
aiua-10710	68	49	treatment	treatment	NOUN
aiua-10710	68	50	by	by	ADP
aiua-10710	68	51	american	american	ADJ
aiua-10710	68	52	urological	urological	PROPN
aiua-10710	68	53	association	association	PROPN
aiua-10710	68	54	(	(	PUNCT
aiua-10710	68	55	aua	aua	PROPN
aiua-10710	68	56	)	)	PUNCT
aiua-10710	68	57	or	or	CCONJ
aiua-10710	68	58	european	european	ADJ
aiua-10710	68	59	urological	urological	ADJ
aiua-10710	68	60	association	association	PROPN
aiua-10710	68	61	(	(	PUNCT
aiua-10710	68	62	eau	eau	PROPN
aiua-10710	68	63	)	)	PUNCT
aiua-10710	68	64	(	(	PUNCT
aiua-10710	68	65	12	12	NUM
aiua-10710	68	66	,	,	PUNCT
aiua-10710	68	67	13	13	NUM
aiua-10710	68	68	)	)	PUNCT
aiua-10710	68	69	.	.	PUNCT
aiua-10710	69	1	ptx	ptx	PROPN
aiua-10710	69	2	-	-	PUNCT
aiua-10710	69	3	colchicine	colchicine	NOUN
aiua-10710	69	4	combination	combination	NOUN
aiua-10710	69	5	is	be	AUX
aiua-10710	69	6	a	a	DET
aiua-10710	69	7	preferred	preferred	ADJ
aiua-10710	69	8	treatment	treatment	NOUN
aiua-10710	69	9	alternative	alternative	NOUN
aiua-10710	69	10	for	for	ADP
aiua-10710	69	11	pd	pd	PROPN
aiua-10710	69	12	patients	patient	NOUN
aiua-10710	69	13	in	in	ADP
aiua-10710	69	14	our	our	PRON
aiua-10710	69	15	clinic	clinic	NOUN
aiua-10710	69	16	,	,	PUNCT
aiua-10710	69	17	which	which	PRON
aiua-10710	69	18	is	be	AUX
aiua-10710	69	19	associated	associate	VERB
aiua-10710	69	20	with	with	ADP
aiua-10710	69	21	low	low	ADJ
aiua-10710	69	22	side	side	NOUN
aiua-10710	69	23	effect	effect	NOUN
aiua-10710	69	24	,	,	PUNCT
aiua-10710	69	25	low	low	ADJ
aiua-10710	69	26	price	price	NOUN
aiua-10710	69	27	,	,	PUNCT
aiua-10710	69	28	and	and	CCONJ
aiua-10710	69	29	proven	prove	VERB
aiua-10710	69	30	success	success	NOUN
aiua-10710	69	31	rates	rate	NOUN
aiua-10710	69	32	from	from	ADP
aiua-10710	69	33	previous	previous	ADJ
aiua-10710	69	34	studies	study	NOUN
aiua-10710	69	35	.	.	PUNCT
aiua-10710	70	1	10	10	NUM
aiua-10710	70	2	ptx	ptx	NOUN
aiua-10710	70	3	is	be	AUX
aiua-10710	70	4	an	an	DET
aiua-10710	70	5	oral	oral	ADJ
aiua-10710	70	6	drug	drug	NOUN
aiua-10710	70	7	that	that	PRON
aiua-10710	70	8	works	work	VERB
aiua-10710	70	9	through	through	ADP
aiua-10710	70	10	mechanism	mechanism	NOUN
aiua-10710	70	11	that	that	PRON
aiua-10710	70	12	increase	increase	VERB
aiua-10710	70	13	collagen	collagen	NOUN
aiua-10710	70	14	metabolism	metabolism	NOUN
aiua-10710	70	15	,	,	PUNCT
aiua-10710	70	16	downregulate	downregulate	PROPN
aiua-10710	70	17	tgf	tgf	PROPN
aiua-10710	70	18	-	-	PUNCT
aiua-10710	70	19	beta	beta	NOUN
aiua-10710	70	20	,	,	PUNCT
aiua-10710	70	21	and	and	CCONJ
aiua-10710	70	22	reduce	reduce	VERB
aiua-10710	70	23	fibrogenesis	fibrogenesis	NOUN
aiua-10710	70	24	and	and	CCONJ
aiua-10710	70	25	has	have	AUX
aiua-10710	70	26	been	be	AUX
aiua-10710	70	27	used	use	VERB
aiua-10710	70	28	clinically	clinically	ADV
aiua-10710	70	29	in	in	ADP
aiua-10710	70	30	a	a	DET
aiua-10710	70	31	variety	variety	NOUN
aiua-10710	70	32	of	of	ADP
aiua-10710	70	33	inflammatory	inflammatory	ADJ
aiua-10710	70	34	and	and	CCONJ
aiua-10710	70	35	fibrotic	fibrotic	ADJ
aiua-10710	70	36	conditions	condition	NOUN
aiua-10710	70	37	,	,	PUNCT
aiua-10710	70	38	such	such	ADJ
aiua-10710	70	39	as	as	ADP
aiua-10710	70	40	radiation	radiation	NOUN
aiua-10710	70	41	fibrosis	fibrosis	NOUN
aiua-10710	70	42	,	,	PUNCT
aiua-10710	70	43	radiation	radiation	NOUN
aiua-10710	70	44	proctitis	proctitis	NOUN
aiua-10710	70	45	,	,	PUNCT
aiua-10710	70	46	cystic	cystic	ADJ
aiua-10710	70	47	fibrosis	fibrosis	NOUN
aiua-10710	70	48	,	,	PUNCT
aiua-10710	70	49	radiation	radiation	NOUN
aiua-10710	70	50	pneumonitis	pneumonitis	NOUN
aiua-10710	70	51	(	(	PUNCT
aiua-10710	70	52	14	14	NUM
aiua-10710	70	53	,	,	PUNCT
aiua-10710	70	54	15	15	NUM
aiua-10710	70	55	)	)	PUNCT
aiua-10710	70	56	.	.	PUNCT
aiua-10710	71	1	significant	significant	ADJ
aiua-10710	71	2	improvements	improvement	NOUN
aiua-10710	71	3	in	in	ADP
aiua-10710	71	4	degree	degree	NOUN
aiua-10710	71	5	of	of	ADP
aiua-10710	71	6	curvature	curvature	NOUN
aiua-10710	71	7	,	,	PUNCT
aiua-10710	71	8	plaque	plaque	NOUN
aiua-10710	71	9	volume	volume	NOUN
aiua-10710	71	10	,	,	PUNCT
aiua-10710	71	11	pain	pain	NOUN
aiua-10710	71	12	intensity	intensity	NOUN
aiua-10710	71	13	,	,	PUNCT
aiua-10710	71	14	and	and	CCONJ
aiua-10710	71	15	penile	penile	ADJ
aiua-10710	71	16	rigidity	rigidity	NOUN
aiua-10710	71	17	after	after	SCONJ
aiua-10710	71	18	ptx	ptx	NOUN
aiua-10710	71	19	treatment	treatment	NOUN
aiua-10710	71	20	support	support	VERB
aiua-10710	71	21	the	the	DET
aiua-10710	71	22	effectiveness	effectiveness	NOUN
aiua-10710	71	23	of	of	ADP
aiua-10710	71	24	the	the	DET
aiua-10710	71	25	treatment	treatment	NOUN
aiua-10710	71	26	in	in	ADP
aiua-10710	71	27	pd	pd	PROPN
aiua-10710	71	28	patients	patient	NOUN
aiua-10710	71	29	(	(	PUNCT
aiua-10710	71	30	16	16	NUM
aiua-10710	71	31	,	,	PUNCT
aiua-10710	71	32	17	17	NUM
aiua-10710	71	33	)	)	PUNCT
aiua-10710	71	34	.	.	PUNCT
aiua-10710	72	1	colchicine	colchicine	PROPN
aiua-10710	72	2	,	,	PUNCT
aiua-10710	72	3	a	a	DET
aiua-10710	72	4	commonly	commonly	ADV
aiua-10710	72	5	used	use	VERB
aiua-10710	72	6	oral	oral	ADJ
aiua-10710	72	7	therapy	therapy	NOUN
aiua-10710	72	8	,	,	PUNCT
aiua-10710	72	9	can	can	AUX
aiua-10710	72	10	significantly	significantly	ADV
aiua-10710	72	11	improve	improve	VERB
aiua-10710	72	12	pain	pain	NOUN
aiua-10710	72	13	relief	relief	NOUN
aiua-10710	72	14	and	and	CCONJ
aiua-10710	72	15	penile	penile	NOUN
aiua-10710	72	16	curvature	curvature	NOUN
aiua-10710	72	17	as	as	ADP
aiua-10710	72	18	monotherapy	monotherapy	NOUN
aiua-10710	72	19	or	or	CCONJ
aiua-10710	72	20	in	in	ADP
aiua-10710	72	21	combination	combination	NOUN
aiua-10710	72	22	therapy	therapy	NOUN
aiua-10710	72	23	(	(	PUNCT
aiua-10710	72	24	18	18	NUM
aiua-10710	72	25	)	)	PUNCT
aiua-10710	72	26	.	.	PUNCT
aiua-10710	73	1	colchicine	colchicine	PROPN
aiua-10710	73	2	binds	bind	VERB
aiua-10710	73	3	to	to	ADP
aiua-10710	73	4	tubulin	tubulin	NOUN
aiua-10710	73	5	,	,	PUNCT
aiua-10710	73	6	blocks	block	NOUN
aiua-10710	73	7	mitosis	mitosis	NOUN
aiua-10710	73	8	,	,	PUNCT
aiua-10710	73	9	reduces	reduce	VERB
aiua-10710	73	10	inflammation	inflammation	NOUN
aiua-10710	73	11	and	and	CCONJ
aiua-10710	73	12	procollagen	procollagen	NOUN
aiua-10710	73	13	formation	formation	NOUN
aiua-10710	73	14	,	,	PUNCT
aiua-10710	73	15	and	and	CCONJ
aiua-10710	73	16	increases	increase	VERB
aiua-10710	73	17	collagenase	collagenase	NOUN
aiua-10710	73	18	production	production	NOUN
aiua-10710	73	19	.	.	PUNCT
aiua-10710	74	1	colchicine	colchicine	PROPN
aiua-10710	74	2	therapy	therapy	NOUN
aiua-10710	74	3	appears	appear	VERB
aiua-10710	74	4	to	to	PART
aiua-10710	74	5	have	have	VERB
aiua-10710	74	6	conflicting	conflicting	ADJ
aiua-10710	74	7	results	result	NOUN
aiua-10710	74	8	,	,	PUNCT
aiua-10710	74	9	and	and	CCONJ
aiua-10710	74	10	most	most	ADJ
aiua-10710	74	11	studies	study	NOUN
aiua-10710	74	12	show	show	VERB
aiua-10710	74	13	colchicine	colchicine	NOUN
aiua-10710	74	14	success	success	NOUN
aiua-10710	74	15	in	in	ADP
aiua-10710	74	16	30	30	NUM
aiua-10710	74	17	%	%	NOUN
aiua-10710	74	18	to	to	PART
aiua-10710	74	19	50	50	NUM
aiua-10710	74	20	%	%	NOUN
aiua-10710	74	21	of	of	ADP
aiua-10710	74	22	pd	pd	PROPN
aiua-10710	74	23	patients	patient	NOUN
aiua-10710	74	24	(	(	PUNCT
aiua-10710	74	25	18	18	NUM
aiua-10710	74	26	-	-	SYM
aiua-10710	74	27	19	19	NUM
aiua-10710	74	28	)	)	PUNCT
aiua-10710	74	29	.	.	PUNCT
aiua-10710	75	1	although	although	SCONJ
aiua-10710	75	2	various	various	ADJ
aiua-10710	75	3	oral	oral	ADJ
aiua-10710	75	4	treatments	treatment	NOUN
aiua-10710	75	5	are	be	AUX
aiua-10710	75	6	effective	effective	ADJ
aiua-10710	75	7	in	in	ADP
aiua-10710	75	8	pd	pd	PROPN
aiua-10710	75	9	patients	patient	NOUN
aiua-10710	75	10	,	,	PUNCT
aiua-10710	75	11	the	the	DET
aiua-10710	75	12	lack	lack	NOUN
aiua-10710	75	13	of	of	ADP
aiua-10710	75	14	consensus	consensus	NOUN
aiua-10710	75	15	on	on	ADP
aiua-10710	75	16	oral	oral	ADJ
aiua-10710	75	17	treatment	treatment	NOUN
aiua-10710	75	18	increases	increase	VERB
aiua-10710	75	19	the	the	DET
aiua-10710	75	20	trend	trend	NOUN
aiua-10710	75	21	towards	towards	ADP
aiua-10710	75	22	alternative	alternative	ADJ
aiua-10710	75	23	treatments	treatment	NOUN
aiua-10710	75	24	.	.	PUNCT
aiua-10710	76	1	we	we	PRON
aiua-10710	76	2	assessed	assess	VERB
aiua-10710	76	3	the	the	DET
aiua-10710	76	4	effect	effect	NOUN
aiua-10710	76	5	of	of	ADP
aiua-10710	76	6	supplementation	supplementation	NOUN
aiua-10710	76	7	with	with	ADP
aiua-10710	76	8	50	50	NUM
aiua-10710	76	9	mg	mg	NOUN
aiua-10710	76	10	of	of	ADP
aiua-10710	76	11	sildenafil	sildenafil	NOUN
aiua-10710	76	12	on	on	ADP
aiua-10710	76	13	the	the	DET
aiua-10710	76	14	conventional	conventional	ADJ
aiua-10710	76	15	therapy	therapy	NOUN
aiua-10710	76	16	of	of	ADP
aiua-10710	76	17	pd	pd	PROPN
aiua-10710	76	18	.	.	PUNCT
aiua-10710	77	1	the	the	DET
aiua-10710	77	2	use	use	NOUN
aiua-10710	77	3	of	of	ADP
aiua-10710	77	4	pde5i	pde5i	PROPN
aiua-10710	77	5	in	in	ADP
aiua-10710	77	6	pd	pd	PROPN
aiua-10710	77	7	patients	patient	NOUN
aiua-10710	77	8	is	be	AUX
aiua-10710	77	9	supported	support	VERB
aiua-10710	77	10	by	by	ADP
aiua-10710	77	11	the	the	DET
aiua-10710	77	12	fact	fact	NOUN
aiua-10710	77	13	that	that	SCONJ
aiua-10710	77	14	almost	almost	ADV
aiua-10710	77	15	all	all	DET
aiua-10710	77	16	pd	pd	ADJ
aiua-10710	77	17	patients	patient	NOUN
aiua-10710	77	18	suffer	suffer	VERB
aiua-10710	77	19	from	from	ADP
aiua-10710	77	20	ed	ed	NOUN
aiua-10710	77	21	and	and	CCONJ
aiua-10710	77	22	the	the	DET
aiua-10710	77	23	proven	prove	VERB
aiua-10710	77	24	effects	effect	NOUN
aiua-10710	77	25	of	of	ADP
aiua-10710	77	26	pde5i	pde5i	PROPN
aiua-10710	77	27	on	on	ADP
aiua-10710	77	28	both	both	DET
aiua-10710	77	29	pathologies	pathology	NOUN
aiua-10710	77	30	.	.	PUNCT
aiua-10710	78	1	several	several	ADJ
aiua-10710	78	2	in	in	ADP
aiua-10710	78	3	vitro	vitro	X
aiua-10710	78	4	studies	study	NOUN
aiua-10710	78	5	have	have	AUX
aiua-10710	78	6	shown	show	VERB
aiua-10710	78	7	that	that	SCONJ
aiua-10710	78	8	pde5i	pde5i	PROPN
aiua-10710	78	9	has	have	VERB
aiua-10710	78	10	a	a	DET
aiua-10710	78	11	potential	potential	ADJ
aiua-10710	78	12	anti	anti	ADJ
aiua-10710	78	13	-	-	ADJ
aiua-10710	78	14	fibrotic	fibrotic	ADJ
aiua-10710	78	15	effect	effect	NOUN
aiua-10710	78	16	against	against	ADP
aiua-10710	78	17	peyronie's	peyronie's	NOUN
aiua-10710	78	18	-	-	PUNCT
aiua-10710	78	19	like	like	ADJ
aiua-10710	78	20	plaque	plaque	NOUN
aiua-10710	78	21	(	(	PUNCT
aiua-10710	78	22	6	6	NUM
aiua-10710	78	23	-	-	SYM
aiua-10710	78	24	20	20	NUM
aiua-10710	78	25	)	)	PUNCT
aiua-10710	78	26	.	.	PUNCT
aiua-10710	79	1	no	no	INTJ
aiua-10710	79	2	and	and	CCONJ
aiua-10710	79	3	cyclic	cyclic	ADJ
aiua-10710	79	4	guanosine	guanosine	NOUN
aiua-10710	79	5	3’,5’-monophosphate	3’,5’-monophosphate	NUM
aiua-10710	79	6	(	(	PUNCT
aiua-10710	79	7	cgmp	cgmp	PROPN
aiua-10710	79	8	)	)	PUNCT
aiua-10710	79	9	have	have	VERB
aiua-10710	79	10	anti	anti	ADJ
aiua-10710	79	11	-	-	ADJ
aiua-10710	79	12	fibrotic	fibrotic	ADJ
aiua-10710	79	13	actions	action	NOUN
aiua-10710	79	14	with	with	ADP
aiua-10710	79	15	remarkable	remarkable	ADJ
aiua-10710	79	16	effects	effect	NOUN
aiua-10710	79	17	on	on	ADP
aiua-10710	79	18	collagen	collagen	NOUN
aiua-10710	79	19	synthesis	synthesis	NOUN
aiua-10710	79	20	and	and	CCONJ
aiua-10710	79	21	myofibroblast	myofibroblast	NOUN
aiua-10710	79	22	differentiation	differentiation	NOUN
aiua-10710	79	23	.	.	PUNCT
aiua-10710	80	1	pde-5i	pde-5i	PROPN
aiua-10710	80	2	shows	show	VERB
aiua-10710	80	3	anti	anti	ADJ
aiua-10710	80	4	-	-	ADJ
aiua-10710	80	5	fibrotic	fibrotic	ADJ
aiua-10710	80	6	effects	effect	NOUN
aiua-10710	80	7	by	by	ADP
aiua-10710	80	8	reducing	reduce	VERB
aiua-10710	80	9	collagen	collagen	NOUN
aiua-10710	80	10	deposits	deposit	NOUN
aiua-10710	80	11	and	and	CCONJ
aiua-10710	80	12	oxidative	oxidative	ADJ
aiua-10710	80	13	stress	stress	NOUN
aiua-10710	80	14	,	,	PUNCT
aiua-10710	80	15	inhibiting	inhibit	VERB
aiua-10710	80	16	myofibroblast	myofibroblast	NOUN
aiua-10710	80	17	proliferation	proliferation	NOUN
aiua-10710	80	18	and	and	CCONJ
aiua-10710	80	19	profibrotic	profibrotic	ADJ
aiua-10710	80	20	factor	factor	NOUN
aiua-10710	80	21	secretion	secretion	NOUN
aiua-10710	80	22	(	(	PUNCT
aiua-10710	80	23	3	3	NUM
aiua-10710	80	24	)	)	PUNCT
aiua-10710	80	25	.	.	PUNCT
aiua-10710	81	1	transforming	transform	VERB
aiua-10710	81	2	growth	growth	NOUN
aiua-10710	81	3	factor	factor	NOUN
aiua-10710	81	4	b1	b1	NOUN
aiua-10710	81	5	(	(	PUNCT
aiua-10710	81	6	tgfb1	tgfb1	NOUN
aiua-10710	81	7	)	)	PUNCT
aiua-10710	81	8	is	be	AUX
aiua-10710	81	9	a	a	DET
aiua-10710	81	10	key	key	ADJ
aiua-10710	81	11	profibrotic	profibrotic	ADJ
aiua-10710	81	12	factor	factor	NOUN
aiua-10710	81	13	,	,	PUNCT
aiua-10710	81	14	found	find	VERB
aiua-10710	81	15	in	in	ADP
aiua-10710	81	16	many	many	ADJ
aiua-10710	81	17	tissues	tissue	NOUN
aiua-10710	81	18	and	and	CCONJ
aiua-10710	81	19	demonstrated	demonstrate	VERB
aiua-10710	81	20	in	in	ADP
aiua-10710	81	21	human	human	ADJ
aiua-10710	81	22	pd	pd	NOUN
aiua-10710	81	23	plaques	plaque	NOUN
aiua-10710	81	24	,	,	PUNCT
aiua-10710	81	25	that	that	PRON
aiua-10710	81	26	was	be	AUX
aiua-10710	81	27	also	also	ADV
aiua-10710	81	28	shown	show	VERB
aiua-10710	81	29	at	at	ADP
aiua-10710	81	30	high	high	ADJ
aiua-10710	81	31	levels	level	NOUN
aiua-10710	81	32	in	in	ADP
aiua-10710	81	33	the	the	DET
aiua-10710	81	34	serum	serum	NOUN
aiua-10710	81	35	of	of	ADP
aiua-10710	81	36	pd	pd	PROPN
aiua-10710	81	37	patients	patient	NOUN
aiua-10710	81	38	(	(	PUNCT
aiua-10710	81	39	21	21	NUM
aiua-10710	81	40	)	)	PUNCT
aiua-10710	81	41	.	.	PUNCT
aiua-10710	82	1	following	follow	VERB
aiua-10710	82	2	inhibition	inhibition	NOUN
aiua-10710	82	3	of	of	ADP
aiua-10710	82	4	pde-5	pde-5	ADJ
aiua-10710	82	5	,	,	PUNCT
aiua-10710	82	6	elevated	elevated	ADJ
aiua-10710	82	7	levels	level	NOUN
aiua-10710	82	8	of	of	ADP
aiua-10710	82	9	cgmp	cgmp	PROPN
aiua-10710	82	10	and	and	CCONJ
aiua-10710	82	11	camp	camp	NOUN
aiua-10710	82	12	activate	activate	VERB
aiua-10710	82	13	protein	protein	NOUN
aiua-10710	82	14	kinase	kinase	PROPN
aiua-10710	82	15	g	g	PROPN
aiua-10710	82	16	,	,	PUNCT
aiua-10710	82	17	which	which	PRON
aiua-10710	82	18	play	play	VERB
aiua-10710	82	19	important	important	ADJ
aiua-10710	82	20	role	role	NOUN
aiua-10710	82	21	in	in	ADP
aiua-10710	82	22	the	the	DET
aiua-10710	82	23	apoptosis	apoptosis	NOUN
aiua-10710	82	24	and	and	CCONJ
aiua-10710	82	25	reduced	reduce	VERB
aiua-10710	82	26	collagen	collagen	NOUN
aiua-10710	82	27	synthesis	synthesis	NOUN
aiua-10710	82	28	.	.	PUNCT
aiua-10710	83	1	the	the	DET
aiua-10710	83	2	mentioned	mention	VERB
aiua-10710	83	3	anti	anti	ADJ
aiua-10710	83	4	-	-	ADJ
aiua-10710	83	5	fibrotic	fibrotic	ADJ
aiua-10710	83	6	effects	effect	NOUN
aiua-10710	83	7	are	be	AUX
aiua-10710	83	8	also	also	ADV
aiua-10710	83	9	mediated	mediate	VERB
aiua-10710	83	10	by	by	ADP
aiua-10710	83	11	guanylate	guanylate	NOUN
aiua-10710	83	12	cyclase	cyclase	NOUN
aiua-10710	83	13	inducers	inducer	NOUN
aiua-10710	83	14	by	by	ADP
aiua-10710	83	15	stimulating	stimulate	VERB
aiua-10710	83	16	protein	protein	NOUN
aiua-10710	83	17	kinase	kinase	NOUN
aiua-10710	83	18	g	g	PROPN
aiua-10710	83	19	and	and	CCONJ
aiua-10710	83	20	inhibiting	inhibit	VERB
aiua-10710	83	21	fibrotic	fibrotic	ADJ
aiua-10710	83	22	mediators	mediator	NOUN
aiua-10710	83	23	such	such	ADJ
aiua-10710	83	24	as	as	ADP
aiua-10710	83	25	angiotensin	angiotensin	NOUN
aiua-10710	83	26	2	2	NUM
aiua-10710	83	27	or	or	CCONJ
aiua-10710	83	28	activating	activate	VERB
aiua-10710	83	29	tgf	tgf	PROPN
aiua-10710	83	30	-	-	PUNCT
aiua-10710	83	31	b	b	NOUN
aiua-10710	83	32	and	and	CCONJ
aiua-10710	83	33	rho	rho	ADJ
aiua-10710	83	34	activation	activation	NOUN
aiua-10710	83	35	(	(	PUNCT
aiua-10710	83	36	22	22	NUM
aiua-10710	83	37	,	,	PUNCT
aiua-10710	83	38	23	23	NUM
aiua-10710	83	39	)	)	PUNCT
aiua-10710	83	40	.	.	PUNCT
aiua-10710	84	1	an	an	DET
aiua-10710	84	2	experimental	experimental	ADJ
aiua-10710	84	3	study	study	NOUN
aiua-10710	84	4	showed	show	VERB
aiua-10710	84	5	that	that	SCONJ
aiua-10710	84	6	sildenafil	sildenafil	NOUN
aiua-10710	84	7	and	and	CCONJ
aiua-10710	84	8	oral	oral	ADJ
aiua-10710	84	9	ptx	ptx	NOUN
aiua-10710	84	10	,	,	PUNCT
aiua-10710	84	11	a	a	DET
aiua-10710	84	12	major	major	ADJ
aiua-10710	84	13	pde4	pde4	NOUN
aiua-10710	84	14	inhibitor	inhibitor	NOUN
aiua-10710	84	15	that	that	PRON
aiua-10710	84	16	increases	increase	VERB
aiua-10710	84	17	camp	camp	NOUN
aiua-10710	84	18	synthesis	synthesis	NOUN
aiua-10710	84	19	,	,	PUNCT
aiua-10710	84	20	inhibited	inhibit	VERB
aiua-10710	84	21	the	the	DET
aiua-10710	84	22	development	development	NOUN
aiua-10710	84	23	of	of	ADP
aiua-10710	84	24	pd	pd	ADJ
aiua-10710	84	25	-	-	PUNCT
aiua-10710	84	26	like	like	ADJ
aiua-10710	84	27	plaques	plaque	NOUN
aiua-10710	84	28	(	(	PUNCT
aiua-10710	84	29	24	24	NUM
aiua-10710	84	30	)	)	PUNCT
aiua-10710	84	31	.	.	PUNCT
aiua-10710	85	1	previous	previous	ADJ
aiua-10710	85	2	studies	study	NOUN
aiua-10710	85	3	have	have	AUX
aiua-10710	85	4	shown	show	VERB
aiua-10710	85	5	a	a	DET
aiua-10710	85	6	strong	strong	ADJ
aiua-10710	85	7	relationship	relationship	NOUN
aiua-10710	85	8	between	between	ADP
aiua-10710	85	9	ed	ed	PROPN
aiua-10710	85	10	and	and	CCONJ
aiua-10710	85	11	pd	pd	PROPN
aiua-10710	85	12	,	,	PUNCT
aiua-10710	85	13	ranging	range	VERB
aiua-10710	85	14	from	from	ADP
aiua-10710	85	15	20	20	NUM
aiua-10710	85	16	%	%	NOUN
aiua-10710	85	17	to	to	PART
aiua-10710	85	18	70	70	NUM
aiua-10710	85	19	%	%	NOUN
aiua-10710	85	20	(	(	PUNCT
aiua-10710	85	21	3	3	NUM
aiua-10710	85	22	,	,	PUNCT
aiua-10710	85	23	8	8	NUM
aiua-10710	85	24	,	,	PUNCT
aiua-10710	85	25	25	25	NUM
aiua-10710	85	26	)	)	PUNCT
aiua-10710	85	27	çakan	çakan	PROPN
aiua-10710	85	28	et	et	PROPN
aiua-10710	85	29	al	al	PROPN
aiua-10710	85	30	.	.	PROPN
aiua-10710	85	31	indicated	indicate	VERB
aiua-10710	85	32	that	that	SCONJ
aiua-10710	85	33	one	one	NUM
aiua-10710	85	34	of	of	ADP
aiua-10710	85	35	the	the	DET
aiua-10710	85	36	most	most	ADV
aiua-10710	85	37	common	common	ADJ
aiua-10710	85	38	(	(	PUNCT
aiua-10710	85	39	68.5	68.5	NUM
aiua-10710	85	40	%	%	NOUN
aiua-10710	85	41	)	)	PUNCT
aiua-10710	85	42	presenting	present	VERB
aiua-10710	85	43	symptom	symptom	NOUN
aiua-10710	85	44	in	in	ADP
aiua-10710	85	45	pd	pd	PROPN
aiua-10710	85	46	is	be	AUX
aiua-10710	85	47	ed	ed	NOUN
aiua-10710	85	48	(	(	PUNCT
aiua-10710	85	49	26	26	NUM
aiua-10710	85	50	)	)	PUNCT
aiua-10710	85	51	.	.	PUNCT
aiua-10710	86	1	ed	ed	NOUN
aiua-10710	86	2	may	may	AUX
aiua-10710	86	3	be	be	AUX
aiua-10710	86	4	the	the	DET
aiua-10710	86	5	result	result	NOUN
aiua-10710	86	6	of	of	ADP
aiua-10710	86	7	pd	pd	PROPN
aiua-10710	86	8	,	,	PUNCT
aiua-10710	86	9	or	or	CCONJ
aiua-10710	86	10	the	the	DET
aiua-10710	86	11	two	two	NUM
aiua-10710	86	12	diseases	disease	NOUN
aiua-10710	86	13	may	may	AUX
aiua-10710	86	14	share	share	VERB
aiua-10710	86	15	common	common	ADJ
aiua-10710	86	16	pathophysiological	pathophysiological	ADJ
aiua-10710	86	17	features	feature	NOUN
aiua-10710	86	18	.	.	PUNCT
aiua-10710	87	1	the	the	DET
aiua-10710	87	2	possible	possible	ADJ
aiua-10710	87	3	mechanisms	mechanism	NOUN
aiua-10710	87	4	of	of	ADP
aiua-10710	87	5	development	development	NOUN
aiua-10710	87	6	ed	ed	PROPN
aiua-10710	87	7	in	in	ADP
aiua-10710	87	8	pd	pd	PROPN
aiua-10710	87	9	include	include	VERB
aiua-10710	87	10	avoiding	avoid	VERB
aiua-10710	87	11	coitus	coitus	NOUN
aiua-10710	87	12	due	due	ADP
aiua-10710	87	13	to	to	ADP
aiua-10710	87	14	performance	performance	NOUN
aiua-10710	87	15	anxiety	anxiety	NOUN
aiua-10710	87	16	,	,	PUNCT
aiua-10710	87	17	penile	penile	ADJ
aiua-10710	87	18	pain	pain	NOUN
aiua-10710	87	19	,	,	PUNCT
aiua-10710	87	20	difficulty	difficulty	NOUN
aiua-10710	87	21	in	in	ADP
aiua-10710	87	22	penetration	penetration	NOUN
aiua-10710	87	23	and	and	CCONJ
aiua-10710	87	24	vascular	vascular	ADJ
aiua-10710	87	25	insufficiency	insufficiency	NOUN
aiua-10710	87	26	.	.	PUNCT
aiua-10710	88	1	although	although	SCONJ
aiua-10710	88	2	there	there	PRON
aiua-10710	88	3	are	be	VERB
aiua-10710	88	4	many	many	ADJ
aiua-10710	88	5	well	well	ADV
aiua-10710	88	6	-	-	PUNCT
aiua-10710	88	7	designed	design	VERB
aiua-10710	88	8	experimental	experimental	ADJ
aiua-10710	88	9	studies	study	NOUN
aiua-10710	88	10	and	and	CCONJ
aiua-10710	88	11	animal	animal	NOUN
aiua-10710	88	12	models	model	NOUN
aiua-10710	88	13	regarding	regard	VERB
aiua-10710	88	14	the	the	DET
aiua-10710	88	15	anti	anti	ADJ
aiua-10710	88	16	-	-	ADJ
aiua-10710	88	17	fibrotic	fibrotic	ADJ
aiua-10710	88	18	effects	effect	NOUN
aiua-10710	88	19	of	of	ADP
aiua-10710	88	20	pde5i	pde5i	PROPN
aiua-10710	88	21	,	,	PUNCT
aiua-10710	88	22	clinical	clinical	ADJ
aiua-10710	88	23	trials	trial	NOUN
aiua-10710	88	24	investigating	investigate	VERB
aiua-10710	88	25	the	the	DET
aiua-10710	88	26	effects	effect	NOUN
aiua-10710	88	27	pde5i	pde5i	PROPN
aiua-10710	88	28	as	as	ADP
aiua-10710	88	29	monotherapy	monotherapy	NOUN
aiua-10710	88	30	or	or	CCONJ
aiua-10710	88	31	in	in	ADP
aiua-10710	88	32	a	a	DET
aiua-10710	88	33	combination	combination	NOUN
aiua-10710	88	34	treatment	treatment	NOUN
aiua-10710	88	35	are	be	AUX
aiua-10710	88	36	limited	limited	ADJ
aiua-10710	88	37	.	.	PUNCT
aiua-10710	89	1	in	in	ADP
aiua-10710	89	2	a	a	DET
aiua-10710	89	3	retrospective	retrospective	ADJ
aiua-10710	89	4	study	study	NOUN
aiua-10710	89	5	of	of	ADP
aiua-10710	89	6	patients	patient	NOUN
aiua-10710	89	7	with	with	ADP
aiua-10710	89	8	isolated	isolated	ADJ
aiua-10710	89	9	septal	septal	ADJ
aiua-10710	89	10	scarring	scarring	NOUN
aiua-10710	89	11	and	and	CCONJ
aiua-10710	89	12	no	no	DET
aiua-10710	89	13	evidence	evidence	NOUN
aiua-10710	89	14	of	of	ADP
aiua-10710	89	15	penile	penile	ADJ
aiua-10710	89	16	deformity	deformity	NOUN
aiua-10710	89	17	,	,	PUNCT
aiua-10710	89	18	septal	septal	ADJ
aiua-10710	89	19	scarring	scarring	NOUN
aiua-10710	89	20	was	be	AUX
aiua-10710	89	21	significantly	significantly	ADV
aiua-10710	89	22	regressed	regress	VERB
aiua-10710	89	23	in	in	ADP
aiua-10710	89	24	the	the	DET
aiua-10710	89	25	tadalafil	tadalafil	PROPN
aiua-10710	89	26	group	group	NOUN
aiua-10710	89	27	compared	compare	VERB
aiua-10710	89	28	with	with	ADP
aiua-10710	89	29	control	control	NOUN
aiua-10710	89	30	group	group	NOUN
aiua-10710	89	31	(	(	PUNCT
aiua-10710	89	32	27	27	NUM
aiua-10710	89	33	)	)	PUNCT
aiua-10710	89	34	.	.	PUNCT
aiua-10710	90	1	ozturk	ozturk	PROPN
aiua-10710	90	2	et	et	PROPN
aiua-10710	90	3	al	al	PROPN
aiua-10710	90	4	.	.	PROPN
aiua-10710	90	5	investigated	investigate	VERB
aiua-10710	90	6	the	the	DET
aiua-10710	90	7	effect	effect	NOUN
aiua-10710	90	8	of	of	ADP
aiua-10710	90	9	daily	daily	ADJ
aiua-10710	90	10	50	50	NUM
aiua-10710	90	11	mg	mg	NOUN
aiua-10710	90	12	of	of	ADP
aiua-10710	90	13	sildenafil	sildenafil	NOUN
aiua-10710	90	14	on	on	ADP
aiua-10710	90	15	peyronie	peyronie	NOUN
aiua-10710	90	16	's	's	PART
aiua-10710	90	17	plaque	plaque	NOUN
aiua-10710	90	18	and	and	CCONJ
aiua-10710	90	19	observed	observe	VERB
aiua-10710	90	20	a	a	DET
aiua-10710	90	21	statistically	statistically	ADV
aiua-10710	90	22	significant	significant	ADJ
aiua-10710	90	23	reduction	reduction	NOUN
aiua-10710	90	24	in	in	ADP
aiua-10710	90	25	pain	pain	NOUN
aiua-10710	90	26	,	,	PUNCT
aiua-10710	90	27	whereas	whereas	SCONJ
aiua-10710	90	28	there	there	PRON
aiua-10710	90	29	was	be	VERB
aiua-10710	90	30	no	no	DET
aiua-10710	90	31	significant	significant	ADJ
aiua-10710	90	32	difference	difference	NOUN
aiua-10710	90	33	in	in	ADP
aiua-10710	90	34	penile	penile	ADJ
aiua-10710	90	35	curvature	curvature	NOUN
aiua-10710	90	36	between	between	ADP
aiua-10710	90	37	the	the	DET
aiua-10710	90	38	two	two	NUM
aiua-10710	90	39	groups	group	NOUN
aiua-10710	90	40	(	(	PUNCT
aiua-10710	90	41	28	28	NUM
aiua-10710	90	42	)	)	PUNCT
aiua-10710	90	43	.	.	PUNCT
aiua-10710	91	1	subjective	subjective	ADJ
aiua-10710	91	2	and	and	CCONJ
aiua-10710	91	3	objective	objective	ADJ
aiua-10710	91	4	improvements	improvement	NOUN
aiua-10710	91	5	in	in	ADP
aiua-10710	91	6	the	the	DET
aiua-10710	91	7	characteristics	characteristic	NOUN
aiua-10710	91	8	of	of	ADP
aiua-10710	91	9	pd	pd	PROPN
aiua-10710	91	10	receiving	receive	VERB
aiua-10710	91	11	daily	daily	ADJ
aiua-10710	91	12	doses	dose	NOUN
aiua-10710	91	13	of	of	ADP
aiua-10710	91	14	tadalafil	tadalafil	PROPN
aiua-10710	91	15	were	be	AUX
aiua-10710	91	16	also	also	ADV
aiua-10710	91	17	reported	report	VERB
aiua-10710	91	18	by	by	ADP
aiua-10710	91	19	vernet	vernet	PROPN
aiua-10710	91	20	et	et	PROPN
aiua-10710	91	21	al	al	PROPN
aiua-10710	91	22	.	.	PROPN
aiua-10710	92	1	(	(	PUNCT
aiua-10710	92	2	20	20	NUM
aiua-10710	92	3	)	)	PUNCT
aiua-10710	92	4	it	it	PRON
aiua-10710	92	5	was	be	AUX
aiua-10710	92	6	shown	show	VERB
aiua-10710	92	7	that	that	SCONJ
aiua-10710	92	8	the	the	DET
aiua-10710	92	9	addition	addition	NOUN
aiua-10710	92	10	of	of	ADP
aiua-10710	92	11	25	25	NUM
aiua-10710	92	12	mg	mg	NOUN
aiua-10710	92	13	sildenafil	sildenafil	NOUN
aiua-10710	92	14	to	to	ADP
aiua-10710	92	15	collagenase	collagenase	PROPN
aiua-10710	92	16	histolyticum	histolyticum	PROPN
aiua-10710	92	17	(	(	PUNCT
aiua-10710	92	18	cch	cch	PROPN
aiua-10710	92	19	)	)	PUNCT
aiua-10710	92	20	was	be	AUX
aiua-10710	92	21	superior	superior	ADJ
aiua-10710	92	22	to	to	ADP
aiua-10710	92	23	cch	cch	NOUN
aiua-10710	92	24	monotherapy	monotherapy	NOUN
aiua-10710	92	25	in	in	ADP
aiua-10710	92	26	improving	improve	VERB
aiua-10710	92	27	penile	penile	ADJ
aiua-10710	92	28	curvature	curvature	NOUN
aiua-10710	92	29	(	(	PUNCT
aiua-10710	92	30	10	10	NUM
aiua-10710	92	31	)	)	PUNCT
aiua-10710	92	32	.	.	PUNCT
aiua-10710	93	1	in	in	ADP
aiua-10710	93	2	contrast	contrast	NOUN
aiua-10710	93	3	,	,	PUNCT
aiua-10710	93	4	palmieri	palmieri	PROPN
aiua-10710	93	5	et	et	PROPN
aiua-10710	93	6	al	al	PROPN
aiua-10710	93	7	.	.	PROPN
aiua-10710	93	8	reported	report	VERB
aiua-10710	93	9	similar	similar	ADJ
aiua-10710	93	10	outcomes	outcome	NOUN
aiua-10710	93	11	in	in	ADP
aiua-10710	93	12	tadafil	tadafil	NOUN
aiua-10710	93	13	-	-	PUNCT
aiua-10710	93	14	eswt	eswt	NOUN
aiua-10710	93	15	group	group	NOUN
aiua-10710	93	16	compared	compare	VERB
aiua-10710	93	17	to	to	ADP
aiua-10710	93	18	eswt	eswt	PROPN
aiua-10710	93	19	group	group	NOUN
aiua-10710	93	20	(	(	PUNCT
aiua-10710	93	21	29	29	NUM
aiua-10710	93	22	)	)	PUNCT
aiua-10710	93	23	.	.	PUNCT
aiua-10710	94	1	our	our	PRON
aiua-10710	94	2	study	study	NOUN
aiua-10710	94	3	showed	show	VERB
aiua-10710	94	4	a	a	DET
aiua-10710	94	5	significant	significant	ADJ
aiua-10710	94	6	improvement	improvement	NOUN
aiua-10710	94	7	in	in	ADP
aiua-10710	94	8	degree	degree	NOUN
aiua-10710	94	9	of	of	ADP
aiua-10710	94	10	curvature	curvature	NOUN
aiua-10710	94	11	and	and	CCONJ
aiua-10710	94	12	significant	significant	ADJ
aiua-10710	94	13	reduction	reduction	NOUN
aiua-10710	94	14	in	in	ADP
aiua-10710	94	15	ef	ef	PROPN
aiua-10710	94	16	-	-	ADJ
aiua-10710	94	17	vas	vas	ADJ
aiua-10710	94	18	score	score	NOUN
aiua-10710	94	19	in	in	ADP
aiua-10710	94	20	the	the	DET
aiua-10710	94	21	sildenafil	sildenafil	NOUN
aiua-10710	94	22	received	receive	VERB
aiua-10710	94	23	group	group	NOUN
aiua-10710	94	24	,	,	PUNCT
aiua-10710	94	25	compared	compare	VERB
aiua-10710	94	26	to	to	ADP
aiua-10710	94	27	the	the	DET
aiua-10710	94	28	conventional	conventional	ADJ
aiua-10710	94	29	treatment	treatment	NOUN
aiua-10710	94	30	group	group	NOUN
aiua-10710	94	31	.	.	PUNCT
aiua-10710	95	1	changes	change	NOUN
aiua-10710	95	2	in	in	ADP
aiua-10710	95	3	degree	degree	NOUN
aiua-10710	95	4	of	of	ADP
aiua-10710	95	5	curvature	curvature	NOUN
aiua-10710	95	6	and	and	CCONJ
aiua-10710	95	7	pain	pain	NOUN
aiua-10710	95	8	status	status	NOUN
aiua-10710	95	9	were	be	AUX
aiua-10710	95	10	considered	consider	VERB
aiua-10710	95	11	as	as	ADP
aiua-10710	95	12	the	the	DET
aiua-10710	95	13	primary	primary	ADJ
aiua-10710	95	14	endpoints	endpoint	NOUN
aiua-10710	95	15	of	of	ADP
aiua-10710	95	16	the	the	DET
aiua-10710	95	17	study	study	NOUN
aiua-10710	95	18	.	.	PUNCT
aiua-10710	96	1	as	as	SCONJ
aiua-10710	96	2	expected	expect	VERB
aiua-10710	96	3	,	,	PUNCT
aiua-10710	96	4	an	an	DET
aiua-10710	96	5	improvement	improvement	NOUN
aiua-10710	96	6	in	in	ADP
aiua-10710	96	7	the	the	DET
aiua-10710	96	8	iief-5	iief-5	NUM
aiua-10710	96	9	score	score	NOUN
aiua-10710	96	10	,	,	PUNCT
aiua-10710	96	11	a	a	DET
aiua-10710	96	12	secondary	secondary	ADJ
aiua-10710	96	13	endpoint	endpoint	NOUN
aiua-10710	96	14	of	of	ADP
aiua-10710	96	15	the	the	DET
aiua-10710	96	16	study	study	NOUN
aiua-10710	96	17	,	,	PUNCT
aiua-10710	96	18	was	be	AUX
aiua-10710	96	19	found	find	VERB
aiua-10710	96	20	to	to	PART
aiua-10710	96	21	be	be	AUX
aiua-10710	96	22	more	more	ADV
aiua-10710	96	23	pronounced	pronounce	VERB
aiua-10710	96	24	in	in	ADP
aiua-10710	96	25	the	the	DET
aiua-10710	96	26	sildenafil	sildenafil	NOUN
aiua-10710	96	27	-	-	PUNCT
aiua-10710	96	28	treated	treat	VERB
aiua-10710	96	29	group	group	NOUN
aiua-10710	96	30	.	.	PUNCT
aiua-10710	97	1	at	at	ADP
aiua-10710	97	2	this	this	DET
aiua-10710	97	3	point	point	NOUN
aiua-10710	97	4	,	,	PUNCT
aiua-10710	97	5	we	we	PRON
aiua-10710	97	6	did	do	AUX
aiua-10710	97	7	not	not	PART
aiua-10710	97	8	evaluate	evaluate	VERB
aiua-10710	97	9	the	the	DET
aiua-10710	97	10	change	change	NOUN
aiua-10710	97	11	in	in	ADP
aiua-10710	97	12	plaque	plaque	NOUN
aiua-10710	97	13	size	size	NOUN
aiua-10710	97	14	as	as	ADP
aiua-10710	97	15	a	a	DET
aiua-10710	97	16	criterion	criterion	NOUN
aiua-10710	97	17	for	for	ADP
aiua-10710	97	18	treatment	treatment	NOUN
aiua-10710	97	19	success	success	NOUN
aiua-10710	97	20	.	.	PUNCT
aiua-10710	98	1	some	some	DET
aiua-10710	98	2	investigators	investigator	NOUN
aiua-10710	98	3	have	have	AUX
aiua-10710	98	4	suggested	suggest	VERB
aiua-10710	98	5	that	that	SCONJ
aiua-10710	98	6	the	the	DET
aiua-10710	98	7	evaluation	evaluation	NOUN
aiua-10710	98	8	of	of	ADP
aiua-10710	98	9	plaque	plaque	NOUN
aiua-10710	98	10	size	size	NOUN
aiua-10710	98	11	using	use	VERB
aiua-10710	98	12	any	any	DET
aiua-10710	98	13	type	type	NOUN
aiua-10710	98	14	of	of	ADP
aiua-10710	98	15	imaging	imaging	NOUN
aiua-10710	98	16	is	be	AUX
aiua-10710	98	17	unnecessary	unnecessary	ADJ
aiua-10710	98	18	,	,	PUNCT
aiua-10710	98	19	as	as	SCONJ
aiua-10710	98	20	these	these	DET
aiua-10710	98	21	measurements	measurement	NOUN
aiua-10710	98	22	are	be	AUX
aiua-10710	98	23	often	often	ADV
aiua-10710	98	24	inaccurate	inaccurate	ADJ
aiua-10710	98	25	and	and	CCONJ
aiua-10710	98	26	changes	change	NOUN
aiua-10710	98	27	in	in	ADP
aiua-10710	98	28	plaque	plaque	NOUN
aiua-10710	98	29	size	size	NOUN
aiua-10710	98	30	after	after	ADP
aiua-10710	98	31	treatment	treatment	NOUN
aiua-10710	98	32	are	be	AUX
aiua-10710	98	33	not	not	PART
aiua-10710	98	34	associated	associate	VERB
aiua-10710	98	35	with	with	ADP
aiua-10710	98	36	changes	change	NOUN
aiua-10710	98	37	in	in	ADP
aiua-10710	98	38	overall	overall	ADJ
aiua-10710	98	39	deformity	deformity	NOUN
aiua-10710	98	40	and	and	CCONJ
aiua-10710	98	41	do	do	AUX
aiua-10710	98	42	not	not	PART
aiua-10710	98	43	directly	directly	ADV
aiua-10710	98	44	indicate	indicate	VERB
aiua-10710	98	45	treatment	treatment	NOUN
aiua-10710	98	46	success	success	NOUN
aiua-10710	98	47	(	(	PUNCT
aiua-10710	98	48	30	30	NUM
aiua-10710	98	49	)	)	PUNCT
aiua-10710	98	50	.	.	PUNCT
aiua-10710	99	1	treatment	treatment	NOUN
aiua-10710	99	2	of	of	ADP
aiua-10710	99	3	pd	pd	PROPN
aiua-10710	99	4	mainly	mainly	ADV
aiua-10710	99	5	depends	depend	VERB
aiua-10710	99	6	on	on	ADP
aiua-10710	99	7	the	the	DET
aiua-10710	99	8	severity	severity	NOUN
aiua-10710	99	9	of	of	ADP
aiua-10710	99	10	curvature	curvature	NOUN
aiua-10710	99	11	and	and	CCONJ
aiua-10710	99	12	the	the	DET
aiua-10710	99	13	degree	degree	NOUN
aiua-10710	99	14	of	of	ADP
aiua-10710	99	15	ed	ed	PROPN
aiua-10710	99	16	(	(	PUNCT
aiua-10710	99	17	12	12	NUM
aiua-10710	99	18	,	,	PUNCT
aiua-10710	99	19	13	13	NUM
aiua-10710	99	20	)	)	PUNCT
aiua-10710	99	21	.	.	PUNCT
aiua-10710	100	1	in	in	ADP
aiua-10710	100	2	addition	addition	NOUN
aiua-10710	100	3	peyronie	peyronie	NOUN
aiua-10710	100	4	’s	’s	PART
aiua-10710	100	5	plaque	plaque	NOUN
aiua-10710	100	6	is	be	AUX
aiua-10710	100	7	not	not	PART
aiua-10710	100	8	well	well	ADV
aiua-10710	100	9	formed	form	VERB
aiua-10710	100	10	in	in	ADP
aiua-10710	100	11	acute	acute	ADJ
aiua-10710	100	12	phase	phase	NOUN
aiua-10710	100	13	of	of	ADP
aiua-10710	100	14	the	the	DET
aiua-10710	100	15	disease	disease	NOUN
aiua-10710	100	16	and	and	CCONJ
aiua-10710	100	17	possible	possible	ADJ
aiua-10710	100	18	spontaneous	spontaneous	ADJ
aiua-10710	100	19	remission	remission	NOUN
aiua-10710	100	20	in	in	ADP
aiua-10710	100	21	plaque	plaque	NOUN
aiua-10710	100	22	size	size	NOUN
aiua-10710	100	23	can	can	AUX
aiua-10710	100	24	be	be	AUX
aiua-10710	100	25	expected	expect	VERB
aiua-10710	100	26	in	in	ADP
aiua-10710	100	27	the	the	DET
aiua-10710	100	28	acute	acute	ADJ
aiua-10710	100	29	phase	phase	NOUN
aiua-10710	100	30	.	.	PUNCT
aiua-10710	101	1	our	our	PRON
aiua-10710	101	2	study	study	NOUN
aiua-10710	101	3	has	have	VERB
aiua-10710	101	4	some	some	DET
aiua-10710	101	5	limitations	limitation	NOUN
aiua-10710	101	6	which	which	PRON
aiua-10710	101	7	need	need	VERB
aiua-10710	101	8	to	to	PART
aiua-10710	101	9	be	be	AUX
aiua-10710	101	10	considered	consider	VERB
aiua-10710	101	11	while	while	SCONJ
aiua-10710	101	12	evaluating	evaluate	VERB
aiua-10710	101	13	its	its	PRON
aiua-10710	101	14	findings	finding	NOUN
aiua-10710	101	15	.	.	PUNCT
aiua-10710	102	1	first	first	ADV
aiua-10710	102	2	,	,	PUNCT
aiua-10710	102	3	it	it	PRON
aiua-10710	102	4	is	be	AUX
aiua-10710	102	5	a	a	DET
aiua-10710	102	6	retrospective	retrospective	ADJ
aiua-10710	102	7	,	,	PUNCT
aiua-10710	102	8	non	non	ADJ
aiua-10710	102	9	-	-	ADJ
aiua-10710	102	10	randomized	randomized	ADJ
aiua-10710	102	11	study	study	NOUN
aiua-10710	102	12	that	that	PRON
aiua-10710	102	13	can	can	AUX
aiua-10710	102	14	be	be	AUX
aiua-10710	102	15	affected	affect	VERB
aiua-10710	102	16	by	by	ADP
aiua-10710	102	17	all	all	DET
aiua-10710	102	18	potential	potential	ADJ
aiua-10710	102	19	weaknesses	weakness	NOUN
aiua-10710	102	20	stemming	stem	VERB
aiua-10710	102	21	from	from	ADP
aiua-10710	102	22	its	its	PRON
aiua-10710	102	23	retrospective	retrospective	ADJ
aiua-10710	102	24	design	design	NOUN
aiua-10710	102	25	and	and	CCONJ
aiua-10710	102	26	six	six	NUM
aiua-10710	102	27	months	month	NOUN
aiua-10710	102	28	of	of	ADP
aiua-10710	102	29	follow	follow	NOUN
aiua-10710	102	30	-	-	PUNCT
aiua-10710	102	31	up	up	NOUN
aiua-10710	102	32	period	period	NOUN
aiua-10710	102	33	of	of	ADP
aiua-10710	102	34	to	to	PART
aiua-10710	102	35	evaluate	evaluate	VERB
aiua-10710	102	36	the	the	DET
aiua-10710	102	37	treatment	treatment	NOUN
aiua-10710	102	38	outcomes	outcome	NOUN
aiua-10710	102	39	is	be	AUX
aiua-10710	102	40	relatively	relatively	ADV
aiua-10710	102	41	short	short	ADJ
aiua-10710	102	42	for	for	ADP
aiua-10710	102	43	this	this	DET
aiua-10710	102	44	chronic	chronic	ADJ
aiua-10710	102	45	disease	disease	NOUN
aiua-10710	102	46	.	.	PUNCT
aiua-10710	103	1	conclusions	conclusion	NOUN
aiua-10710	103	2	to	to	ADP
aiua-10710	103	3	our	our	PRON
aiua-10710	103	4	knowledge	knowledge	NOUN
aiua-10710	103	5	,	,	PUNCT
aiua-10710	103	6	this	this	PRON
aiua-10710	103	7	is	be	AUX
aiua-10710	103	8	the	the	DET
aiua-10710	103	9	first	first	ADJ
aiua-10710	103	10	clinical	clinical	ADJ
aiua-10710	103	11	study	study	NOUN
aiua-10710	103	12	in	in	ADP
aiua-10710	103	13	the	the	DET
aiua-10710	103	14	relevant	relevant	ADJ
aiua-10710	103	15	literature	literature	NOUN
aiua-10710	103	16	investigating	investigate	VERB
aiua-10710	103	17	the	the	DET
aiua-10710	103	18	effect	effect	NOUN
aiua-10710	103	19	of	of	ADP
aiua-10710	103	20	pde5i	pde5i	PROPN
aiua-10710	103	21	in	in	ADP
aiua-10710	103	22	an	an	DET
aiua-10710	103	23	oral	oral	ADJ
aiua-10710	103	24	combination	combination	NOUN
aiua-10710	103	25	therapy	therapy	NOUN
aiua-10710	103	26	in	in	ADP
aiua-10710	103	27	pd	pd	PROPN
aiua-10710	103	28	patients	patient	NOUN
aiua-10710	103	29	.	.	PUNCT
aiua-10710	104	1	we	we	PRON
aiua-10710	104	2	showed	show	VERB
aiua-10710	104	3	that	that	SCONJ
aiua-10710	104	4	adding	add	VERB
aiua-10710	104	5	daily	daily	ADJ
aiua-10710	104	6	sildenafil	sildenafil	NOUN
aiua-10710	104	7	50	50	NUM
aiua-10710	104	8	mg	mg	NOUN
aiua-10710	104	9	to	to	PART
aiua-10710	104	10	colchicine	colchicine	VERB
aiua-10710	104	11	and	and	CCONJ
aiua-10710	104	12	ptx	ptx	NOUN
aiua-10710	104	13	combination	combination	NOUN
aiua-10710	104	14	treatment	treatment	NOUN
aiua-10710	104	15	improves	improve	VERB
aiua-10710	104	16	the	the	DET
aiua-10710	104	17	pd	pd	PROPN
aiua-10710	104	18	’s	’s	PART
aiua-10710	104	19	related	related	ADJ
aiua-10710	104	20	symptoms	symptom	NOUN
aiua-10710	104	21	of	of	ADP
aiua-10710	104	22	patients	patient	NOUN
aiua-10710	104	23	in	in	ADP
aiua-10710	104	24	the	the	DET
aiua-10710	104	25	acute	acute	ADJ
aiua-10710	104	26	phase	phase	NOUN
aiua-10710	104	27	of	of	ADP
aiua-10710	104	28	pd	pd	PROPN
aiua-10710	104	29	.	.	PUNCT
aiua-10710	105	1	considering	consider	VERB
aiua-10710	105	2	the	the	DET
aiua-10710	105	3	proven	prove	VERB
aiua-10710	105	4	antifibrotic	antifibrotic	ADJ
aiua-10710	105	5	efficacy	efficacy	NOUN
aiua-10710	105	6	of	of	ADP
aiua-10710	105	7	pde5i	pde5i	PROPN
aiua-10710	105	8	,	,	PUNCT
aiua-10710	105	9	they	they	PRON
aiua-10710	105	10	may	may	AUX
aiua-10710	105	11	contribute	contribute	VERB
aiua-10710	105	12	to	to	ADP
aiua-10710	105	13	relieving	relieve	VERB
aiua-10710	105	14	peyronie	peyronie	NOUN
aiua-10710	105	15	's	's	PART
aiua-10710	105	16	symptoms	symptom	NOUN
aiua-10710	105	17	in	in	ADP
aiua-10710	105	18	patients	patient	NOUN
aiua-10710	105	19	with	with	ADP
aiua-10710	105	20	ed	ed	NOUN
aiua-10710	105	21	.	.	PUNCT
aiua-10710	106	1	further	further	ADJ
aiua-10710	106	2	multicenter	multicenter	ADJ
aiua-10710	106	3	prospective	prospective	ADJ
aiua-10710	106	4	studies	study	NOUN
aiua-10710	106	5	with	with	ADP
aiua-10710	106	6	larger	large	ADJ
aiua-10710	106	7	number	number	NOUN
aiua-10710	106	8	of	of	ADP
aiua-10710	106	9	cases	case	NOUN
aiua-10710	106	10	are	be	AUX
aiua-10710	106	11	needed	need	VERB
aiua-10710	106	12	to	to	PART
aiua-10710	106	13	obtain	obtain	VERB
aiua-10710	106	14	more	more	ADV
aiua-10710	106	15	precise	precise	ADJ
aiua-10710	106	16	results	result	NOUN
aiua-10710	106	17	.	.	PUNCT
aiua-10710	107	1	archivio	archivio	NOUN
aiua-10710	107	2	italiano	italiano	X
aiua-10710	107	3	di	di	X
aiua-10710	107	4	urologia	urologia	PROPN
aiua-10710	107	5	e	e	PROPN
aiua-10710	107	6	andrologia	andrologia	PROPN
aiua-10710	107	7	2022	2022	NUM
aiua-10710	107	8	;	;	PUNCT
aiua-10710	107	9	94	94	NUM
aiua-10710	107	10	,	,	PUNCT
aiua-10710	107	11	3	3	NUM
aiua-10710	107	12	m.	m.	NOUN
aiua-10710	107	13	topcuoglu	topcuoglu	NOUN
aiua-10710	107	14	,	,	PUNCT
aiua-10710	107	15	m.	m.	NOUN
aiua-10710	107	16	çakan	çakan	VERB
aiua-10710	107	17	322	322	NUM
aiua-10710	107	18	references	reference	NOUN
aiua-10710	107	19	1	1	NUM
aiua-10710	107	20	.	.	PUNCT
aiua-10710	107	21	tunuguntla	tunuguntla	PROPN
aiua-10710	107	22	.	.	PUNCT
aiua-10710	108	1	hs	hs	PROPN
aiua-10710	108	2	.	.	PROPN
aiua-10710	108	3	management	management	NOUN
aiua-10710	108	4	of	of	ADP
aiua-10710	108	5	peyronie	peyronie	NOUN
aiua-10710	108	6	's	's	PART
aiua-10710	108	7	disease	disease	NOUN
aiua-10710	108	8	a	a	DET
aiua-10710	108	9	review	review	NOUN
aiua-10710	108	10	.	.	PUNCT
aiua-10710	109	1	world	world	PROPN
aiua-10710	109	2	j	j	PROPN
aiua-10710	109	3	urol	urol	PROPN
aiua-10710	109	4	.	.	PUNCT
aiua-10710	110	1	2001	2001	NUM
aiua-10710	110	2	;	;	PUNCT
aiua-10710	110	3	19:244	19:244	NUM
aiua-10710	110	4	-	-	SYM
aiua-10710	110	5	250	250	NUM
aiua-10710	110	6	.	.	PUNCT
aiua-10710	111	1	2	2	X
aiua-10710	111	2	.	.	X
aiua-10710	111	3	kadioglu	kadioglu	PROPN
aiua-10710	111	4	a	a	PROPN
aiua-10710	111	5	,	,	PUNCT
aiua-10710	111	6	tefekli	tefekli	NOUN
aiua-10710	111	7	a	a	X
aiua-10710	111	8	,	,	PUNCT
aiua-10710	111	9	erol	erol	PROPN
aiua-10710	111	10	b	b	NUM
aiua-10710	111	11	,	,	PUNCT
aiua-10710	111	12	et	et	PROPN
aiua-10710	111	13	al	al	PROPN
aiua-10710	111	14	.	.	PROPN
aiua-10710	112	1	retrospective	retrospective	ADJ
aiua-10710	112	2	review	review	NOUN
aiua-10710	112	3	of	of	ADP
aiua-10710	112	4	307	307	NUM
aiua-10710	112	5	men	man	NOUN
aiua-10710	112	6	with	with	ADP
aiua-10710	112	7	peyronie	peyronie	NOUN
aiua-10710	112	8	’s	’s	PART
aiua-10710	112	9	disease	disease	NOUN
aiua-10710	112	10	.	.	PUNCT
aiua-10710	113	1	j	j	PROPN
aiua-10710	113	2	urol	urol	PROPN
aiua-10710	113	3	.	.	PUNCT
aiua-10710	113	4	2002	2002	NUM
aiua-10710	113	5	;	;	PUNCT
aiua-10710	113	6	168:1075	168:1075	NUM
aiua-10710	113	7	.	.	PUNCT
aiua-10710	114	1	3	3	X
aiua-10710	114	2	.	.	X
aiua-10710	114	3	schwarzer	schwarzer	PROPN
aiua-10710	114	4	u	u	PROPN
aiua-10710	114	5	,	,	PUNCT
aiua-10710	114	6	sommer	sommer	PROPN
aiua-10710	114	7	f	f	PROPN
aiua-10710	114	8	,	,	PUNCT
aiua-10710	114	9	klotz	klotz	PROPN
aiua-10710	114	10	t	t	PROPN
aiua-10710	114	11	,	,	PUNCT
aiua-10710	114	12	et	et	PROPN
aiua-10710	114	13	al	al	PROPN
aiua-10710	114	14	.	.	PUNCT
aiua-10710	115	1	the	the	DET
aiua-10710	115	2	prevalence	prevalence	NOUN
aiua-10710	115	3	of	of	ADP
aiua-10710	115	4	peyronie	peyronie	NOUN
aiua-10710	115	5	's	's	PART
aiua-10710	115	6	disease	disease	NOUN
aiua-10710	115	7	:	:	PUNCT
aiua-10710	115	8	results	result	NOUN
aiua-10710	115	9	of	of	ADP
aiua-10710	115	10	a	a	DET
aiua-10710	115	11	large	large	ADJ
aiua-10710	115	12	survey	survey	NOUN
aiua-10710	115	13	.	.	PUNCT
aiua-10710	116	1	bju	bju	NOUN
aiua-10710	116	2	int	int	PROPN
aiua-10710	116	3	.	.	PUNCT
aiua-10710	117	1	2001	2001	NUM
aiua-10710	117	2	;	;	PUNCT
aiua-10710	117	3	88:727	88:727	NUM
aiua-10710	117	4	-	-	SYM
aiua-10710	117	5	30	30	NUM
aiua-10710	117	6	.	.	PUNCT
aiua-10710	118	1	4	4	NUM
aiua-10710	118	2	.	.	X
aiua-10710	118	3	bilgutay	bilgutay	VERB
aiua-10710	118	4	an	an	DET
aiua-10710	118	5	,	,	PUNCT
aiua-10710	118	6	pastuszak	pastuszak	NOUN
aiua-10710	118	7	aw	aw	INTJ
aiua-10710	118	8	.	.	PUNCT
aiua-10710	118	9	peyronıe	peyronıe	PROPN
aiua-10710	118	10	's	's	PART
aiua-10710	118	11	disease	disease	NOUN
aiua-10710	118	12	:	:	PUNCT
aiua-10710	118	13	a	a	DET
aiua-10710	118	14	review	review	NOUN
aiua-10710	118	15	of	of	ADP
aiua-10710	118	16	etiology	etiology	NOUN
aiua-10710	118	17	,	,	PUNCT
aiua-10710	118	18	diagnosis	diagnosis	NOUN
aiua-10710	118	19	,	,	PUNCT
aiua-10710	118	20	and	and	CCONJ
aiua-10710	118	21	management	management	NOUN
aiua-10710	118	22	.	.	PUNCT
aiua-10710	119	1	curr	curr	PROPN
aiua-10710	119	2	sex	sex	PROPN
aiua-10710	119	3	health	health	PROPN
aiua-10710	119	4	rep	rep	PROPN
aiua-10710	119	5	.	.	PROPN
aiua-10710	119	6	2015	2015	NUM
aiua-10710	119	7	;	;	PUNCT
aiua-10710	119	8	7:117131	7:117131	X
aiua-10710	119	9	.	.	NOUN
aiua-10710	119	10	5	5	NUM
aiua-10710	119	11	.	.	PUNCT
aiua-10710	119	12	chung	chung	PROPN
aiua-10710	119	13	e	e	PROPN
aiua-10710	119	14	,	,	PUNCT
aiua-10710	119	15	ralph	ralph	PROPN
aiua-10710	119	16	d	d	PROPN
aiua-10710	119	17	,	,	PUNCT
aiua-10710	119	18	kadioglu	kadioglu	PROPN
aiua-10710	119	19	a	a	PROPN
aiua-10710	119	20	,	,	PUNCT
aiua-10710	119	21	et	et	PROPN
aiua-10710	119	22	al	al	PROPN
aiua-10710	119	23	.	.	PROPN
aiua-10710	119	24	evidence	evidence	NOUN
aiua-10710	119	25	-	-	PUNCT
aiua-10710	119	26	based	base	VERB
aiua-10710	119	27	management	management	NOUN
aiua-10710	119	28	guidelines	guideline	NOUN
aiua-10710	119	29	on	on	ADP
aiua-10710	119	30	peyronie	peyronie	NOUN
aiua-10710	119	31	's	's	PART
aiua-10710	119	32	disease	disease	NOUN
aiua-10710	119	33	.	.	PUNCT
aiua-10710	120	1	j	j	PROPN
aiua-10710	120	2	sex	sex	PROPN
aiua-10710	120	3	med	me	VERB
aiua-10710	120	4	.	.	PUNCT
aiua-10710	120	5	2016	2016	NUM
aiua-10710	120	6	;	;	PUNCT
aiua-10710	120	7	13:905	13:905	NUM
aiua-10710	120	8	-	-	SYM
aiua-10710	120	9	923	923	NUM
aiua-10710	120	10	.	.	NOUN
aiua-10710	121	1	6	6	NUM
aiua-10710	121	2	.	.	X
aiua-10710	121	3	ferrini	ferrini	PROPN
aiua-10710	121	4	mg	mg	PROPN
aiua-10710	121	5	,	,	PUNCT
aiua-10710	121	6	davila	davila	PROPN
aiua-10710	121	7	h	h	PROPN
aiua-10710	121	8	,	,	PUNCT
aiua-10710	121	9	kovanecz	kovanecz	VERB
aiua-10710	121	10	i	i	PRON
aiua-10710	121	11	,	,	PUNCT
aiua-10710	121	12	et	et	PROPN
aiua-10710	121	13	al	al	PROPN
aiua-10710	121	14	.	.	PUNCT
aiua-10710	122	1	long	long	ADJ
aiua-10710	122	2	-	-	PUNCT
aiua-10710	122	3	term	term	NOUN
aiua-10710	122	4	continuous	continuous	ADJ
aiua-10710	122	5	treatment	treatment	NOUN
aiua-10710	122	6	with	with	ADP
aiua-10710	122	7	vardenafil	vardenafil	NOUN
aiua-10710	122	8	prevents	prevent	VERB
aiua-10710	122	9	fibrosis	fibrosis	NOUN
aiua-10710	122	10	and	and	CCONJ
aiua-10710	122	11	preserves	preserve	VERB
aiua-10710	122	12	smooth	smooth	ADJ
aiua-10710	122	13	muscle	muscle	NOUN
aiua-10710	122	14	content	content	NOUN
aiua-10710	122	15	in	in	ADP
aiua-10710	122	16	the	the	DET
aiua-10710	122	17	rat	rat	NOUN
aiua-10710	122	18	corpora	corpora	VERB
aiua-10710	122	19	cavernosa	cavernosa	NOUN
aiua-10710	122	20	after	after	ADP
aiua-10710	122	21	bilateral	bilateral	ADJ
aiua-10710	122	22	cavernosal	cavernosal	ADJ
aiua-10710	122	23	nerve	nerve	NOUN
aiua-10710	122	24	transection	transection	NOUN
aiua-10710	122	25	.	.	PUNCT
aiua-10710	123	1	urology	urology	NOUN
aiua-10710	123	2	.	.	PUNCT
aiua-10710	124	1	2006	2006	NUM
aiua-10710	124	2	;	;	PUNCT
aiua-10710	124	3	68:429	68:429	PROPN
aiua-10710	124	4	-	-	SYM
aiua-10710	124	5	435	435	NUM
aiua-10710	124	6	.	.	NOUN
aiua-10710	124	7	7	7	X
aiua-10710	124	8	.	.	PUNCT
aiua-10710	124	9	ilg	ilg	PROPN
aiua-10710	124	10	mm	mm	PROPN
aiua-10710	124	11	,	,	PUNCT
aiua-10710	124	12	mateus	mateus	PROPN
aiua-10710	124	13	m	m	PROPN
aiua-10710	124	14	,	,	PUNCT
aiua-10710	124	15	stebbeds	stebbed	VERB
aiua-10710	124	16	wj	wj	PROPN
aiua-10710	124	17	,	,	PUNCT
aiua-10710	124	18	et	et	PROPN
aiua-10710	124	19	al	al	PROPN
aiua-10710	124	20	.	.	PUNCT
aiua-10710	125	1	anti	anti	ADJ
aiua-10710	125	2	-	-	ADJ
aiua-10710	125	3	fibrotic	fibrotic	ADJ
aiua-10710	125	4	synergy	synergy	NOUN
aiua-10710	125	5	between	between	ADP
aiua-10710	125	6	phosphodiesterase	phosphodiesterase	NOUN
aiua-10710	125	7	type	type	NOUN
aiua-10710	125	8	5	5	NUM
aiua-10710	125	9	inhibitors	inhibitor	NOUN
aiua-10710	125	10	and	and	CCONJ
aiua-10710	125	11	selective	selective	ADJ
aiua-10710	125	12	oestrogen	oestrogen	NOUN
aiua-10710	125	13	receptor	receptor	NOUN
aiua-10710	125	14	modulators	modulator	NOUN
aiua-10710	125	15	in	in	ADP
aiua-10710	125	16	peyronie	peyronie	NOUN
aiua-10710	125	17	’s	’s	PART
aiua-10710	125	18	disease	disease	NOUN
aiua-10710	125	19	models	model	NOUN
aiua-10710	125	20	.	.	PUNCT
aiua-10710	126	1	eur	eur	PROPN
aiua-10710	126	2	urol	urol	PROPN
aiua-10710	126	3	.	.	PUNCT
aiua-10710	127	1	2019	2019	NUM
aiua-10710	127	2	;	;	PUNCT
aiua-10710	128	1	75:329	75:329	NUM
aiua-10710	128	2	-	-	SYM
aiua-10710	128	3	340	340	NUM
aiua-10710	128	4	.	.	PUNCT
aiua-10710	128	5	8	8	NUM
aiua-10710	128	6	.	.	X
aiua-10710	128	7	kadioğlu	kadioğlu	PROPN
aiua-10710	128	8	a	a	PRON
aiua-10710	128	9	,	,	PUNCT
aiua-10710	128	10	tefekli	tefekli	NOUN
aiua-10710	128	11	a	a	X
aiua-10710	128	12	,	,	PUNCT
aiua-10710	128	13	erol	erol	PROPN
aiua-10710	128	14	h	h	NOUN
aiua-10710	128	15	,	,	PUNCT
aiua-10710	128	16	et	et	PROPN
aiua-10710	128	17	al	al	PROPN
aiua-10710	128	18	.	.	PUNCT
aiua-10710	128	19	color	color	NOUN
aiua-10710	128	20	doppler	doppler	NOUN
aiua-10710	128	21	ultrasound	ultrasound	NOUN
aiua-10710	128	22	assessment	assessment	NOUN
aiua-10710	128	23	of	of	ADP
aiua-10710	128	24	penile	penile	ADJ
aiua-10710	128	25	vascular	vascular	ADJ
aiua-10710	128	26	system	system	NOUN
aiua-10710	128	27	in	in	ADP
aiua-10710	128	28	men	man	NOUN
aiua-10710	128	29	with	with	ADP
aiua-10710	128	30	peyronie	peyronie	NOUN
aiua-10710	128	31	's	's	PART
aiua-10710	128	32	disease	disease	NOUN
aiua-10710	128	33	.	.	PUNCT
aiua-10710	129	1	int	int	PROPN
aiua-10710	129	2	j	j	PROPN
aiua-10710	129	3	impot	impot	NOUN
aiua-10710	129	4	res	re	NOUN
aiua-10710	129	5	.	.	PUNCT
aiua-10710	129	6	2000	2000	NUM
aiua-10710	129	7	;	;	PUNCT
aiua-10710	129	8	12:263	12:263	NUM
aiua-10710	129	9	-	-	SYM
aiua-10710	129	10	7	7	NUM
aiua-10710	129	11	9	9	NUM
aiua-10710	129	12	.	.	PUNCT
aiua-10710	130	1	vande	vande	PROPN
aiua-10710	130	2	berg	berg	PROPN
aiua-10710	130	3	js	js	PROPN
aiua-10710	130	4	,	,	PUNCT
aiua-10710	130	5	devine	devine	PROPN
aiua-10710	130	6	cj	cj	PROPN
aiua-10710	130	7	,	,	PUNCT
aiua-10710	130	8	horton	horton	PROPN
aiua-10710	130	9	ce	ce	PROPN
aiua-10710	130	10	,	,	PUNCT
aiua-10710	130	11	et	et	PROPN
aiua-10710	130	12	al	al	PROPN
aiua-10710	130	13	.	.	PROPN
aiua-10710	130	14	mechanisms	mechanism	NOUN
aiua-10710	130	15	of	of	ADP
aiua-10710	130	16	calcification	calcification	NOUN
aiua-10710	130	17	in	in	ADP
aiua-10710	130	18	peyronie	peyronie	NOUN
aiua-10710	130	19	's	's	PART
aiua-10710	130	20	disease	disease	NOUN
aiua-10710	130	21	.	.	PUNCT
aiua-10710	131	1	j	j	PROPN
aiua-10710	131	2	urol	urol	PROPN
aiua-10710	131	3	.	.	PUNCT
aiua-10710	131	4	1982	1982	NUM
aiua-10710	131	5	;	;	PUNCT
aiua-10710	131	6	127:52	127:52	NUM
aiua-10710	131	7	-	-	SYM
aiua-10710	131	8	54	54	NUM
aiua-10710	131	9	.	.	PUNCT
aiua-10710	132	1	10	10	NUM
aiua-10710	132	2	.	.	PUNCT
aiua-10710	133	1	ibrahim	ibrahim	PROPN
aiua-10710	133	2	a	a	PRON
aiua-10710	133	3	,	,	PUNCT
aiua-10710	133	4	gazzard	gazzard	NOUN
aiua-10710	133	5	l	l	NOUN
aiua-10710	133	6	,	,	PUNCT
aiua-10710	133	7	alharbi	alharbi	PROPN
aiua-10710	133	8	m	m	PROPN
aiua-10710	133	9	,	,	PUNCT
aiua-10710	133	10	et	et	PROPN
aiua-10710	133	11	al	al	PROPN
aiua-10710	133	12	.	.	PUNCT
aiua-10710	133	13	evaluation	evaluation	NOUN
aiua-10710	133	14	of	of	ADP
aiua-10710	133	15	oral	oral	ADJ
aiua-10710	133	16	pentoxifylline	pentoxifylline	NOUN
aiua-10710	133	17	,	,	PUNCT
aiua-10710	133	18	colchicine	colchicine	PROPN
aiua-10710	133	19	,	,	PUNCT
aiua-10710	133	20	and	and	CCONJ
aiua-10710	133	21	penile	penile	ADJ
aiua-10710	133	22	traction	traction	NOUN
aiua-10710	133	23	for	for	ADP
aiua-10710	133	24	the	the	DET
aiua-10710	133	25	management	management	NOUN
aiua-10710	133	26	of	of	ADP
aiua-10710	133	27	peyronie	peyronie	NOUN
aiua-10710	133	28	’s	’s	PART
aiua-10710	133	29	disease	disease	NOUN
aiua-10710	133	30	.	.	PUNCT
aiua-10710	134	1	sex	sex	NOUN
aiua-10710	134	2	med	med	PROPN
aiua-10710	134	3	.	.	PROPN
aiua-10710	134	4	2019	2019	NUM
aiua-10710	134	5	;	;	PUNCT
aiua-10710	134	6	7:459	7:459	X
aiua-10710	134	7	-	-	SYM
aiua-10710	134	8	63	63	NUM
aiua-10710	134	9	.	.	PUNCT
aiua-10710	135	1	11	11	NUM
aiua-10710	135	2	.	.	PUNCT
aiua-10710	136	1	hellstrom	hellstrom	NOUN
aiua-10710	136	2	wj	wj	PROPN
aiua-10710	136	3	,	,	PUNCT
aiua-10710	136	4	bivalacqua	bivalacqua	NOUN
aiua-10710	136	5	tj	tj	PROPN
aiua-10710	136	6	.	.	PROPN
aiua-10710	136	7	peyronie	peyronie	PROPN
aiua-10710	136	8	's	's	PART
aiua-10710	136	9	disease	disease	NOUN
aiua-10710	136	10	:	:	PUNCT
aiua-10710	136	11	etiology	etiology	NOUN
aiua-10710	136	12	,	,	PUNCT
aiua-10710	136	13	medical	medical	ADJ
aiua-10710	136	14	,	,	PUNCT
aiua-10710	136	15	and	and	CCONJ
aiua-10710	136	16	surgical	surgical	ADJ
aiua-10710	136	17	therapy	therapy	NOUN
aiua-10710	136	18	.	.	PUNCT
aiua-10710	137	1	j	j	PROPN
aiua-10710	137	2	androl	androl	PROPN
aiua-10710	137	3	2000	2000	NUM
aiua-10710	137	4	;	;	PUNCT
aiua-10710	137	5	21:347	21:347	NUM
aiua-10710	137	6	-	-	SYM
aiua-10710	137	7	354	354	NUM
aiua-10710	137	8	.	.	NOUN
aiua-10710	137	9	12	12	NUM
aiua-10710	137	10	.	.	PUNCT
aiua-10710	138	1	hatzimouratidis	hatzimouratidis	PROPN
aiua-10710	138	2	k	k	PROPN
aiua-10710	138	3	,	,	PUNCT
aiua-10710	138	4	eardley	eardley	PROPN
aiua-10710	138	5	i	i	PRON
aiua-10710	138	6	,	,	PUNCT
aiua-10710	138	7	giuliano	giuliano	PROPN
aiua-10710	138	8	f	f	PROPN
aiua-10710	138	9	,	,	PUNCT
aiua-10710	138	10	et	et	PROPN
aiua-10710	138	11	al	al	PROPN
aiua-10710	138	12	.	.	PUNCT
aiua-10710	139	1	eau	eau	PROPN
aiua-10710	139	2	guidelines	guideline	NOUN
aiua-10710	139	3	on	on	ADP
aiua-10710	139	4	penile	penile	ADJ
aiua-10710	139	5	curvature	curvature	NOUN
aiua-10710	139	6	.	.	PUNCT
aiua-10710	140	1	eur	eur	PROPN
aiua-10710	140	2	urol	urol	PROPN
aiua-10710	140	3	.	.	PUNCT
aiua-10710	140	4	2012	2012	NUM
aiua-10710	140	5	;	;	PUNCT
aiua-10710	140	6	62:543	62:543	NUM
aiua-10710	140	7	-	-	SYM
aiua-10710	140	8	52	52	NUM
aiua-10710	140	9	.	.	NOUN
aiua-10710	141	1	13	13	NUM
aiua-10710	141	2	.	.	PUNCT
aiua-10710	141	3	nehra	nehra	PROPN
aiua-10710	141	4	a	a	PROPN
aiua-10710	141	5	,	,	PUNCT
aiua-10710	141	6	alterowitz	alterowitz	NOUN
aiua-10710	141	7	r	r	NOUN
aiua-10710	141	8	,	,	PUNCT
aiua-10710	141	9	culkin	culkin	PROPN
aiua-10710	141	10	dj	dj	PROPN
aiua-10710	141	11	,	,	PUNCT
aiua-10710	141	12	et	et	PROPN
aiua-10710	141	13	al	al	PROPN
aiua-10710	141	14	.	.	PROPN
aiua-10710	141	15	peyronie	peyronie	PROPN
aiua-10710	141	16	’s	’s	PART
aiua-10710	141	17	disease	disease	NOUN
aiua-10710	141	18	:	:	PUNCT
aiua-10710	141	19	aua	aua	PROPN
aiua-10710	141	20	guideline	guideline	PROPN
aiua-10710	141	21	.	.	PUNCT
aiua-10710	142	1	j	j	PROPN
aiua-10710	142	2	urol	urol	PROPN
aiua-10710	142	3	.	.	PROPN
aiua-10710	143	1	2015	2015	NUM
aiua-10710	143	2	;	;	PUNCT
aiua-10710	144	1	194:745	194:745	NUM
aiua-10710	144	2	-	-	SYM
aiua-10710	144	3	753	753	NUM
aiua-10710	144	4	.	.	PUNCT
aiua-10710	145	1	14	14	NUM
aiua-10710	145	2	.	.	PUNCT
aiua-10710	146	1	chiao	chiao	PROPN
aiua-10710	146	2	tb	tb	PROPN
aiua-10710	146	3	,	,	PUNCT
aiua-10710	146	4	lee	lee	PROPN
aiua-10710	146	5	aj	aj	PROPN
aiua-10710	146	6	.	.	PROPN
aiua-10710	146	7	role	role	NOUN
aiua-10710	146	8	of	of	ADP
aiua-10710	146	9	pentoxifylline	pentoxifylline	NOUN
aiua-10710	146	10	and	and	CCONJ
aiua-10710	146	11	vitamin	vitamin	NOUN
aiua-10710	146	12	e	e	NOUN
aiua-10710	146	13	in	in	ADP
aiua-10710	146	14	attenuation	attenuation	NOUN
aiua-10710	146	15	of	of	ADP
aiua-10710	146	16	radiation	radiation	NOUN
aiua-10710	146	17	-	-	PUNCT
aiua-10710	146	18	induced	induce	VERB
aiua-10710	146	19	fibrosis	fibrosis	NOUN
aiua-10710	146	20	.	.	PUNCT
aiua-10710	147	1	ann	ann	PROPN
aiua-10710	147	2	pharmacother	pharmacother	PROPN
aiua-10710	147	3	.	.	PUNCT
aiua-10710	148	1	2005	2005	NUM
aiua-10710	148	2	;	;	PUNCT
aiua-10710	148	3	39:516	39:516	NUM
aiua-10710	148	4	-	-	SYM
aiua-10710	148	5	522	522	NUM
aiua-10710	148	6	.	.	PUNCT
aiua-10710	149	1	15	15	NUM
aiua-10710	149	2	.	.	PUNCT
aiua-10710	150	1	safarinejad	safarinejad	PROPN
aiua-10710	150	2	mr	mr	PROPN
aiua-10710	150	3	,	,	PUNCT
aiua-10710	150	4	asgari	asgari	PROPN
aiua-10710	150	5	ma	ma	PROPN
aiua-10710	150	6	,	,	PUNCT
aiua-10710	150	7	hosseini	hosseini	PROPN
aiua-10710	150	8	sy	sy	PROPN
aiua-10710	150	9	,	,	PUNCT
aiua-10710	150	10	farid	farid	PROPN
aiua-10710	150	11	d.	d.	PROPN
aiua-10710	150	12	a	a	DET
aiua-10710	150	13	double	double	ADJ
aiua-10710	150	14	-	-	PUNCT
aiua-10710	150	15	blind	blind	ADJ
aiua-10710	150	16	placebo	placebo	NOUN
aiua-10710	150	17	-	-	PUNCT
aiua-10710	150	18	controlled	control	VERB
aiua-10710	150	19	study	study	NOUN
aiua-10710	150	20	of	of	ADP
aiua-10710	150	21	the	the	DET
aiua-10710	150	22	efficacy	efficacy	NOUN
aiua-10710	150	23	and	and	CCONJ
aiua-10710	150	24	safety	safety	NOUN
aiua-10710	150	25	of	of	ADP
aiua-10710	150	26	pentoxifylline	pentoxifylline	NOUN
aiua-10710	150	27	in	in	ADP
aiua-10710	150	28	early	early	ADJ
aiua-10710	150	29	chronic	chronic	ADJ
aiua-10710	150	30	peyronie	peyronie	NOUN
aiua-10710	150	31	’s	’s	PART
aiua-10710	150	32	disease	disease	NOUN
aiua-10710	150	33	.	.	PUNCT
aiua-10710	151	1	bju	bju	NOUN
aiua-10710	151	2	int	int	PROPN
aiua-10710	151	3	.	.	PUNCT
aiua-10710	152	1	2009	2009	NUM
aiua-10710	152	2	;	;	PUNCT
aiua-10710	152	3	106:240	106:240	NOUN
aiua-10710	152	4	-	-	PUNCT
aiua-10710	152	5	248	248	NUM
aiua-10710	152	6	.	.	PUNCT
aiua-10710	153	1	16	16	NUM
aiua-10710	153	2	.	.	PUNCT
aiua-10710	154	1	alizadeh	alizadeh	PROPN
aiua-10710	154	2	m	m	PROPN
aiua-10710	154	3	,	,	PUNCT
aiua-10710	154	4	karimi	karimi	PROPN
aiua-10710	154	5	f	f	PROPN
aiua-10710	154	6	,	,	PUNCT
aiua-10710	154	7	fallah	fallah	PROPN
aiua-10710	154	8	mr	mr	PROPN
aiua-10710	154	9	.	.	PROPN
aiua-10710	154	10	evaluation	evaluation	NOUN
aiua-10710	154	11	of	of	ADP
aiua-10710	154	12	verapamil	verapamil	NOUN
aiua-10710	154	13	efficacy	efficacy	NOUN
aiua-10710	154	14	in	in	ADP
aiua-10710	154	15	peyronie	peyronie	NOUN
aiua-10710	154	16	's	's	PART
aiua-10710	154	17	disease	disease	NOUN
aiua-10710	154	18	comparing	compare	VERB
aiua-10710	154	19	with	with	ADP
aiua-10710	154	20	pentoxifylline	pentoxifylline	NOUN
aiua-10710	154	21	.	.	PUNCT
aiua-10710	155	1	glob	glob	PROPN
aiua-10710	155	2	j	j	PROPN
aiua-10710	155	3	health	health	PROPN
aiua-10710	155	4	sci	sci	PROPN
aiua-10710	155	5	.	.	PROPN
aiua-10710	155	6	2014	2014	NUM
aiua-10710	156	1	;	;	PUNCT
aiua-10710	156	2	6(7	6(7	NUM
aiua-10710	156	3	spec	spec	VERB
aiua-10710	156	4	no):23	no):23	AUX
aiua-10710	156	5	-	-	SYM
aiua-10710	156	6	30	30	NUM
aiua-10710	156	7	.	.	PUNCT
aiua-10710	156	8	17	17	NUM
aiua-10710	156	9	.	.	PUNCT
aiua-10710	157	1	brant	brant	PROPN
aiua-10710	157	2	wo	will	AUX
aiua-10710	157	3	,	,	PUNCT
aiua-10710	157	4	dean	dean	PROPN
aiua-10710	157	5	rc	rc	PROPN
aiua-10710	157	6	,	,	PUNCT
aiua-10710	157	7	lue	lue	PROPN
aiua-10710	157	8	tf	tf	PROPN
aiua-10710	157	9	.	.	PUNCT
aiua-10710	158	1	treatment	treatment	NOUN
aiua-10710	158	2	of	of	ADP
aiua-10710	158	3	peyronie	peyronie	NOUN
aiua-10710	158	4	's	's	PART
aiua-10710	158	5	disease	disease	NOUN
aiua-10710	158	6	with	with	ADP
aiua-10710	158	7	oral	oral	ADJ
aiua-10710	158	8	pentoxifylline	pentoxifylline	NOUN
aiua-10710	158	9	.	.	PUNCT
aiua-10710	159	1	nat	nat	PROPN
aiua-10710	159	2	clin	clin	PROPN
aiua-10710	159	3	pract	pract	PROPN
aiua-10710	159	4	urol	urol	PROPN
aiua-10710	159	5	.	.	PUNCT
aiua-10710	160	1	2006	2006	NUM
aiua-10710	160	2	;	;	PUNCT
aiua-10710	160	3	3:111	3:111	NUM
aiua-10710	160	4	-	-	SYM
aiua-10710	160	5	5	5	NUM
aiua-10710	160	6	.	.	NOUN
aiua-10710	160	7	18	18	NUM
aiua-10710	160	8	.	.	PUNCT
aiua-10710	160	9	prieto	prieto	PROPN
aiua-10710	160	10	castro	castro	PROPN
aiua-10710	160	11	rm	rm	PROPN
aiua-10710	160	12	,	,	PUNCT
aiua-10710	160	13	leva	leva	PROPN
aiua-10710	160	14	vallejo	vallejo	PROPN
aiua-10710	160	15	me	me	PROPN
aiua-10710	160	16	,	,	PUNCT
aiua-10710	160	17	regueiro	regueiro	PROPN
aiua-10710	160	18	lopez	lopez	PROPN
aiua-10710	160	19	jc	jc	PROPN
aiua-10710	160	20	,	,	PUNCT
aiua-10710	160	21	et	et	PROPN
aiua-10710	160	22	al	al	PROPN
aiua-10710	160	23	.	.	PROPN
aiua-10710	160	24	combined	combine	VERB
aiua-10710	160	25	treatment	treatment	NOUN
aiua-10710	160	26	with	with	ADP
aiua-10710	160	27	vitamin	vitamin	NOUN
aiua-10710	160	28	e	e	NOUN
aiua-10710	160	29	and	and	CCONJ
aiua-10710	160	30	colchicine	colchicine	PROPN
aiua-10710	160	31	in	in	ADP
aiua-10710	160	32	the	the	DET
aiua-10710	160	33	early	early	ADJ
aiua-10710	160	34	stages	stage	NOUN
aiua-10710	160	35	of	of	ADP
aiua-10710	160	36	peyronie	peyronie	NOUN
aiua-10710	160	37	's	's	PART
aiua-10710	160	38	disease	disease	NOUN
aiua-10710	160	39	.	.	PUNCT
aiua-10710	161	1	bju	bju	NOUN
aiua-10710	161	2	int	int	PROPN
aiua-10710	161	3	.	.	PUNCT
aiua-10710	162	1	2003	2003	NUM
aiua-10710	162	2	;	;	PUNCT
aiua-10710	162	3	91:522	91:522	NUM
aiua-10710	162	4	-	-	SYM
aiua-10710	163	1	4	4	NUM
aiua-10710	163	2	.	.	NOUN
aiua-10710	163	3	19	19	NUM
aiua-10710	163	4	.	.	PUNCT
aiua-10710	163	5	akkus	akkus	PUNCT
aiua-10710	164	1	e	e	X
aiua-10710	164	2	,	,	PUNCT
aiua-10710	164	3	breza	breza	PROPN
aiua-10710	164	4	j	j	PROPN
aiua-10710	164	5	,	,	PUNCT
aiua-10710	164	6	carrier	carrier	NOUN
aiua-10710	164	7	s	s	PART
aiua-10710	164	8	,	,	PUNCT
aiua-10710	164	9	et	et	PROPN
aiua-10710	164	10	al	al	PROPN
aiua-10710	164	11	.	.	PROPN
aiua-10710	164	12	is	be	AUX
aiua-10710	164	13	colchicine	colchicine	PROPN
aiua-10710	164	14	effective	effective	ADJ
aiua-10710	164	15	in	in	ADP
aiua-10710	164	16	peyronie	peyronie	NOUN
aiua-10710	164	17	’s	’s	PART
aiua-10710	164	18	disease	disease	NOUN
aiua-10710	164	19	?	?	PUNCT
aiua-10710	165	1	a	a	DET
aiua-10710	165	2	pilot	pilot	NOUN
aiua-10710	165	3	study	study	NOUN
aiua-10710	165	4	.	.	PUNCT
aiua-10710	166	1	urology	urology	NOUN
aiua-10710	166	2	.	.	PUNCT
aiua-10710	166	3	1994	1994	NUM
aiua-10710	166	4	;	;	PUNCT
aiua-10710	166	5	44:291	44:291	NUM
aiua-10710	166	6	-	-	SYM
aiua-10710	166	7	295	295	NUM
aiua-10710	166	8	.	.	PUNCT
aiua-10710	167	1	20	20	NUM
aiua-10710	167	2	.	.	PUNCT
aiua-10710	168	1	vernet	vernet	PROPN
aiua-10710	168	2	d	d	PROPN
aiua-10710	168	3	,	,	PUNCT
aiua-10710	168	4	magee	magee	PROPN
aiua-10710	168	5	t	t	PROPN
aiua-10710	168	6	,	,	PUNCT
aiua-10710	168	7	qian	qian	PROPN
aiua-10710	168	8	a	a	X
aiua-10710	168	9	,	,	PUNCT
aiua-10710	168	10	et	et	PROPN
aiua-10710	168	11	al	al	PROPN
aiua-10710	168	12	.	.	PROPN
aiua-10710	168	13	phosphodiesterase	phosphodiesterase	NOUN
aiua-10710	168	14	type	type	NOUN
aiua-10710	168	15	5	5	NUM
aiua-10710	168	16	is	be	AUX
aiua-10710	168	17	not	not	PART
aiua-10710	168	18	upregulated	upregulate	VERB
aiua-10710	168	19	by	by	ADP
aiua-10710	168	20	tadalafil	tadalafil	NOUN
aiua-10710	168	21	in	in	ADP
aiua-10710	168	22	cultures	culture	NOUN
aiua-10710	168	23	of	of	ADP
aiua-10710	168	24	human	human	ADJ
aiua-10710	168	25	penile	penile	NOUN
aiua-10710	168	26	cells	cell	NOUN
aiua-10710	168	27	.	.	PUNCT
aiua-10710	169	1	j	j	PROPN
aiua-10710	169	2	sex	sex	PROPN
aiua-10710	169	3	med	med	PROPN
aiua-10710	169	4	.	.	PUNCT
aiua-10710	169	5	2006	2006	NUM
aiua-10710	169	6	;	;	PUNCT
aiua-10710	169	7	3:84	3:84	NUM
aiua-10710	169	8	-	-	SYM
aiua-10710	169	9	94	94	NUM
aiua-10710	169	10	.	.	PUNCT
aiua-10710	170	1	21	21	NUM
aiua-10710	170	2	.	.	X
aiua-10710	171	1	el	el	NOUN
aiua-10710	171	2	-	-	PUNCT
aiua-10710	171	3	sakka	sakka	NOUN
aiua-10710	171	4	ai	ai	VERB
aiua-10710	171	5	,	,	PUNCT
aiua-10710	171	6	hassoba	hassoba	PROPN
aiua-10710	171	7	hm	hm	INTJ
aiua-10710	171	8	,	,	PUNCT
aiua-10710	171	9	pillarisetty	pillarisetty	PROPN
aiua-10710	171	10	rj	rj	PROPN
aiua-10710	171	11	,	,	PUNCT
aiua-10710	171	12	et	et	PROPN
aiua-10710	171	13	al	al	PROPN
aiua-10710	171	14	.	.	PROPN
aiua-10710	171	15	peyronie	peyronie	PROPN
aiua-10710	171	16	’s	’s	PART
aiua-10710	171	17	disease	disease	NOUN
aiua-10710	171	18	is	be	AUX
aiua-10710	171	19	associated	associate	VERB
aiua-10710	171	20	with	with	ADP
aiua-10710	171	21	an	an	DET
aiua-10710	171	22	increase	increase	NOUN
aiua-10710	171	23	in	in	ADP
aiua-10710	171	24	transforming	transform	VERB
aiua-10710	171	25	growth	growth	NOUN
aiua-10710	171	26	factorbeta	factorbeta	NOUN
aiua-10710	171	27	protein	protein	NOUN
aiua-10710	171	28	expression	expression	NOUN
aiua-10710	171	29	.	.	PUNCT
aiua-10710	172	1	j	j	PROPN
aiua-10710	172	2	urol	urol	PROPN
aiua-10710	172	3	.	.	PUNCT
aiua-10710	172	4	1997	1997	NUM
aiua-10710	172	5	;	;	PUNCT
aiua-10710	172	6	158:1391	158:1391	NUM
aiua-10710	172	7	-	-	SYM
aiua-10710	172	8	1394	1394	NUM
aiua-10710	172	9	.	.	PUNCT
aiua-10710	173	1	22	22	NUM
aiua-10710	173	2	.	.	X
aiua-10710	173	3	dunkern	dunkern	PROPN
aiua-10710	173	4	tr	tr	VERB
aiua-10710	173	5	,	,	PUNCT
aiua-10710	173	6	feurstein	feurstein	ADJ
aiua-10710	173	7	d	d	PROPN
aiua-10710	173	8	,	,	PUNCT
aiua-10710	173	9	rossi	rossi	PROPN
aiua-10710	173	10	ga	ga	PROPN
aiua-10710	173	11	,	,	PUNCT
aiua-10710	173	12	et	et	PROPN
aiua-10710	173	13	al	al	PROPN
aiua-10710	173	14	.	.	PROPN
aiua-10710	173	15	inhibition	inhibition	NOUN
aiua-10710	173	16	of	of	ADP
aiua-10710	173	17	tgf	tgf	PROPN
aiua-10710	173	18	-	-	PUNCT
aiua-10710	173	19	b	b	NOUN
aiua-10710	173	20	induced	induced	ADJ
aiua-10710	173	21	lung	lung	NOUN
aiua-10710	173	22	fibroblast	fibroblast	NOUN
aiua-10710	173	23	to	to	ADP
aiua-10710	173	24	myofibroblast	myofibroblast	NOUN
aiua-10710	173	25	conversion	conversion	NOUN
aiua-10710	173	26	by	by	ADP
aiua-10710	173	27	phosphodiesterase	phosphodiesterase	NOUN
aiua-10710	173	28	inhibiting	inhibit	VERB
aiua-10710	173	29	drugs	drug	NOUN
aiua-10710	173	30	and	and	CCONJ
aiua-10710	173	31	activators	activator	NOUN
aiua-10710	173	32	of	of	ADP
aiua-10710	173	33	soluble	soluble	ADJ
aiua-10710	173	34	guanylyl	guanylyl	ADJ
aiua-10710	173	35	cyclase	cyclase	NOUN
aiua-10710	173	36	.	.	PUNCT
aiua-10710	174	1	eur	eur	PROPN
aiua-10710	174	2	j	j	PROPN
aiua-10710	174	3	pharmacol	pharmacol	PROPN
aiua-10710	174	4	.	.	PUNCT
aiua-10710	175	1	2007	2007	NUM
aiua-10710	175	2	;	;	PUNCT
aiua-10710	175	3	572:12	572:12	NUM
aiua-10710	175	4	-	-	SYM
aiua-10710	175	5	22	22	NUM
aiua-10710	175	6	.	.	PUNCT
aiua-10710	176	1	23	23	NUM
aiua-10710	176	2	.	.	PUNCT
aiua-10710	177	1	wang	wang	PROPN
aiua-10710	177	2	-	-	PUNCT
aiua-10710	177	3	rosenke	rosenke	PROPN
aiua-10710	177	4	y	y	PROPN
aiua-10710	177	5	,	,	PUNCT
aiua-10710	177	6	neumayer	neumayer	NOUN
aiua-10710	177	7	hh	hh	PROPN
aiua-10710	177	8	,	,	PUNCT
aiua-10710	177	9	peters	peters	PROPN
aiua-10710	177	10	h.	h.	PROPN
aiua-10710	178	1	no	no	PRON
aiua-10710	178	2	signaling	signal	VERB
aiua-10710	178	3	through	through	ADP
aiua-10710	178	4	cgmp	cgmp	NOUN
aiua-10710	178	5	in	in	ADP
aiua-10710	178	6	renal	renal	ADJ
aiua-10710	178	7	tissue	tissue	NOUN
aiua-10710	178	8	fibrosis	fibrosis	NOUN
aiua-10710	178	9	and	and	CCONJ
aiua-10710	178	10	beyond	beyond	ADP
aiua-10710	178	11	:	:	PUNCT
aiua-10710	178	12	key	key	ADJ
aiua-10710	178	13	pathway	pathway	NOUN
aiua-10710	178	14	and	and	CCONJ
aiua-10710	178	15	novel	novel	ADJ
aiua-10710	178	16	therapeutic	therapeutic	ADJ
aiua-10710	178	17	target	target	NOUN
aiua-10710	178	18	.	.	PUNCT
aiua-10710	179	1	curr	curr	PROPN
aiua-10710	179	2	med	med	PROPN
aiua-10710	179	3	chem	chem	NOUN
aiua-10710	179	4	.	.	PUNCT
aiua-10710	179	5	2008	2008	NUM
aiua-10710	179	6	;	;	PUNCT
aiua-10710	179	7	15:1396	15:1396	NUM
aiua-10710	179	8	-	-	SYM
aiua-10710	179	9	1406	1406	NUM
aiua-10710	179	10	.	.	PUNCT
aiua-10710	180	1	24	24	NUM
aiua-10710	180	2	.	.	PUNCT
aiua-10710	180	3	valente	valente	PROPN
aiua-10710	180	4	eg	eg	PROPN
aiua-10710	180	5	,	,	PUNCT
aiua-10710	180	6	vernet	vernet	NOUN
aiua-10710	180	7	d	d	PROPN
aiua-10710	180	8	,	,	PUNCT
aiua-10710	180	9	ferrini	ferrini	NOUN
aiua-10710	180	10	mg	mg	PROPN
aiua-10710	180	11	,	,	PUNCT
aiua-10710	180	12	et	et	PROPN
aiua-10710	180	13	al	al	PROPN
aiua-10710	180	14	.	.	PUNCT
aiua-10710	181	1	l	l	NOUN
aiua-10710	181	2	-	-	NOUN
aiua-10710	181	3	arginine	arginine	NOUN
aiua-10710	181	4	and	and	CCONJ
aiua-10710	181	5	phosphodiesterase	phosphodiesterase	NOUN
aiua-10710	181	6	(	(	PUNCT
aiua-10710	181	7	pde	pde	NOUN
aiua-10710	181	8	)	)	PUNCT
aiua-10710	181	9	inhibitors	inhibitor	NOUN
aiua-10710	181	10	counteract	counteract	VERB
aiua-10710	181	11	fibrosis	fibrosis	NOUN
aiua-10710	181	12	in	in	ADP
aiua-10710	181	13	the	the	DET
aiua-10710	181	14	peyronie	peyronie	NOUN
aiua-10710	181	15	's	's	PART
aiua-10710	181	16	fibrotic	fibrotic	ADJ
aiua-10710	181	17	plaque	plaque	NOUN
aiua-10710	181	18	and	and	CCONJ
aiua-10710	181	19	related	relate	VERB
aiua-10710	181	20	fibroblast	fibroblast	ADJ
aiua-10710	181	21	cultures	culture	NOUN
aiua-10710	181	22	.	.	PUNCT
aiua-10710	182	1	nitric	nitric	ADJ
aiua-10710	182	2	oxide	oxide	NOUN
aiua-10710	182	3	.	.	PUNCT
aiua-10710	183	1	2003	2003	NUM
aiua-10710	183	2	;	;	PUNCT
aiua-10710	183	3	9:229	9:229	NUM
aiua-10710	183	4	-	-	SYM
aiua-10710	183	5	44	44	NUM
aiua-10710	183	6	.	.	PUNCT
aiua-10710	184	1	25	25	NUM
aiua-10710	184	2	.	.	PUNCT
aiua-10710	185	1	gholami	gholami	PROPN
aiua-10710	185	2	ss	ss	PROPN
aiua-10710	185	3	,	,	PUNCT
aiua-10710	185	4	gonzalez	gonzalez	PROPN
aiua-10710	185	5	-	-	PUNCT
aiua-10710	185	6	cadavid	cadavid	PROPN
aiua-10710	185	7	nf	nf	NOUN
aiua-10710	185	8	,	,	PUNCT
aiua-10710	185	9	lin	lin	PROPN
aiua-10710	185	10	cs	cs	PROPN
aiua-10710	185	11	,	,	PUNCT
aiua-10710	185	12	et	et	PROPN
aiua-10710	185	13	al	al	PROPN
aiua-10710	185	14	.	.	PROPN
aiua-10710	185	15	peyronie	peyronie	PROPN
aiua-10710	185	16	’s	’s	PART
aiua-10710	185	17	disease	disease	NOUN
aiua-10710	185	18	:	:	PUNCT
aiua-10710	185	19	a	a	DET
aiua-10710	185	20	review	review	NOUN
aiua-10710	185	21	.	.	PUNCT
aiua-10710	186	1	j	j	PROPN
aiua-10710	186	2	urol	urol	PROPN
aiua-10710	186	3	.	.	PUNCT
aiua-10710	186	4	2003	2003	NUM
aiua-10710	186	5	;	;	PUNCT
aiua-10710	186	6	169:1234	169:1234	NUM
aiua-10710	186	7	.	.	NOUN
aiua-10710	186	8	26	26	NUM
aiua-10710	186	9	.	.	PUNCT
aiua-10710	187	1	cakan	cakan	PROPN
aiua-10710	187	2	m	m	PROPN
aiua-10710	187	3	,	,	PUNCT
aiua-10710	187	4	akman	akman	PROPN
aiua-10710	187	5	t	t	PROPN
aiua-10710	187	6	,	,	PUNCT
aiua-10710	187	7	oktar	oktar	PROPN
aiua-10710	187	8	t	t	PROPN
aiua-10710	187	9	,	,	PUNCT
aiua-10710	187	10	et	et	PROPN
aiua-10710	187	11	al	al	PROPN
aiua-10710	187	12	.	.	PUNCT
aiua-10710	188	1	the	the	DET
aiua-10710	188	2	clinical	clinical	ADJ
aiua-10710	188	3	characteristics	characteristic	NOUN
aiua-10710	188	4	of	of	ADP
aiua-10710	188	5	peyronie	peyronie	NOUN
aiua-10710	188	6	's	's	PART
aiua-10710	188	7	patients	patient	NOUN
aiua-10710	188	8	with	with	ADP
aiua-10710	188	9	notching	notch	VERB
aiua-10710	188	10	deformity	deformity	NOUN
aiua-10710	188	11	.	.	PUNCT
aiua-10710	189	1	j	j	PROPN
aiua-10710	189	2	sex	sex	PROPN
aiua-10710	189	3	med	med	PROPN
aiua-10710	189	4	.	.	PUNCT
aiua-10710	189	5	2007	2007	NUM
aiua-10710	189	6	;	;	PUNCT
aiua-10710	189	7	4:1174	4:1174	NUM
aiua-10710	189	8	-	-	SYM
aiua-10710	189	9	1178	1178	NUM
aiua-10710	189	10	.	.	PUNCT
aiua-10710	190	1	27	27	NUM
aiua-10710	190	2	.	.	PUNCT
aiua-10710	191	1	chung	chung	PROPN
aiua-10710	191	2	e	e	PROPN
aiua-10710	191	3	,	,	PUNCT
aiua-10710	191	4	deyoung	deyoung	PROPN
aiua-10710	191	5	l	l	PROPN
aiua-10710	191	6	,	,	PUNCT
aiua-10710	191	7	brock	brock	PROPN
aiua-10710	191	8	gb	gb	PROPN
aiua-10710	191	9	.	.	PUNCT
aiua-10710	192	1	the	the	DET
aiua-10710	192	2	role	role	NOUN
aiua-10710	192	3	of	of	ADP
aiua-10710	192	4	pde5	pde5	NOUN
aiua-10710	192	5	inhibitors	inhibitor	NOUN
aiua-10710	192	6	in	in	ADP
aiua-10710	192	7	penile	penile	ADJ
aiua-10710	192	8	septal	septal	ADJ
aiua-10710	192	9	scar	scar	NOUN
aiua-10710	192	10	modeling	modeling	NOUN
aiua-10710	192	11	:	:	PUNCT
aiua-10710	192	12	assessment	assessment	NOUN
aiua-10710	192	13	of	of	ADP
aiua-10710	192	14	clinical	clinical	ADJ
aiua-10710	192	15	and	and	CCONJ
aiua-10710	192	16	radiological	radiological	ADJ
aiua-10710	192	17	outcomes	outcome	NOUN
aiua-10710	192	18	.	.	PUNCT
aiua-10710	193	1	j	j	PROPN
aiua-10710	193	2	sex	sex	PROPN
aiua-10710	193	3	med	med	PROPN
aiua-10710	193	4	.	.	PUNCT
aiua-10710	193	5	2011	2011	NUM
aiua-10710	193	6	;	;	PUNCT
aiua-10710	193	7	8:1472	8:1472	NUM
aiua-10710	193	8	-	-	SYM
aiua-10710	193	9	7	7	NUM
aiua-10710	193	10	.	.	NOUN
aiua-10710	193	11	28	28	NUM
aiua-10710	193	12	.	.	PUNCT
aiua-10710	194	1	ozturk	ozturk	PROPN
aiua-10710	194	2	u	u	PROPN
aiua-10710	194	3	,	,	PUNCT
aiua-10710	194	4	yesil	yesil	PROPN
aiua-10710	194	5	s	s	PROPN
aiua-10710	194	6	,	,	PUNCT
aiua-10710	194	7	goktug	goktug	PROPN
aiua-10710	194	8	hn	hn	PROPN
aiua-10710	194	9	,	,	PUNCT
aiua-10710	194	10	et	et	PROPN
aiua-10710	194	11	al	al	PROPN
aiua-10710	194	12	.	.	PUNCT
aiua-10710	195	1	effects	effect	NOUN
aiua-10710	195	2	of	of	ADP
aiua-10710	195	3	sildenafil	sildenafil	NOUN
aiua-10710	195	4	treatment	treatment	NOUN
aiua-10710	195	5	on	on	ADP
aiua-10710	195	6	patients	patient	NOUN
aiua-10710	195	7	with	with	ADP
aiua-10710	195	8	peyronie	peyronie	NOUN
aiua-10710	195	9	's	's	PART
aiua-10710	195	10	disease	disease	NOUN
aiua-10710	195	11	and	and	CCONJ
aiua-10710	195	12	erectile	erectile	ADJ
aiua-10710	195	13	dysfunction	dysfunction	NOUN
aiua-10710	195	14	.	.	PUNCT
aiua-10710	196	1	ir	ir	PROPN
aiua-10710	196	2	j	j	PROPN
aiua-10710	196	3	med	med	PROPN
aiua-10710	196	4	sci	sci	PROPN
aiua-10710	196	5	.	.	PROPN
aiua-10710	196	6	2014	2014	NUM
aiua-10710	196	7	;	;	PUNCT
aiua-10710	196	8	183:449	183:449	PROPN
aiua-10710	196	9	-	-	SYM
aiua-10710	196	10	53	53	NUM
aiua-10710	196	11	.	.	NOUN
aiua-10710	196	12	29	29	NUM
aiua-10710	196	13	.	.	PUNCT
aiua-10710	197	1	palmieri	palmieri	PROPN
aiua-10710	197	2	a	a	PROPN
aiua-10710	197	3	,	,	PUNCT
aiua-10710	197	4	imbimbo	imbimbo	PROPN
aiua-10710	197	5	c	c	NOUN
aiua-10710	197	6	,	,	PUNCT
aiua-10710	197	7	creta	creta	PROPN
aiua-10710	197	8	m	m	PROPN
aiua-10710	197	9	,	,	PUNCT
aiua-10710	197	10	et	et	PROPN
aiua-10710	197	11	al	al	PROPN
aiua-10710	197	12	.	.	PUNCT
aiua-10710	197	13	tadalafil	tadalafil	PROPN
aiua-10710	197	14	once	once	ADV
aiua-10710	197	15	daily	daily	ADJ
aiua-10710	197	16	and	and	CCONJ
aiua-10710	197	17	extracorporeal	extracorporeal	NOUN
aiua-10710	197	18	shock	shock	NOUN
aiua-10710	197	19	wave	wave	NOUN
aiua-10710	197	20	therapy	therapy	NOUN
aiua-10710	197	21	in	in	ADP
aiua-10710	197	22	the	the	DET
aiua-10710	197	23	management	management	NOUN
aiua-10710	197	24	of	of	ADP
aiua-10710	197	25	patients	patient	NOUN
aiua-10710	197	26	with	with	ADP
aiua-10710	197	27	peyronie	peyronie	NOUN
aiua-10710	197	28	’s	’s	PART
aiua-10710	197	29	disease	disease	NOUN
aiua-10710	197	30	and	and	CCONJ
aiua-10710	197	31	erectile	erectile	ADJ
aiua-10710	197	32	dysfunction	dysfunction	NOUN
aiua-10710	197	33	:	:	PUNCT
aiua-10710	197	34	results	result	NOUN
aiua-10710	197	35	from	from	ADP
aiua-10710	197	36	a	a	DET
aiua-10710	197	37	prospective	prospective	ADJ
aiua-10710	197	38	randomized	randomized	ADJ
aiua-10710	197	39	trial	trial	NOUN
aiua-10710	197	40	.	.	PUNCT
aiua-10710	198	1	int	int	PROPN
aiua-10710	199	1	j	j	PROPN
aiua-10710	199	2	androl	androl	PROPN
aiua-10710	199	3	.	.	PROPN
aiua-10710	199	4	2012	2012	NUM
aiua-10710	199	5	;	;	PUNCT
aiua-10710	199	6	35:190	35:190	NUM
aiua-10710	199	7	-	-	PUNCT
aiua-10710	199	8	195	195	NUM
aiua-10710	199	9	.	.	NOUN
aiua-10710	199	10	30	30	NUM
aiua-10710	199	11	.	.	PUNCT
aiua-10710	200	1	levine	levine	PROPN
aiua-10710	200	2	la	la	PROPN
aiua-10710	200	3	,	,	PUNCT
aiua-10710	200	4	greenfield	greenfield	PROPN
aiua-10710	200	5	jm	jm	PROPN
aiua-10710	200	6	.	.	PUNCT
aiua-10710	200	7	establishing	establish	VERB
aiua-10710	200	8	a	a	DET
aiua-10710	200	9	standardized	standardized	ADJ
aiua-10710	200	10	evaluation	evaluation	NOUN
aiua-10710	200	11	of	of	ADP
aiua-10710	200	12	the	the	DET
aiua-10710	200	13	man	man	NOUN
aiua-10710	200	14	with	with	ADP
aiua-10710	200	15	peyronie	peyronie	NOUN
aiua-10710	200	16	’s	’s	PART
aiua-10710	200	17	disease	disease	NOUN
aiua-10710	200	18	.	.	PUNCT
aiua-10710	201	1	int	int	PROPN
aiua-10710	201	2	j	j	PROPN
aiua-10710	201	3	impot	impot	NOUN
aiua-10710	201	4	res	re	NOUN
aiua-10710	201	5	.	.	PUNCT
aiua-10710	201	6	2003	2003	NUM
aiua-10710	201	7	;	;	PUNCT
aiua-10710	201	8	15	15	NUM
aiua-10710	201	9	:	:	PUNCT
aiua-10710	201	10	s103	s103	NOUN
aiua-10710	201	11	-	-	PUNCT
aiua-10710	201	12	s112	s112	PROPN
aiua-10710	201	13	.	.	PUNCT
aiua-10710	201	14	correspondence	correspondence	NOUN
aiua-10710	201	15	murat	murat	PROPN
aiua-10710	201	16	topcuoğlu	topcuoğlu	PROPN
aiua-10710	201	17	,	,	PUNCT
aiua-10710	201	18	md	md	PROPN
aiua-10710	201	19	muraturo@yahoo.com	muraturo@yahoo.com	PROPN
aiua-10710	201	20	assistant	assistant	PROPN
aiua-10710	201	21	professor	professor	NOUN
aiua-10710	201	22	,	,	PUNCT
aiua-10710	201	23	department	department	NOUN
aiua-10710	201	24	of	of	ADP
aiua-10710	201	25	urology	urology	NOUN
aiua-10710	201	26	,	,	PUNCT
aiua-10710	201	27	alaaddin	alaaddin	VERB
aiua-10710	201	28	keykubat	keykubat	PROPN
aiua-10710	201	29	university	university	PROPN
aiua-10710	201	30	,	,	PUNCT
aiua-10710	201	31	antalya	antalya	PROPN
aiua-10710	201	32	(	(	PUNCT
aiua-10710	201	33	turkey	turkey	PROPN
aiua-10710	201	34	)	)	PUNCT
aiua-10710	201	35	murat	murat	PROPN
aiua-10710	201	36	çakan	çakan	PROPN
aiua-10710	201	37	,	,	PUNCT
aiua-10710	201	38	md	md	PROPN
aiua-10710	201	39	muratcakandr@yahoo.com	muratcakandr@yahoo.com	PROPN
aiua-10710	201	40	department	department	PROPN
aiua-10710	201	41	of	of	ADP
aiua-10710	201	42	urology	urology	NOUN
aiua-10710	201	43	,	,	PUNCT
aiua-10710	201	44	dışkapı	dışkapı	PROPN
aiua-10710	201	45	yıldırım	yıldırım	NOUN
aiua-10710	201	46	beyazıt	beyazıt	NOUN
aiua-10710	201	47	training	training	NOUN
aiua-10710	201	48	and	and	CCONJ
aiua-10710	201	49	research	research	NOUN
aiua-10710	201	50	hospital	hospital	NOUN
aiua-10710	201	51	,	,	PUNCT
aiua-10710	201	52	ankara	ankara	PROPN
aiua-10710	201	53	(	(	PUNCT
aiua-10710	201	54	turkey	turkey	PROPN
aiua-10710	201	55	)	)	PUNCT